Hugo_Symbol	Entrez_Gene_Id	Center	NCBI_Build	Chromosome	Start_position	End_position	Strand	Variant_Classification	Variant_Type	Reference_Allele	Tumor_Seq_Allele1	Tumor_Seq_Allele2	dbSNP_RS	dbSNP_Val_Status	Tumor_Sample_Barcode	Matched_Norm_Sample_Barcode	Match_Norm_Seq_Allele1	Match_Norm_Seq_Allele2	Tumor_Validation_Allele1	Tumor_Validation_Allele2	Match_Norm_Validation_Allele1	Match_Norm_Validation_Allele2	Verification_Status	Validation_Status	Mutation_Status	Sequencing_Phase	Sequence_Source	Validation_Method	Score	BAM_file	Sequencer	Tumor_Sample_UUID	Matched_Norm_Sample_UUID	Genome_Change	Annotation_Transcript	Transcript_Strand	Transcript_Exon	Transcript_Position	cDNA_Change	Codon_Change	Protein_Change	Other_Transcripts	Refseq_mRNA_Id	Refseq_prot_Id	SwissProt_acc_Id	SwissProt_entry_Id	Description	UniProt_AApos	UniProt_Region	UniProt_Site	UniProt_Natural_Variations	UniProt_Experimental_Info	GO_Biological_Process	GO_Cellular_Component	GO_Molecular_Function	COSMIC_overlapping_mutations	COSMIC_fusion_genes	COSMIC_tissue_types_affected	COSMIC_total_alterations_in_gene	Tumorscape_Amplification_Peaks	Tumorscape_Deletion_Peaks	TCGAscape_Amplification_Peaks	TCGAscape_Deletion_Peaks	DrugBank	ref_context	gc_content	CCLE_ONCOMAP_overlapping_mutations	CCLE_ONCOMAP_total_mutations_in_gene	CGC_Mutation_Type	CGC_Translocation_Partner	CGC_Tumor_Types_Somatic	CGC_Tumor_Types_Germline	CGC_Other_Diseases	DNARepairGenes_Role	FamilialCancerDatabase_Syndromes	MUTSIG_Published_Results	OREGANNO_ID	OREGANNO_Values	i_1000Genome_AA	i_1000Genome_AC	i_1000Genome_AF	i_1000Genome_AFR_AF	i_1000Genome_AMR_AF	i_1000Genome_AN	i_1000Genome_ASN_AF	i_1000Genome_AVGPOST	i_1000Genome_CIEND	i_1000Genome_CIPOS	i_1000Genome_END	i_1000Genome_ERATE	i_1000Genome_EUR_AF	i_1000Genome_HOMLEN	i_1000Genome_HOMSEQ	i_1000Genome_LDAF	i_1000Genome_RSQ	i_1000Genome_SNPSOURCE	i_1000Genome_SVLEN	i_1000Genome_SVTYPE	i_1000Genome_THETA	i_1000Genome_VT	i_ACHILLES_Lineage_Results_Top_Genes	i_CGC_CancerGermlineMut	i_CGC_CancerMolecularGenetics	i_CGC_CancerSomaticMut	i_CGC_CancerSyndrome	i_CGC_Chr	i_CGC_ChrBand	i_CGC_GeneID	i_CGC_Name	i_CGC_OtherGermlineMut	i_CGC_TissueType	i_COSMIC_n_overlapping_mutations	i_COSMIC_overlapping_mutation_descriptions	i_COSMIC_overlapping_primary_sites	i_ClinVar_ASSEMBLY	i_ClinVar_HGMD_ID	i_ClinVar_SYM	i_ClinVar_TYPE	i_ClinVar_rs	i_ESP_AA	i_ESP_AAC	i_ESP_AA_AC	i_ESP_AA_AGE	i_ESP_AA_GTC	i_ESP_AvgAAsampleReadDepth	i_ESP_AvgEAsampleReadDepth	i_ESP_AvgSampleReadDepth	i_ESP_CA	i_ESP_CDP	i_ESP_CG	i_ESP_CP	i_ESP_Chromosome	i_ESP_DBSNP	i_ESP_DP	i_ESP_EA_AC	i_ESP_EA_AGE	i_ESP_EA_GTC	i_ESP_EXOME_CHIP	i_ESP_FG	i_ESP_GL	i_ESP_GM	i_ESP_GS	i_ESP_GTC	i_ESP_GTS	i_ESP_GWAS_PUBMED	i_ESP_MAF	i_ESP_PH	i_ESP_PP	i_ESP_Position	i_ESP_TAC	i_ESP_TotalAAsamplesCovered	i_ESP_TotalEAsamplesCovered	i_ESP_TotalSamplesCovered	i_Ensembl_so_accession	i_Ensembl_so_term	i_Familial_Cancer_Genes_Reference	i_Familial_Cancer_Genes_Synonym	i_HGNC_EnsemblGeneID	i_HGNC_HGNCID	i_HGNC_RefSeqIDs	i_HGNC_Status	i_HGNC_UCSCIDsuppliedbyUCSC	i_ORegAnno_bin	i_UniProt_alt_uniprot_accessions	i_annotation_transcript	i_build	i_ccds_id	i_dbNSFP_1000Gp1_AC	i_dbNSFP_1000Gp1_AF	i_dbNSFP_1000Gp1_AFR_AC	i_dbNSFP_1000Gp1_AFR_AF	i_dbNSFP_1000Gp1_AMR_AC	i_dbNSFP_1000Gp1_AMR_AF	i_dbNSFP_1000Gp1_ASN_AC	i_dbNSFP_1000Gp1_ASN_AF	i_dbNSFP_1000Gp1_EUR_AC	i_dbNSFP_1000Gp1_EUR_AF	i_dbNSFP_Ancestral_allele	i_dbNSFP_CADD_phred	i_dbNSFP_CADD_raw	i_dbNSFP_CADD_raw_rankscore	i_dbNSFP_ESP6500_AA_AF	i_dbNSFP_ESP6500_EA_AF	i_dbNSFP_Ensembl_geneid	i_dbNSFP_Ensembl_transcriptid	i_dbNSFP_FATHMM_pred	i_dbNSFP_FATHMM_rankscore	i_dbNSFP_FATHMM_score	i_dbNSFP_GERP_NR	i_dbNSFP_GERP_RS	i_dbNSFP_GERP_RS_rankscore	i_dbNSFP_Interpro_domain	i_dbNSFP_LRT_Omega	i_dbNSFP_LRT_converted_rankscore	i_dbNSFP_LRT_pred	i_dbNSFP_LRT_score	i_dbNSFP_LR_pred	i_dbNSFP_LR_rankscore	i_dbNSFP_LR_score	i_dbNSFP_MutationAssessor_pred	i_dbNSFP_MutationAssessor_rankscore	i_dbNSFP_MutationAssessor_score	i_dbNSFP_MutationTaster_converted_rankscore	i_dbNSFP_MutationTaster_pred	i_dbNSFP_MutationTaster_score	i_dbNSFP_Polyphen2_HDIV_pred	i_dbNSFP_Polyphen2_HDIV_rankscore	i_dbNSFP_Polyphen2_HDIV_score	i_dbNSFP_Polyphen2_HVAR_pred	i_dbNSFP_Polyphen2_HVAR_rankscore	i_dbNSFP_Polyphen2_HVAR_score	i_dbNSFP_RadialSVM_pred	i_dbNSFP_RadialSVM_rankscore	i_dbNSFP_RadialSVM_score	i_dbNSFP_Reliability_index	i_dbNSFP_SIFT_converted_rankscore	i_dbNSFP_SIFT_pred	i_dbNSFP_SIFT_score	i_dbNSFP_SLR_test_statistic	i_dbNSFP_SiPhy_29way_logOdds	i_dbNSFP_SiPhy_29way_logOdds_rankscore	i_dbNSFP_SiPhy_29way_pi	i_dbNSFP_UniSNP_ids	i_dbNSFP_Uniprot_aapos	i_dbNSFP_Uniprot_acc	i_dbNSFP_Uniprot_id	i_dbNSFP_aaalt	i_dbNSFP_aapos	i_dbNSFP_aapos_FATHMM	i_dbNSFP_aapos_SIFT	i_dbNSFP_aaref	i_dbNSFP_cds_strand	i_dbNSFP_codonpos	i_dbNSFP_folddegenerate	i_dbNSFP_genename	i_dbNSFP_hg18_pos1coor	i_dbNSFP_phastCons100way_vertebrate	i_dbNSFP_phastCons100way_vertebrate_rankscore	i_dbNSFP_phastCons46way_placental	i_dbNSFP_phastCons46way_placental_rankscore	i_dbNSFP_phastCons46way_primate	i_dbNSFP_phastCons46way_primate_rankscore	i_dbNSFP_phyloP100way_vertebrate	i_dbNSFP_phyloP100way_vertebrate_rankscore	i_dbNSFP_phyloP46way_placental	i_dbNSFP_phyloP46way_placental_rankscore	i_dbNSFP_phyloP46way_primate	i_dbNSFP_phyloP46way_primate_rankscore	i_dbNSFP_refcodon	i_gencode_transcript_name	i_gencode_transcript_status	i_gencode_transcript_tags	i_gencode_transcript_type	i_gene_id	i_gene_type	i_havana_transcript	i_init_t_lod	i_judgement	i_secondary_variant_classification	i_strand	i_t_lod_fstar	i_tumor_f	t_alt_count	t_ref_count	validation_alt_allele	validation_method	validation_status	validation_tumor_sample	validation_judgement_rna	validation_power_rna	validation_tumor_alt_count_rna	validation_tumor_ref_count_rna	validation_normal_alt_count_rna	validation_normal_ref_count_rna	discovery_tumor_alt_count_rna	discovery_tumor_ref_count_rna	discovery_normal_alt_count_rna	discovery_normal_ref_count_rna	min_val_count_rna	validation_judgement_targeted	validation_power_targeted	validation_tumor_alt_count_targeted	validation_tumor_ref_count_targeted	validation_normal_alt_count_targeted	validation_normal_ref_count_targeted	discovery_tumor_alt_count_targeted	discovery_tumor_ref_count_targeted	discovery_normal_alt_count_targeted	discovery_normal_ref_count_targeted	min_val_count_targeted	validation_status_consensus
KIF1B	23095	broad.mit.edu	37	1	10356638	10356638	+	Splice_Site	SNP	A	A	T			GBM-TCGA-06-2559-Tumor-SM-16Y9G	GBM-TCGA-06-2559-Normal-SM-1QXN8	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-06-2559-Tumor-SM-16Y9G	GBM-TCGA-06-2559-Normal-SM-1QXN8	g.chr1:10356638A>T	ENST00000377086.1	+	20	1979		c.e20-1		KIF1B_ENST00000377081.1_Splice_Site|KIF1B_ENST00000263934.6_Splice_Site|RNU6-37P_ENST00000362692.1_RNA|KIF1B_ENST00000377093.4_Splice_Site|KIF1B_ENST00000377083.1_Splice_Site			O60333	KIF1B_HUMAN	kinesin family member 1B	NA		NA			anterograde axon cargo transport|apoptosis|neuromuscular synaptic transmission|neuron-neuron synaptic transmission	cytoplasmic vesicle membrane|microtubule|microtubule associated complex|mitochondrion	ATP binding|ATPase activity|kinesin binding|microtubule motor activity|protein binding			breast(2)|endometrium(7)|kidney(8)|large_intestine(9)|lung(29)|ovary(3)|prostate(3)|skin(5)|stomach(3)|upper_aerodigestive_tract(2)	71	Ovarian(185;0.203)	all_lung(284;1.31e-05)|Lung NSC(185;2.2e-05)|Renal(390;0.000147)|Breast(348;0.00093)|Colorectal(325;0.00205)|Hepatocellular(190;0.00913)|Ovarian(437;0.0228)|Myeloproliferative disorder(586;0.0255)		UCEC - Uterine corpus endometrioid carcinoma (279;0.0259)|Colorectal(212;9.79e-07)|COAD - Colon adenocarcinoma(227;0.000143)|BRCA - Breast invasive adenocarcinoma(304;0.000413)|Kidney(185;0.00134)|KIRC - Kidney renal clear cell carcinoma(229;0.0037)|STAD - Stomach adenocarcinoma(132;0.0113)|READ - Rectum adenocarcinoma(331;0.0642)		TGTTCCTCTTAGTTATCGTGA	0.433	NA	NA												NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA									NA				0													87	81	83	NA		NA	NA	1		NA											NA				10356638		2203	4300	6503	SO:0001630	splice_region_variant			ENSG00000054523	HGNC:16636		Approved	uc001aqw.4	NA	A6NFS8|A6NKQ4|Q4VXC3|Q4VXC5|Q4VXC6|Q96Q94|Q9BV80|Q9P280	ENST00000377086.1	37		.	.	.	.	.	.	.	.	.	.	A	25.2	4.616718	0.87359	.	.	ENSG00000054523	ENST00000355249;ENST00000263934;ENST00000377093;ENST00000377086;ENST00000377083;ENST00000377081	.	.	.	5.81	5.81	0.92471	.	.	.	.	.	.	.	.	.	.	.	0.80722	D	1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	16.1699	0.81801	1.0:0.0:0.0:0.0	.	.	.	.	.	-1	.	.	.	+	.	.	KIF1B	10279225	1.000000	0.71417	1.000000	0.80357	0.990000	0.78478	6.273000	0.72581	2.217000	0.71921	0.533000	0.62120	.	KIF1B-001	NOVEL	basic	protein_coding	NA	protein_coding	OTTHUMT00000005102.1	-12.611595	KEEP	Intron	+	7.247519	0.053191	5	89	---	---	---	---	1	0.6744909	50	0	0	60	5	111	0	60	2	0	0	0	0	0	0	5	111	0	60	2	TP
IFI6	2537	broad.mit.edu	37	1	27992966	27992966	+	Missense_Mutation	SNP	C	C	T	rs74937564		GBM-TCGA-06-2559-Tumor-SM-16Y9G	GBM-TCGA-06-2559-Normal-SM-1QXN8	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-06-2559-Tumor-SM-16Y9G	GBM-TCGA-06-2559-Normal-SM-1QXN8	g.chr1:27992966C>T	ENST00000361157.6	-	5	446	c.319G>A	c.(319-321)Gtc>Atc	p.V107I	IFI6_ENST00000339145.4_Missense_Mutation_p.V115I|IFI6_ENST00000362020.4_Missense_Mutation_p.V111I	NM_002038.3|NM_022872.2|NM_022873.2	NP_002029.3|NP_075010.1|NP_075011.1	P09912	IFI6_HUMAN	interferon, alpha-inducible protein 6	107		NA			anti-apoptosis|negative regulation of caspase activity|negative regulation of mitochondrial depolarization|release of cytochrome c from mitochondria|type I interferon-mediated signaling pathway	integral to membrane|mitochondrion	protein binding			lung(1)|ovary(1)	2		Colorectal(325;3.46e-05)|all_lung(284;4.29e-05)|Lung NSC(340;7.75e-05)|Renal(390;0.00121)|Breast(348;0.0021)|Ovarian(437;0.00503)|Myeloproliferative disorder(586;0.0255)|all_neural(195;0.0381)		UCEC - Uterine corpus endometrioid carcinoma (279;0.0416)|OV - Ovarian serous cystadenocarcinoma(117;1.11e-24)|Colorectal(126;1.24e-08)|COAD - Colon adenocarcinoma(152;1.7e-06)|BRCA - Breast invasive adenocarcinoma(304;0.00244)|KIRC - Kidney renal clear cell carcinoma(1967;0.0027)|STAD - Stomach adenocarcinoma(196;0.00303)|READ - Rectum adenocarcinoma(331;0.0419)		TTACCTATGACGACGCTGCTG	0.542	NA	NA											c	1	5e-04	0.002	NA	2184	NA	1	,	,	NA	3e-04	NA	NA	NA	5e-04	1	LOWCOV	NA	NA	0.0013	SNP								NA				0								T	ILE/VAL,ILE/VAL,ILE/VAL	3,4403	6.2+/-15.9	0,3,2200	69	61	64	NA	319,331,343	-2	0	1	dbSNP_131	64	0,8600		0,0,4300	no	missense,missense,missense	IFI6	NM_002038.3,NM_022872.2,NM_022873.2	29,29,29	0,3,6500	TT,TC,CC	NA	0.0,0.0681,0.0231	benign,benign,benign	107/131,111/135,115/139	27992966	3,13003	2203	4300	6503	SO:0001583	missense			ENSG00000126709	HGNC:4054	NM_022873	Approved	uc001bon.1	NA	Q13141|Q13142|Q5VVR3|Q969M8	ENST00000361157.6	37	CCDS306.1	1	4.578754578754579E-4	1	0.0020325203252032522	0	0.0	0	0.0	0	0.0	c	0.016	-1.514999	0.00975	6.81E-4	0.0	ENSG00000126709	ENST00000361157;ENST00000339145;ENST00000362020	T;T;T	0.31769	1.48;1.48;1.48	3.29	-1.97	0.07503	.	1.364740	0.05149	N	0.495686	T	0.12518	0.0304	N	0.05050	-0.12	0.09310	N	1	B;B;B	0.02656	0.0;0.0;0.0	B;B;B	0.01281	0.0;0.0;0.0	T	0.26224	-1.0109	10	0.07325	T	0.83	.	6.6641	0.23031	0.0:0.3023:0.2523:0.4455	.	111;107;115	Q5VVR2;P09912;P09912-3	.;IFI6_HUMAN;.	I	107;115;111	ENSP00000354736:V107I;ENSP00000342513:V115I;ENSP00000355152:V111I	ENSP00000342513:V115I	V	-	1	0	IFI6	27865553	0.023000	0.18921	0.000000	0.03702	0.000000	0.00434	-0.541000	0.06099	-0.417000	0.07461	-1.841000	0.00585	GTC	IFI6-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000009780.1	49.045962	KEEP		-	88.957292	0.122378	35	251	---	---	---	---	1	1	94	784	0	64	52	317	0	64	2	0	0	0	0	0	0	52	317	0	64	2	TP
GMEB1	10691	broad.mit.edu	37	1	29019452	29019452	+	Splice_Site	SNP	A	A	T			GBM-TCGA-06-2559-Tumor-SM-16Y9G	GBM-TCGA-06-2559-Normal-SM-1QXN8	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-06-2559-Tumor-SM-16Y9G	GBM-TCGA-06-2559-Normal-SM-1QXN8	g.chr1:29019452A>T	ENST00000373816.1	+	5	474		c.e5-1		GMEB1_ENST00000361872.4_Splice_Site|GMEB1_ENST00000294409.2_Splice_Site|GMEB1_ENST00000480454.1_Splice_Site	NM_024482.2	NP_077808.1	Q9Y692	GMEB1_HUMAN	glucocorticoid modulatory element binding protein 1	NA		NA			regulation of transcription, DNA-dependent|transcription, DNA-dependent	cytoplasm|nucleus	DNA binding|metal ion binding|transcription coactivator activity			endometrium(1)|haematopoietic_and_lymphoid_tissue(1)|large_intestine(5)|lung(4)	11		Colorectal(325;3.46e-05)|Lung NSC(340;0.000451)|all_lung(284;0.00063)|Breast(348;0.00502)|Renal(390;0.00555)|all_neural(195;0.0227)|Myeloproliferative disorder(586;0.0255)|Ovarian(437;0.0563)|Medulloblastoma(700;0.123)		Colorectal(126;2.96e-08)|COAD - Colon adenocarcinoma(152;1.7e-06)|STAD - Stomach adenocarcinoma(196;0.00299)|BRCA - Breast invasive adenocarcinoma(304;0.0221)|KIRC - Kidney renal clear cell carcinoma(1967;0.0296)|READ - Rectum adenocarcinoma(331;0.0649)		TTTTACTTTTAGTTCAATGAT	0.403	NA	NA												NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA									NA				0													110	101	104	NA		NA	NA	1		NA											NA				29019452		2203	4300	6503	SO:0001630	splice_region_variant			ENSG00000162419	HGNC:4370	NM_006582	Approved	uc001bra.3	NA	B1AT48|Q9NWH1|Q9UKD0	ENST00000373816.1	37	CCDS328.1	.	.	.	.	.	.	.	.	.	.	A	24.4	4.528904	0.85706	.	.	ENSG00000162419	ENST00000373816;ENST00000456852;ENST00000361872;ENST00000294409	.	.	.	6.02	6.02	0.97574	.	.	.	.	.	.	.	.	.	.	.	0.80722	D	1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	15.5272	0.75919	1.0:0.0:0.0:0.0	.	.	.	.	.	-1	.	.	.	+	.	.	GMEB1	28892039	1.000000	0.71417	0.996000	0.52242	0.912000	0.54170	7.283000	0.78640	2.311000	0.77944	0.533000	0.62120	.	GMEB1-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000010331.1	-16.089136	KEEP	Intron	+	12.600253	0.051852	7	128	---	---	---	---	1	0.3306019	23	0	0	93	7	146	0	93	2	0	0	0	0	0	0	7	146	0	93	2	TP
RBBP4	5928	broad.mit.edu	37	1	33149774	33149774	+	3'UTR	SNP	G	G	T			GBM-TCGA-06-2559-Tumor-SM-16Y9G	GBM-TCGA-06-2559-Normal-SM-1QXN8	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-06-2559-Tumor-SM-16Y9G	GBM-TCGA-06-2559-Normal-SM-1QXN8	g.chr1:33149774G>T	ENST00000373493.5	+	0	5905				SYNC_ENST00000409190.3_Intron|SYNC_ENST00000373484.3_Intron	NM_001135255.1|NM_005610.2	NP_001128727.1|NP_005601.1	Q09028	RBBP4_HUMAN	retinoblastoma binding protein 4	NA		NA			cell cycle|CenH3-containing nucleosome assembly at centromere|DNA replication|negative regulation of cell proliferation|regulation of transcription, DNA-dependent|transcription, DNA-dependent	CAF-1 complex|ESC/E(Z) complex|NuRD complex|NURF complex|Sin3 complex	histone binding|histone deacetylase binding			breast(1)|central_nervous_system(1)|endometrium(1)|haematopoietic_and_lymphoid_tissue(1)|kidney(1)|lung(4)|ovary(1)|prostate(4)|urinary_tract(1)	15		Myeloproliferative disorder(586;0.0255)|all_neural(195;0.0837)				TTTTGTTTTTGATTCTAAGGT	0.378	NA	NA												NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA									NA				0													NA	NA	NA	NA		NA	NA			NA											NA				NA		NA	NA	NA	SO:0001624	3_prime_UTR_variant			ENSG00000162521	HGNC:9887	NM_005610	Approved	uc001bvr.3	NA	B2R6G9|B4DRH0|D3DPQ3|P31149|Q53H02|Q96BV9	ENST00000373493.5	37	CCDS366.1																																																																																			RBBP4-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000021957.3	-97.025868	KEEP		+	6.693574	0.015424	6	383	---	---	---	---	1	0.4190195	19	64	0	561	7	444	0	561	2	0	0	0	0	0	0	7	444	0	561	2	TP
LRRC40	55631	broad.mit.edu	37	1	70641517	70641517	+	Missense_Mutation	SNP	T	T	G			GBM-TCGA-06-2559-Tumor-SM-16Y9G	GBM-TCGA-06-2559-Normal-SM-1QXN8	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-06-2559-Tumor-SM-16Y9G	GBM-TCGA-06-2559-Normal-SM-1QXN8	g.chr1:70641517T>G	ENST00000370952.3	-	7	1032	c.953A>C	c.(952-954)gAc>gCc	p.D318A		NM_017768.4	NP_060238.3	Q9H9A6	LRC40_HUMAN	leucine rich repeat containing 40	318		NA								breast(1)|cervix(1)|endometrium(2)|haematopoietic_and_lymphoid_tissue(1)|kidney(3)|large_intestine(5)|lung(10)|ovary(1)|prostate(1)|skin(2)	27						GTTGCTTAGGTCAAGCCTTTC	0.289	NA	NA												NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA									NA				0													80	78	79	NA		NA	NA	1		NA											NA				70641517		2201	4299	6500	SO:0001583	missense			ENSG00000066557	HGNC:26004	NM_017768	Approved	uc001der.2	NA	Q9BTR7|Q9NSK1|Q9NXC1	ENST00000370952.3	37	CCDS646.1	.	.	.	.	.	.	.	.	.	.	T	23.0	4.362931	0.82353	.	.	ENSG00000066557	ENST00000370952	T	0.60299	0.2	5.46	5.46	0.80206	.	0.000000	0.85682	D	0.000000	T	0.73845	0.3639	M	0.86502	2.82	0.80722	D	1	D	0.76494	0.999	D	0.75020	0.985	T	0.78710	-0.2098	10	0.54805	T	0.06	.	15.197	0.73100	0.0:0.0:0.0:1.0	.	318	Q9H9A6	LRC40_HUMAN	A	318	ENSP00000359990:D318A	ENSP00000359990:D318A	D	-	2	0	LRRC40	70414105	1.000000	0.71417	1.000000	0.80357	0.990000	0.78478	7.392000	0.79840	2.075000	0.62263	0.477000	0.44152	GAC	LRRC40-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000025914.1	49.31453	KEEP		-	50.180491	0.348837	15	28	---	---	---	---	1	0.9999987	29	35	0	90	15	29	0	90	2	0	0	0	0	0	0	15	29	0	90	2	TP
NEXN	91624	broad.mit.edu	37	1	78392171	78392171	+	Missense_Mutation	SNP	A	A	T			GBM-TCGA-06-2559-Tumor-SM-16Y9G	GBM-TCGA-06-2559-Normal-SM-1QXN8	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-06-2559-Tumor-SM-16Y9G	GBM-TCGA-06-2559-Normal-SM-1QXN8	g.chr1:78392171A>T	ENST00000330010.8	+	6	667	c.370A>T	c.(370-372)Aat>Tat	p.N124Y	NEXN_ENST00000334785.7_Missense_Mutation_p.N188Y|NEXN_ENST00000457030.1_Missense_Mutation_p.N174Y	NM_001172309.1	NP_001165780.1	Q0ZGT2	NEXN_HUMAN	nexilin (F actin binding protein)	188	Glu-rich.	NA			regulation of cell migration|regulation of cytoskeleton organization	cytoskeleton|Z disc	actin filament binding|structural constituent of muscle			breast(2)|central_nervous_system(1)|endometrium(5)|kidney(2)|large_intestine(5)|lung(7)|ovary(3)|prostate(2)|skin(2)|upper_aerodigestive_tract(1)	30				Colorectal(170;0.114)		AATGAAAAAGAATTTTGAGGA	0.313	NA	NA												NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA									NA				0													72	70	71	NA		NA	NA	1		NA											NA				78392171		1802	4063	5865	SO:0001583	missense			ENSG00000162614	HGNC:29557	NM_144573	Approved	uc001dic.4	NA	A0PJ84|Q0D2H2|Q14CC2|Q14CC3|Q16081|Q7Z2X0|Q96DL0|Q9Y2V1	ENST00000330010.8	37	CCDS53335.1	.|.	.|.	.|.	.|.	.|.	.|.	.|.	.|.	.|.	.|.	A|A	15.83|15.83	2.948023|2.948023	0.53186|0.53186	.|.	.|.	ENSG00000162614|ENSG00000162614	ENST00000401035;ENST00000457030;ENST00000330010;ENST00000334785;ENST00000440324|ENST00000342754	T;T;T;T;T|.	0.65916|.	-0.16;0.18;0.11;0.2;-0.18|.	5.52|5.52	3.19|3.19	0.36642|0.36642	.|.	0.215935|.	0.31301|.	N|.	0.007899|.	T|T	0.48370|0.48370	0.1496|0.1496	L|L	0.59436|0.59436	1.845|1.845	0.80722|0.80722	D|D	1|1	P;P;P;P|.	0.52061|.	0.882;0.915;0.863;0.95|.	P;P;P;P|.	0.53360|.	0.534;0.724;0.653;0.534|.	T|T	0.47235|0.47235	-0.9133|-0.9133	10|5	0.66056|.	D|.	0.02|.	-16.9232|-16.9232	9.8922|9.8922	0.41296|0.41296	0.8517:0.0:0.1483:0.0|0.8517:0.0:0.1483:0.0	.|.	124;174;188;124|.	D3DQ79;Q0ZGT2-2;Q0ZGT2;B4DPZ7|.	.;.;NEXN_HUMAN;.|.	Y|S	124;174;124;188;174|87	ENSP00000383814:N124Y;ENSP00000388048:N174Y;ENSP00000327363:N124Y;ENSP00000333938:N188Y;ENSP00000411902:N174Y|.	ENSP00000327363:N124Y|.	N|R	+|+	1|3	0|2	NEXN|NEXN	78164759|78164759	0.999000|0.999000	0.42202|0.42202	0.986000|0.986000	0.45419|0.45419	0.992000|0.992000	0.81027|0.81027	3.081000|3.081000	0.50120|0.50120	1.040000|1.040000	0.40099|0.40099	0.533000|0.533000	0.62120|0.62120	AAT|AGA	NEXN-202	KNOWN	basic|CCDS	protein_coding	NA	protein_coding		2.466386	KEEP		+	14.687685	0.094595	7	67	---	---	---	---	1	0.4966636	2	16	0	135	7	76	0	135	2	0	0	0	0	0	0	7	76	0	135	2	TP
WDR3	10885	broad.mit.edu	37	1	118493455	118493455	+	Splice_Site	SNP	A	A	T			GBM-TCGA-06-2559-Tumor-SM-16Y9G	GBM-TCGA-06-2559-Normal-SM-1QXN8	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-06-2559-Tumor-SM-16Y9G	GBM-TCGA-06-2559-Normal-SM-1QXN8	g.chr1:118493455A>T	ENST00000349139.4	+	16	1793		c.e16-1			NM_006784.2	NP_006775.1	Q9UNX4	WDR3_HUMAN	WD repeat domain 3	NA		NA				nuclear membrane|nucleolus				breast(2)|cervix(2)|endometrium(5)|kidney(4)|large_intestine(9)|liver(2)|lung(22)|prostate(2)|upper_aerodigestive_tract(1)	49	Esophageal squamous(2;0.162)	all_cancers(81;2.72e-05)|Acute lymphoblastic leukemia(138;1e-08)|all_epithelial(167;4.4e-07)|all_lung(203;1.7e-06)|Lung NSC(69;1.98e-05)|Prostate(1639;0.00955)|Breast(1374;0.244)		OV - Ovarian serous cystadenocarcinoma(397;1.39e-08)|Epithelial(280;1.82e-07)|all cancers(265;2.04e-05)|Lung(183;0.0525)|BRCA - Breast invasive adenocarcinoma(282;0.0695)|COAD - Colon adenocarcinoma(174;0.111)|LUSC - Lung squamous cell carcinoma(189;0.185)		TTTGATGTTTAGTTTTTTCTG	0.269	NA	NA												NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA									NA				0													193	191	191	NA		NA	NA	1		NA											NA				118493455		2202	4299	6501	SO:0001630	splice_region_variant			ENSG00000065183	HGNC:12755	NM_006784	Approved	uc010oxe.1	NA		ENST00000349139.4	37	CCDS898.1	.	.	.	.	.	.	.	.	.	.	A	19.57	3.852063	0.71719	.	.	ENSG00000065183	ENST00000349139	.	.	.	5.15	5.15	0.70609	.	.	.	.	.	.	.	.	.	.	.	0.80722	D	1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	14.3077	0.66395	1.0:0.0:0.0:0.0	.	.	.	.	.	-1	.	.	.	+	.	.	WDR3	118294978	1.000000	0.71417	0.997000	0.53966	0.848000	0.48234	8.484000	0.90445	2.163000	0.67991	0.455000	0.32223	.	WDR3-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000033720.1	-24.578047	KEEP	Intron	+	8.253665	0.041379	6	139	---	---	---	---	1	0.7389298	77	0	0	293	6	177	0	293	2	0	0	0	0	0	0	6	177	0	293	2	TP
SPTA1	6708	broad.mit.edu	37	1	158654966	158654966	+	Missense_Mutation	SNP	C	C	T			GBM-TCGA-06-2559-Tumor-SM-16Y9G	GBM-TCGA-06-2559-Normal-SM-1QXN8	NA	NA	NA	NA	NA	NA	NA	Untested,Invalid,Invalid,Valid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-06-2559-Tumor-SM-16Y9G	GBM-TCGA-06-2559-Normal-SM-1QXN8	g.chr1:158654966C>T	ENST00000368148.3	-	2	376	c.196G>A	c.(196-198)Ggg>Agg	p.G66R	SPTA1_ENST00000368147.3_Missense_Mutation_p.G66R	NM_003126.2	NP_003117.2	P02549	SPTA1_HUMAN	spectrin, alpha, erythrocytic 1 (elliptocytosis 2)	66		NA			actin filament capping|actin filament organization|axon guidance|regulation of cell shape	cytosol|intrinsic to internal side of plasma membrane|spectrin|spectrin-associated cytoskeleton	actin filament binding|calcium ion binding|structural constituent of cytoskeleton			NS(3)|breast(7)|cervix(1)|endometrium(22)|kidney(9)|large_intestine(29)|liver(2)|lung(183)|ovary(5)|prostate(18)|skin(11)|soft_tissue(1)|stomach(1)|upper_aerodigestive_tract(9)|urinary_tract(6)	307	all_hematologic(112;0.0378)					ATCCACTtccccagatcatct	0.453	NA	NA												NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA									NA				0													115	110	112	NA		NA	NA	1		NA											NA				158654966		1930	4143	6073	SO:0001583	missense			ENSG00000163554	HGNC:11272	NM_003126	Approved	uc001fst.1	NA	Q15514|Q5VYL1|Q5VYL2|Q6LDY5	ENST00000368148.3	37	CCDS41423.1	.	.	.	.	.	.	.	.	.	.	C	17.70	3.454441	0.63290	.	.	ENSG00000163554	ENST00000368148;ENST00000368147	T;T	0.50277	0.75;0.75	5.18	5.18	0.71444	.	0.258089	0.20325	N	0.094546	T	0.31167	0.0788	N	0.14661	0.345	0.46725	D	0.999176	B	0.28378	0.209	B	0.41271	0.352	T	0.38607	-0.9653	10	0.59425	D	0.04	.	17.4478	0.87583	0.0:1.0:0.0:0.0	.	66	P02549	SPTA1_HUMAN	R	66	ENSP00000357130:G66R;ENSP00000357129:G66R	ENSP00000357129:G66R	G	-	1	0	SPTA1	156921590	1.000000	0.71417	1.000000	0.80357	0.384000	0.30261	5.382000	0.66213	2.700000	0.92200	0.467000	0.42956	GGG	SPTA1-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000051851.2	170.789705	KEEP		-	170.945737	0.460177	52	61	---	---	---	---	0	0	0	0	0	154	56	66	0	154	2	1	1	121	118	0	230	56	66	0	154	2	TP
SMG7	9887	broad.mit.edu	37	1	183495729	183495729	+	Splice_Site	SNP	A	A	T			GBM-TCGA-06-2559-Tumor-SM-16Y9G	GBM-TCGA-06-2559-Normal-SM-1QXN8	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-06-2559-Tumor-SM-16Y9G	GBM-TCGA-06-2559-Normal-SM-1QXN8	g.chr1:183495729A>T	ENST00000367537.3	+	6	594		c.e6-1		SMG7_ENST00000508461.1_Splice_Site|SMG7_ENST00000507469.1_Splice_Site|SMG7_ENST00000347615.2_Splice_Site|SMG7_ENST00000515829.2_Splice_Site|SMG7_ENST00000456731.2_Splice_Site|SMG7_ENST00000507406.1_Splice_Site			Q92540	SMG7_HUMAN	SMG7 nonsense mediated mRNA decay factor	NA		NA			mRNA export from nucleus|nuclear-transcribed mRNA catabolic process, nonsense-mediated decay|regulation of dephosphorylation	cytoplasm|intermediate filament cytoskeleton|nucleus	protein phosphatase 2A binding			breast(1)|central_nervous_system(1)|endometrium(7)|haematopoietic_and_lymphoid_tissue(2)|kidney(2)|large_intestine(7)|lung(16)|prostate(3)|skin(5)|upper_aerodigestive_tract(1)|urinary_tract(1)	46						TTTTTCTTTTAGTTATTACAA	0.333	NA	NA												NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA									NA				0													70	75	74	NA		NA	NA	1		NA											NA				183495729		2203	4300	6503	SO:0001630	splice_region_variant			ENSG00000116698	HGNC:16792	NM_014837	Approved	uc001gqf.3	NA	Q5T1Q0|Q6PIE0|Q7Z7H9|Q8IXC1|Q8IXC2	ENST00000367537.3	37		.	.	.	.	.	.	.	.	.	.	A	17.74	3.464105	0.63513	.	.	ENSG00000116698	ENST00000456731;ENST00000367537;ENST00000508461;ENST00000419169;ENST00000347615;ENST00000507469;ENST00000515829	.	.	.	5.61	5.61	0.85477	.	.	.	.	.	.	.	.	.	.	.	0.80722	D	1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	16.1025	0.81194	1.0:0.0:0.0:0.0	.	.	.	.	.	-1	.	.	.	+	.	.	SMG7	181762352	1.000000	0.71417	0.974000	0.42286	0.892000	0.51952	8.638000	0.91019	2.254000	0.74563	0.533000	0.62120	.	SMG7-001	PUTATIVE	basic|exp_conf	protein_coding	NA	protein_coding	OTTHUMT00000085204.3	34.915555	KEEP	Intron	+	51.878278	0.157895	24	128	---	---	---	---	1	0.9896741	43	2	0	203	25	144	0	203	2	0	0	0	0	0	0	25	144	0	203	2	TP
HMCN1	83872	broad.mit.edu	37	1	186092081	186092081	+	Splice_Site	SNP	A	A	T			GBM-TCGA-06-2559-Tumor-SM-16Y9G	GBM-TCGA-06-2559-Normal-SM-1QXN8	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-06-2559-Tumor-SM-16Y9G	GBM-TCGA-06-2559-Normal-SM-1QXN8	g.chr1:186092081A>T	ENST00000271588.4	+	81	12458		c.e81-1		HMCN1_ENST00000367492.2_Splice_Site	NM_031935.2	NP_114141.2	Q96RW7	HMCN1_HUMAN	hemicentin 1	NA		NA			response to stimulus|visual perception	basement membrane	calcium ion binding			NS(2)|autonomic_ganglia(1)|breast(10)|central_nervous_system(2)|cervix(1)|endometrium(28)|haematopoietic_and_lymphoid_tissue(4)|kidney(13)|large_intestine(58)|liver(3)|lung(101)|ovary(23)|pancreas(4)|prostate(20)|skin(8)|stomach(1)|upper_aerodigestive_tract(11)|urinary_tract(18)	308						TGTATATTTTAGTTCCTCCAG	0.388	NA	NA												NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA									NA				0													67	64	65	NA		NA	NA	1		NA											NA				186092081		2203	4300	6503	SO:0001630	splice_region_variant			ENSG00000143341	HGNC:19194	NM_031935	Approved	uc001grq.1	NA	A6NGE3|Q5TYR7|Q96DN3|Q96DN8|Q96SC3	ENST00000271588.4	37	CCDS30956.1	.	.	.	.	.	.	.	.	.	.	A	20.3	3.963601	0.74016	.	.	ENSG00000143341	ENST00000271588;ENST00000367492	.	.	.	5.95	5.95	0.96441	.	.	.	.	.	.	.	.	.	.	.	0.80722	D	1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	16.4237	0.83790	1.0:0.0:0.0:0.0	.	.	.	.	.	-1	.	.	.	+	.	.	HMCN1	184358704	1.000000	0.71417	0.965000	0.40720	0.624000	0.37722	8.707000	0.91367	2.279000	0.76181	0.533000	0.62120	.	HMCN1-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000131848.1	-33.566508	KEEP	Intron	+	11.236809	0.040609	8	189	---	---	---	---	1	0.001834414	2	0	0	204	8	211	0	204	2	0	0	0	0	0	0	8	211	0	204	2	TP
LTBP1	4052	broad.mit.edu	37	2	33335817	33335817	+	Splice_Site	SNP	G	G	A			GBM-TCGA-06-2559-Tumor-SM-16Y9G	GBM-TCGA-06-2559-Normal-SM-1QXN8	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-06-2559-Tumor-SM-16Y9G	GBM-TCGA-06-2559-Normal-SM-1QXN8	g.chr2:33335817G>A	ENST00000404816.2	+	4	1385	c.1033_splice	c.e4+1	p.Q344_splice	LTBP1_ENST00000354476.3_Splice_Site_p.Q344_splice			Q14766	LTBP1_HUMAN	latent transforming growth factor beta binding protein 1	344		NA			negative regulation of transforming growth factor beta receptor signaling pathway by extracellular sequestering of TGFbeta	proteinaceous extracellular matrix	calcium ion binding|growth factor binding|transforming growth factor beta receptor activity			breast(2)|central_nervous_system(1)|endometrium(6)|haematopoietic_and_lymphoid_tissue(1)|kidney(8)|large_intestine(13)|lung(60)|ovary(4)|pancreas(1)|prostate(2)|skin(3)|upper_aerodigestive_tract(4)|urinary_tract(3)	108	all_hematologic(175;0.115)	Medulloblastoma(90;0.215)				CACCTTTTCAGCGTGAGTATA	0.423	NA	NA												NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA									NA				0													112	107	109	NA		NA	NA	2		NA											NA				33335817		2203	4300	6503	SO:0001630	splice_region_variant			ENSG00000049323	HGNC:6714	NM_206943	Approved	uc021vft.1	NA	A1L3V1|P22064|Q53SD8|Q53SF3|Q53SG1|Q59HF7|Q8TD95	ENST00000404816.2	37	CCDS33177.2																																																																																			LTBP1-014	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000326227.2	506.372568	KEEP	Silent	+	507.465399	0.440341	155	197	---	---	---	---	1	0.9837315	3	8	0	187	198	246	0	187	2	0	0	0	0	0	0	198	246	0	187	2	TP
KRCC1	51315	broad.mit.edu	37	2	88327482	88327482	+	Missense_Mutation	SNP	C	C	T			GBM-TCGA-06-2559-Tumor-SM-16Y9G	GBM-TCGA-06-2559-Normal-SM-1QXN8	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-06-2559-Tumor-SM-16Y9G	GBM-TCGA-06-2559-Normal-SM-1QXN8	g.chr2:88327482C>T	ENST00000347055.3	-	4	994	c.601G>A	c.(601-603)Gag>Aag	p.E201K		NM_016618.1	NP_057702.1	Q9NPI7	KRCC1_HUMAN	lysine-rich coiled-coil 1	201	Lys-rich.	NA								cervix(1)|haematopoietic_and_lymphoid_tissue(1)|large_intestine(1)|lung(3)|ovary(1)	7						ATTTCCACCTCTGTTTTCTTT	0.398	NA	NA												NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA									NA				0													150	161	157	NA		NA	NA	2		NA											NA				88327482		2203	4300	6503	SO:0001583	missense			ENSG00000172086	HGNC:28039	NM_016618	Approved	uc002sso.1	NA	Q3B7J7	ENST00000347055.3	37	CCDS2000.1	.	.	.	.	.	.	.	.	.	.	C	8.924	0.961838	0.18583	.	.	ENSG00000172086	ENST00000347055	T	0.32023	1.47	5.91	0.458	0.16670	.	0.367698	0.24920	N	0.034551	T	0.11965	0.0291	N	0.08118	0	0.22017	N	0.999414	B	0.19583	0.037	B	0.19148	0.024	T	0.30446	-0.9978	10	0.15499	T	0.54	.	6.6614	0.23016	0.0:0.5783:0.1284:0.2932	.	201	Q9NPI7	KRCC1_HUMAN	K	201	ENSP00000340083:E201K	ENSP00000340083:E201K	E	-	1	0	KRCC1	88108597	0.253000	0.23982	0.009000	0.14445	0.641000	0.38312	0.789000	0.26886	0.021000	0.15133	0.603000	0.83216	GAG	KRCC1-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000252664.1	-30.129551	KEEP		-	20.345314	0.040541	9	213	---	---	---	---	1	0.9994281	24	260	0	569	13	283	0	569	2	0	0	0	0	0	0	13	283	0	569	2	TP
IL18RAP	8807	broad.mit.edu	37	2	103057838	103057838	+	Splice_Site	SNP	G	G	T			GBM-TCGA-06-2559-Tumor-SM-16Y9G	GBM-TCGA-06-2559-Normal-SM-1QXN8	NA	NA	NA	NA	NA	NA	NA	Untested,Invalid,Invalid,Valid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-06-2559-Tumor-SM-16Y9G	GBM-TCGA-06-2559-Normal-SM-1QXN8	g.chr2:103057838G>T	ENST00000264260.2	+	7	1385		c.e7+1		IL18RAP_ENST00000409369.1_Splice_Site|AC007278.3_ENST00000450893.1_RNA	NM_003853.2	NP_003844.1	O95256	I18RA_HUMAN	interleukin 18 receptor accessory protein	NA		NA			cell surface receptor linked signaling pathway|inflammatory response|innate immune response	integral to membrane	transmembrane receptor activity			autonomic_ganglia(1)|central_nervous_system(2)|endometrium(3)|kidney(4)|large_intestine(5)|lung(10)|ovary(2)|prostate(1)|skin(5)|urinary_tract(4)	37						GTAGAACTTGGTAAGCTGGGC	0.433	NA	NA												NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA									NA				0													119	99	106	NA		NA	NA	2		NA											NA				103057838		2203	4300	6503	SO:0001630	splice_region_variant			ENSG00000115607	HGNC:5989	NM_003853	Approved	uc002tbx.3	NA	B2RPJ3|Q3KPE7|Q53TT4|Q53TU5	ENST00000264260.2	37	CCDS2061.1	.	.	.	.	.	.	.	.	.	.	G	13.95	2.391359	0.42410	.	.	ENSG00000115607	ENST00000264260;ENST00000409369	.	.	.	5.07	5.07	0.68467	.	.	.	.	.	.	.	.	.	.	.	0.80722	D	1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	13.93	0.63989	0.0:0.0:1.0:0.0	.	.	.	.	.	-1	.	.	.	+	.	.	IL18RAP	102424270	1.000000	0.71417	1.000000	0.80357	0.441000	0.31987	4.677000	0.61634	2.365000	0.80145	0.491000	0.48974	.	IL18RAP-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000253291.2	189.643737	KEEP	Intron	+	191.14955	0.391892	58	90	---	---	---	---	0	0.3406641	0	3	0	99	73	114	0	99	2	1	1	131	133	0	298	73	114	0	99	2	TP
RANBP2	5903	broad.mit.edu	37	2	109378555	109378555	+	Splice_Site	SNP	A	A	T			GBM-TCGA-06-2559-Tumor-SM-16Y9G	GBM-TCGA-06-2559-Normal-SM-1QXN8	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-06-2559-Tumor-SM-16Y9G	GBM-TCGA-06-2559-Normal-SM-1QXN8	g.chr2:109378555A>T	ENST00000283195.6	+	19	2728		c.e19-1			NM_006267.4	NP_006258.3	P49792	RBP2_HUMAN	RAN binding protein 2	NA		NA			carbohydrate metabolic process|glucose transport|mitotic prometaphase|mRNA transport|protein folding|protein import into nucleus|regulation of glucose transport|transmembrane transport|viral reproduction	cytosol|nuclear pore	peptidyl-prolyl cis-trans isomerase activity|Ran GTPase binding|zinc ion binding		RANBP2/ALK(34)	NS(1)|biliary_tract(1)|breast(3)|endometrium(13)|haematopoietic_and_lymphoid_tissue(1)|kidney(21)|large_intestine(19)|lung(51)|pancreas(1)|prostate(8)|skin(7)|upper_aerodigestive_tract(2)|urinary_tract(1)	129						TTGTTTTTTTAGTTGCAACTA	0.333	NA	NA												NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA									NA				0													91	100	97	NA		NA	NA	2		NA											NA				109378555		931	2027	2958	SO:0001630	splice_region_variant			ENSG00000153201	HGNC:9848	NM_006267	Approved	uc002tem.4	NA	Q13074|Q15280|Q53TE2|Q59FH7	ENST00000283195.6	37	CCDS2079.1	.	.	.	.	.	.	.	.	.	.	A	22.5	4.294558	0.81025	.	.	ENSG00000153201	ENST00000409491;ENST00000283195	.	.	.	5.22	5.22	0.72569	.	.	.	.	.	.	.	.	.	.	.	0.80722	D	1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	15.3858	0.74699	1.0:0.0:0.0:0.0	.	.	.	.	.	-1	.	.	.	+	.	.	RANBP2	108744987	1.000000	0.71417	1.000000	0.80357	0.983000	0.72400	6.847000	0.75404	2.088000	0.63022	0.455000	0.32223	.	RANBP2-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000253594.1	-7.358066	KEEP	Intron	+	13.623236	0.065421	7	100	---	---	---	---	1	0.1631385	12	0	0	224	7	125	0	224	2	0	0	0	0	0	0	7	125	0	224	2	TP
C2orf27A	29798	broad.mit.edu	37	2	132508374	132508374	+	5'UTR	SNP	G	G	A			GBM-TCGA-06-2559-Tumor-SM-16Y9G	GBM-TCGA-06-2559-Normal-SM-1QXN8	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-06-2559-Tumor-SM-16Y9G	GBM-TCGA-06-2559-Normal-SM-1QXN8	g.chr2:132508374G>A	ENST00000355171.4	+	0	443					NM_013310.3	NP_037442.3	Q580R0	CB027_HUMAN	chromosome 2 open reading frame 27A	NA		NA								kidney(1)	1						ATCAATTTTTGTGCATTCCCA	0.383	NA	NA												NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA									NA				0													NA	NA	NA	NA		NA	NA			NA											NA				NA		NA	NA	NA	SO:0001623	5_prime_UTR_variant			ENSG00000197927	HGNC:25077	NM_013310	Approved	uc002ttf.1	NA	O43575|Q2M1X0|Q52M10|Q86XG2	ENST00000355171.4	37	CCDS2168.1																																																																																			C2orf27A-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000254569.4	35.82079	KEEP		+	35.955048	0.423077	11	15	---	---	---	---	1	0.9742666	2	9	0	43	14	17	0	43	2	0	0	0	0	0	0	14	17	0	43	2	TP
AOX1	316	broad.mit.edu	37	2	201478598	201478598	+	Missense_Mutation	SNP	C	C	T			GBM-TCGA-06-2559-Tumor-SM-16Y9G	GBM-TCGA-06-2559-Normal-SM-1QXN8	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-06-2559-Tumor-SM-16Y9G	GBM-TCGA-06-2559-Normal-SM-1QXN8	g.chr2:201478598C>T	ENST00000374700.2	+	15	1761	c.1520C>T	c.(1519-1521)gCg>gTg	p.A507V	AOX1_ENST00000485106.1_3'UTR	NM_001159.3	NP_001150.3	Q06278	ADO_HUMAN	aldehyde oxidase 1	507		NA			inflammatory response|reactive oxygen species metabolic process	cytoplasm	2 iron, 2 sulfur cluster binding|aldehyde oxidase activity|flavin adenine dinucleotide binding|iron ion binding|NAD binding|xanthine dehydrogenase activity	p.A507V(1)		breast(5)|endometrium(3)|kidney(4)|large_intestine(13)|lung(38)|ovary(5)|pancreas(1)|prostate(2)|skin(3)|stomach(2)|upper_aerodigestive_tract(2)|urinary_tract(3)	81					Brimonidine(DB00484)|Chlorpromazine(DB00477)|Famciclovir(DB00426)|Menadione(DB00170)|Methotrexate(DB00563)|NADH(DB00157)|Palonosetron(DB00377)|Penciclovir(DB00299)|Raloxifene(DB00481)|Zaleplon(DB00962)|Zonisamide(DB00909)	TTGGGCTCGGCGCCAGGTGGG	0.473	NA	NA												NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA									NA				1	Substitution - Missense(1)	lung(1)											94	91	92	NA		NA	NA	2		NA											NA				201478598		2203	4300	6503	SO:0001583	missense			ENSG00000138356	HGNC:553	NM_001159	Approved	uc002uvx.3	NA	O14765|Q53RR8|Q53TV3|Q9BYF0|Q9UPG6	ENST00000374700.2	37	CCDS33360.1	.	.	.	.	.	.	.	.	.	.	C	18.68	3.675041	0.67928	.	.	ENSG00000138356	ENST00000374700	T	0.22945	1.93	5.33	5.33	0.75918	CO dehydrogenase flavoprotein, C-terminal (3);	0.000000	0.85682	D	0.000000	T	0.33206	0.0855	L	0.45744	1.44	0.80722	D	1	P	0.37708	0.606	B	0.43155	0.41	T	0.03212	-1.1060	10	0.49607	T	0.09	-45.5491	19.2079	0.93742	0.0:1.0:0.0:0.0	.	507	Q06278	ADO_HUMAN	V	507	ENSP00000363832:A507V	ENSP00000363832:A507V	A	+	2	0	AOX1	201186843	0.999000	0.42202	0.681000	0.30009	0.039000	0.13416	4.275000	0.58927	2.768000	0.95171	0.655000	0.94253	GCG	AOX1-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000335844.1	312.37135	KEEP		+	312.931227	0.446429	100	124	---	---	---	---	1	0.9665495	4	6	0	105	112	149	0	105	2	0	0	0	0	0	0	112	149	0	105	2	TP
TMF1	7110	broad.mit.edu	37	3	69075241	69075241	+	Missense_Mutation	SNP	T	T	C			GBM-TCGA-06-2559-Tumor-SM-16Y9G	GBM-TCGA-06-2559-Normal-SM-1QXN8	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-06-2559-Tumor-SM-16Y9G	GBM-TCGA-06-2559-Normal-SM-1QXN8	g.chr3:69075241T>C	ENST00000543976.1	-	14	3020	c.2774A>G	c.(2773-2775)aAg>aGg	p.K925R	CTD-2013N24.2_ENST00000597950.1_RNA|CTD-2013N24.2_ENST00000599467.1_RNA|CTD-2013N24.2_ENST00000595925.1_RNA|CTD-2013N24.2_ENST00000482368.2_RNA|TMF1_ENST00000398559.2_Missense_Mutation_p.K922R|CTD-2013N24.2_ENST00000601735.1_RNA|CTD-2013N24.2_ENST00000601511.1_RNA|TMF1_ENST00000489370.1_5'UTR|CTD-2013N24.2_ENST00000597366.1_RNA|CTD-2013N24.2_ENST00000598783.1_RNA|CTD-2013N24.2_ENST00000596732.1_RNA|CTD-2013N24.2_ENST00000596523.1_RNA	NM_007114.2	NP_009045.2	P82094	TMF1_HUMAN	TATA element modulatory factor 1	922		NA			regulation of transcription, DNA-dependent|transcription from RNA polymerase II promoter	Golgi membrane|nucleus	DNA binding|protein binding|transcription cofactor activity			cervix(1)|kidney(1)|large_intestine(4)|lung(13)|prostate(1)|skin(1)|upper_aerodigestive_tract(1)	22		Lung NSC(201;0.0193)|Prostate(884;0.174)		BRCA - Breast invasive adenocarcinoma(55;4.48e-05)|Epithelial(33;0.000274)|LUSC - Lung squamous cell carcinoma(21;0.0123)|KIRC - Kidney renal clear cell carcinoma(39;0.211)|Kidney(39;0.247)		AGAAAATGGCTTGCGTTCCTT	0.393	NA	NA												NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA									NA				0													99	95	96	NA		NA	NA	3		NA											NA				69075241		1890	4121	6011	SO:0001583	missense			ENSG00000144747	HGNC:11870	NM_007114	Approved	uc003dnn.3	NA	B7ZLJ2|Q17R87|Q59GK0	ENST00000543976.1	37		.	.	.	.	.	.	.	.	.	.	T	9.111	1.006572	0.19199	.	.	ENSG00000144747	ENST00000398559;ENST00000543976;ENST00000356248	T;T	0.48836	0.8;0.8	5.04	5.04	0.67666	.	0.000000	0.85682	D	0.000000	T	0.34424	0.0897	L	0.36672	1.1	0.50171	D	0.999857	B;B	0.14805	0.011;0.004	B;B	0.14023	0.01;0.003	T	0.13388	-1.0511	10	0.11794	T	0.64	-18.2333	10.9114	0.47110	0.1405:0.0:0.0:0.8595	.	925;922	P82094-2;P82094	.;TMF1_HUMAN	R	922;925;838	ENSP00000381567:K922R;ENSP00000438706:K925R	ENSP00000348582:K838R	K	-	2	0	TMF1	69157931	1.000000	0.71417	0.615000	0.29064	0.991000	0.79684	4.283000	0.58977	2.019000	0.59389	0.477000	0.44152	AAG	TMF1-201	KNOWN	basic	protein_coding	NA	protein_coding		-10.220192	KEEP		-	13.215519	0.046729	5	102	---	---	---	---	1	0.5312207	2	34	0	94	6	128	0	94	2	0	0	0	0	0	0	6	128	0	94	2	TP
ROBO2	6092	broad.mit.edu	37	3	77089869	77089869	+	5'UTR	SNP	T	T	A			GBM-TCGA-06-2559-Tumor-SM-16Y9G	GBM-TCGA-06-2559-Normal-SM-1QXN8	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-06-2559-Tumor-SM-16Y9G	GBM-TCGA-06-2559-Normal-SM-1QXN8	g.chr3:77089869T>A	ENST00000461745.1	+	0	833				ROBO2_ENST00000487694.3_Intron|ROBO2_ENST00000332191.8_5'Flank	NM_002942.4	NP_002933.1	Q9HCK4	ROBO2_HUMAN	roundabout, axon guidance receptor, homolog 2 (Drosophila)	NA		NA			apoptosis involved in luteolysis|axon midline choice point recognition|cellular response to hormone stimulus|homophilic cell adhesion|metanephros development|negative regulation of negative chemotaxis|negative regulation of synaptogenesis|olfactory bulb interneuron development|positive regulation of axonogenesis|retinal ganglion cell axon guidance|ureteric bud development	axolemma|cell surface|integral to membrane	axon guidance receptor activity|identical protein binding			NS(1)|biliary_tract(5)|breast(3)|central_nervous_system(1)|cervix(1)|endometrium(6)|haematopoietic_and_lymphoid_tissue(3)|kidney(3)|large_intestine(23)|liver(1)|lung(52)|ovary(2)|pancreas(2)|prostate(5)|skin(8)|upper_aerodigestive_tract(1)	117				Epithelial(33;0.00199)|LUSC - Lung squamous cell carcinoma(21;0.008)|BRCA - Breast invasive adenocarcinoma(55;0.00884)|Lung(72;0.0183)|KIRC - Kidney renal clear cell carcinoma(39;0.0832)|Kidney(39;0.103)		TTTTTGATACTCATTTTTGTA	0.368	NA	NA												NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA									NA				0													102	81	88	NA		NA	NA	3		NA											NA				77089869		692	1591	2283	SO:0001623	5_prime_UTR_variant			ENSG00000185008	HGNC:10250	XM_031246	Approved	uc003dpy.4	NA	O43608|Q19AB4	ENST00000461745.1	37	CCDS43109.1																																																																																			ROBO2-002	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000352600.2	34.149104	KEEP		+	34.159449	0.47619	10	11	---	---	---	---	1	0.9955924	4	12	0	137	10	11	0	137	2	0	0	0	0	0	0	10	11	0	137	2	TP
SLC30A9	10463	broad.mit.edu	37	4	42022431	42022431	+	Splice_Site	SNP	A	A	T			GBM-TCGA-06-2559-Tumor-SM-16Y9G	GBM-TCGA-06-2559-Normal-SM-1QXN8	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-06-2559-Tumor-SM-16Y9G	GBM-TCGA-06-2559-Normal-SM-1QXN8	g.chr4:42022431A>T	ENST00000264451.6	+	4	514		c.e4-1			NM_006345.3	NP_006336.3	Q6PML9	ZNT9_HUMAN	solute carrier family 30 (zinc transporter), member 9	NA		NA			nucleotide-excision repair|zinc ion transport	cytoskeleton|integral to membrane|nucleus	cation transmembrane transporter activity|nucleotide binding|sequence-specific DNA binding transcription factor activity			central_nervous_system(2)|endometrium(4)|kidney(2)|large_intestine(8)|lung(6)|ovary(1)|upper_aerodigestive_tract(1)|urinary_tract(1)	25						TTTTTTGTTTAGTTAAAGCAG	0.348	NA	NA												NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA									NA				0													126	115	119	NA		NA	NA	4		NA											NA				42022431		2203	4299	6502	SO:0001630	splice_region_variant			ENSG00000014824	HGNC:1329		Approved	uc003gwl.3	NA	Q4W5B6|Q7Z5I7|Q8TBB2|Q9Y6R2	ENST00000264451.6	37	CCDS3465.1	.	.	.	.	.	.	.	.	.	.	A	25.0	4.592832	0.86953	.	.	ENSG00000014824	ENST00000264451	.	.	.	5.95	5.95	0.96441	.	.	.	.	.	.	.	.	.	.	.	0.80722	D	1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	16.4116	0.83717	1.0:0.0:0.0:0.0	.	.	.	.	.	-1	.	.	.	+	.	.	SLC30A9	41717188	1.000000	0.71417	1.000000	0.80357	0.960000	0.62799	8.788000	0.91834	2.276000	0.75962	0.528000	0.53228	.	SLC30A9-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000216842.2	2.033924	KEEP	Intron	+	20.912936	0.095652	11	104	---	---	---	---	1	0.9986354	129	0	0	153	11	118	0	153	2	0	0	0	0	0	0	11	118	0	153	2	TP
PDGFRA	5156	broad.mit.edu	37	4	55133901	55133901	+	Missense_Mutation	SNP	G	G	A			GBM-TCGA-06-2559-Tumor-SM-16Y9G	GBM-TCGA-06-2559-Normal-SM-1QXN8	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Valid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-06-2559-Tumor-SM-16Y9G	GBM-TCGA-06-2559-Normal-SM-1QXN8	g.chr4:55133901G>A	ENST00000257290.5	+	7	1445	c.1114G>A	c.(1114-1116)Gaa>Aaa	p.E372K	FIP1L1_ENST00000507166.1_Intron	NM_006206.4	NP_006197.1	P16234	PGFRA_HUMAN	platelet-derived growth factor receptor, alpha polypeptide	372	Ig-like C2-type 4.	NA			cardiac myofibril assembly|cell activation|luteinization|metanephric glomerular capillary formation|peptidyl-tyrosine phosphorylation|positive regulation of cell migration|positive regulation of DNA replication|positive regulation of fibroblast proliferation|protein autophosphorylation|retina vasculature development in camera-type eye	cytoplasm|integral to plasma membrane|nucleus	ATP binding|platelet-derived growth factor alpha-receptor activity|platelet-derived growth factor binding|platelet-derived growth factor receptor binding|protein homodimerization activity|vascular endothelial growth factor receptor activity			NS(1)|autonomic_ganglia(1)|bone(1)|breast(4)|central_nervous_system(17)|cervix(1)|endometrium(4)|eye(1)|gastrointestinal_tract_(site_indeterminate)(1)|haematopoietic_and_lymphoid_tissue(22)|kidney(6)|large_intestine(26)|liver(4)|lung(48)|ovary(4)|prostate(6)|skin(11)|small_intestine(49)|soft_tissue(727)|stomach(32)|urinary_tract(1)	967	all_cancers(7;0.000425)|all_lung(4;0.000343)|Lung NSC(11;0.000467)|all_epithelial(27;0.0131)|all_neural(26;0.0209)|Glioma(25;0.08)		GBM - Glioblastoma multiforme(1;4.18e-71)|all cancers(1;4.76e-45)|LUSC - Lung squamous cell carcinoma(32;0.00256)		Becaplermin(DB00102)|Imatinib(DB00619)|Sunitinib(DB01268)	AAAGATTCAGGAAATAAGGTA	0.463	NA	NA	"""Mis, O, T"""	FIP1L1	"""GIST, idiopathic hypereosinophilic syndrome, paediatric GBM"""				Gastrointestinal Stromal Tumors, Sporadic Multiple Primary;Familial Intestinal Neurofibromatosis	TSP Lung(21;0.16)				NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA		Pancreas(151;208 1913 7310 23853 37092)		Dom	yes		4	4q11-q13	5156	"""platelet-derived growth factor, alpha-receptor"""		"""L, M, O"""	0													36	35	35	NA		NA	NA	4		NA											NA				55133901		2203	4300	6503	SO:0001583	missense	Familial Cancer Database	Sporadic Multiple GIST;Familial Intestinal Stromal Tumors, NF3B, subset of Familial GIST,	ENSG00000134853	HGNC:8803	NM_006206	Approved	uc003han.4	NA	B2RE69|Q96KZ7|Q9UD28	ENST00000257290.5	37	CCDS3495.1	.	.	.	.	.	.	.	.	.	.	G	34	5.351694	0.95830	.	.	ENSG00000134853	ENST00000257290	T	0.54279	0.58	5.79	5.79	0.91817	Immunoglobulin subtype (1);Immunoglobulin I-set (1);Immunoglobulin-like fold (1);	0.000000	0.32901	U	0.005519	T	0.72590	0.3479	M	0.76574	2.34	0.80722	D	1	D;D	0.89917	1.0;1.0	D;D	0.80764	0.994;0.989	T	0.66106	-0.6006	10	0.21014	T	0.42	.	20.0361	0.97558	0.0:0.0:1.0:0.0	.	372;372	P16234-3;P16234	.;PGFRA_HUMAN	K	372	ENSP00000257290:E372K	ENSP00000257290:E372K	E	+	1	0	PDGFRA	54828658	1.000000	0.71417	0.994000	0.49952	0.931000	0.56810	7.928000	0.87587	2.745000	0.94114	0.462000	0.41574	GAA	PDGFRA-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000250598.2	1332.683515	KEEP		+	1493.473806	0.228307	542	1832	---	---	---	---	1	1	1108	1088	0	67	677	2309	0	67	2	1	1	25	109	1	106	677	2309	0	67	7	TP
PDGFRA	5156	broad.mit.edu	37	4	55144136	55144136	+	Missense_Mutation	SNP	G	G	C			GBM-TCGA-06-2559-Tumor-SM-16Y9G	GBM-TCGA-06-2559-Normal-SM-1QXN8	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Valid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-06-2559-Tumor-SM-16Y9G	GBM-TCGA-06-2559-Normal-SM-1QXN8	g.chr4:55144136G>C	ENST00000257290.5	+	14	2296	c.1965G>C	c.(1963-1965)ttG>ttC	p.L655F	FIP1L1_ENST00000507166.1_Missense_Mutation_p.L415F	NM_006206.4	NP_006197.1	P16234	PGFRA_HUMAN	platelet-derived growth factor receptor, alpha polypeptide	655	Protein kinase.	NA			cardiac myofibril assembly|cell activation|luteinization|metanephric glomerular capillary formation|peptidyl-tyrosine phosphorylation|positive regulation of cell migration|positive regulation of DNA replication|positive regulation of fibroblast proliferation|protein autophosphorylation|retina vasculature development in camera-type eye	cytoplasm|integral to plasma membrane|nucleus	ATP binding|platelet-derived growth factor alpha-receptor activity|platelet-derived growth factor binding|platelet-derived growth factor receptor binding|protein homodimerization activity|vascular endothelial growth factor receptor activity			NS(1)|autonomic_ganglia(1)|bone(1)|breast(4)|central_nervous_system(17)|cervix(1)|endometrium(4)|eye(1)|gastrointestinal_tract_(site_indeterminate)(1)|haematopoietic_and_lymphoid_tissue(22)|kidney(6)|large_intestine(26)|liver(4)|lung(48)|ovary(4)|prostate(6)|skin(11)|small_intestine(49)|soft_tissue(727)|stomach(32)|urinary_tract(1)	967	all_cancers(7;0.000425)|all_lung(4;0.000343)|Lung NSC(11;0.000467)|all_epithelial(27;0.0131)|all_neural(26;0.0209)|Glioma(25;0.08)		GBM - Glioblastoma multiforme(1;4.18e-71)|all cancers(1;4.76e-45)|LUSC - Lung squamous cell carcinoma(32;0.00256)		Becaplermin(DB00102)|Imatinib(DB00619)|Sunitinib(DB01268)	GGCCACATTTGAACATTGTAA	0.458	NA	NA	"""Mis, O, T"""	FIP1L1	"""GIST, idiopathic hypereosinophilic syndrome, paediatric GBM"""				Gastrointestinal Stromal Tumors, Sporadic Multiple Primary;Familial Intestinal Neurofibromatosis	TSP Lung(21;0.16)				NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA		Pancreas(151;208 1913 7310 23853 37092)		Dom	yes		4	4q11-q13	5156	"""platelet-derived growth factor, alpha-receptor"""		"""L, M, O"""	0													82	82	82	NA		NA	NA	4		NA											NA				55144136		2203	4300	6503	SO:0001583	missense	Familial Cancer Database	Sporadic Multiple GIST;Familial Intestinal Stromal Tumors, NF3B, subset of Familial GIST,	ENSG00000134853	HGNC:8803	NM_006206	Approved	uc003han.4	NA	B2RE69|Q96KZ7|Q9UD28	ENST00000257290.5	37	CCDS3495.1	.	.	.	.	.	.	.	.	.	.	G	19.33	3.807746	0.70797	.	.	ENSG00000145216;ENSG00000134853	ENST00000507166;ENST00000257290	D;D	0.89196	-2.48;-2.48	5.83	-3.28	0.05033	Serine-threonine/tyrosine-protein kinase (1);Tyrosine-protein kinase, receptor class III, conserved site (1);Protein kinase-like domain (1);Tyrosine-protein kinase, catalytic domain (1);Protein kinase, catalytic domain (1);	0.000000	0.26836	U	0.022255	D	0.89462	0.6722	L	0.47716	1.5	0.80722	D	1	D;D	0.89917	1.0;1.0	D;D	0.91635	0.997;0.999	D	0.86183	0.1607	10	0.72032	D	0.01	.	8.5019	0.33163	0.2338:0.2428:0.5234:0.0	.	655;655	P16234-3;P16234	.;PGFRA_HUMAN	F	415;655	ENSP00000423325:L415F;ENSP00000257290:L655F	ENSP00000423325:L415F	L	+	3	2	FIP1L1;PDGFRA	54838893	1.000000	0.71417	0.827000	0.32855	0.946000	0.59487	0.798000	0.27014	-0.325000	0.08577	-0.258000	0.10820	TTG	PDGFRA-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000250598.2	777.007741	KEEP		+	1086.091746	0.138776	340	2110	---	---	---	---	1	1	470	2763	0	75	436	2788	0	75	2	1	1	50	268	0	241	436	2788	0	75	2	TP
EXOC1	55763	broad.mit.edu	37	4	56765849	56765849	+	Splice_Site	SNP	A	A	T			GBM-TCGA-06-2559-Tumor-SM-16Y9G	GBM-TCGA-06-2559-Normal-SM-1QXN8	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-06-2559-Tumor-SM-16Y9G	GBM-TCGA-06-2559-Normal-SM-1QXN8	g.chr4:56765849A>T	ENST00000381295.2	+	17	2485		c.e17-1		EXOC1_ENST00000346134.7_Splice_Site|EXOC1_ENST00000349598.6_Splice_Site	NM_001024924.1	NP_001020095.1	Q9NV70	EXOC1_HUMAN	exocyst complex component 1	NA		NA			exocytosis|protein transport	exocyst	protein binding			breast(2)|central_nervous_system(1)|cervix(1)|endometrium(6)|kidney(1)|large_intestine(3)|lung(14)|ovary(2)|skin(4)|upper_aerodigestive_tract(1)	35	Glioma(25;0.08)|all_neural(26;0.101)					TTTTGGTTTTAGTGGAGAAAG	0.299	NA	NA												NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA									NA				0													88	101	97	NA		NA	NA	4		NA											NA				56765849		2199	4298	6497	SO:0001630	splice_region_variant			ENSG00000090989	HGNC:30380	NM_018261	Approved	uc003hbf.1	NA	Q504V4|Q8WUE7|Q96T15|Q9NZE4	ENST00000381295.2	37	CCDS3502.1	.	.	.	.	.	.	.	.	.	.	A	22.3	4.277654	0.80692	.	.	ENSG00000090989	ENST00000381295;ENST00000346134;ENST00000349598	.	.	.	5.37	5.37	0.77165	.	.	.	.	.	.	.	.	.	.	.	0.80722	D	1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	15.3639	0.74503	1.0:0.0:0.0:0.0	.	.	.	.	.	-1	.	.	.	+	.	.	EXOC1	56460606	1.000000	0.71417	0.993000	0.49108	0.990000	0.78478	8.953000	0.93041	2.016000	0.59253	0.528000	0.53228	.	EXOC1-003	KNOWN	alternative_5_UTR|basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000361799.1	-373.025257	KEEP	Intron	+	8.68323	0.007391	10	1343	---	---	---	---	1	0.998765	1547	0	0	324	12	1641	0	324	2	0	0	0	0	0	0	12	1641	0	324	2	TP
MND1	84057	broad.mit.edu	37	4	154315412	154315412	+	Splice_Site	SNP	A	A	T			GBM-TCGA-06-2559-Tumor-SM-16Y9G	GBM-TCGA-06-2559-Normal-SM-1QXN8	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-06-2559-Tumor-SM-16Y9G	GBM-TCGA-06-2559-Normal-SM-1QXN8	g.chr4:154315412A>T	ENST00000240488.3	+	5	365		c.e5-1		MND1_ENST00000504860.1_Splice_Site	NM_001253861.1|NM_032117.3	NP_001240790.1|NP_115493.1	Q9BWT6	MND1_HUMAN	meiotic nuclear divisions 1 homolog (S. cerevisiae)	NA		NA			DNA recombination|meiosis	nucleus	DNA binding			large_intestine(2)|lung(1)	3	all_hematologic(180;0.093)					TTGATTCTCTAGTTGTCTGAG	0.403	NA	NA												NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA									NA				0													100	98	99	NA		NA	NA	4		NA											NA				154315412		2203	4300	6503	SO:0001630	splice_region_variant			ENSG00000121211	HGNC:24839	NM_032117	Approved	uc003ink.2	NA	B2R5F9	ENST00000240488.3	37	CCDS3782.1	.	.	.	.	.	.	.	.	.	.	A	16.87	3.241582	0.58995	.	.	ENSG00000121211	ENST00000240488;ENST00000508731;ENST00000504860	.	.	.	5.72	5.72	0.89469	.	.	.	.	.	.	.	.	.	.	.	0.80722	D	1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	12.3916	0.55362	1.0:0.0:0.0:0.0	.	.	.	.	.	-1	.	.	.	+	.	.	MND1	154534862	0.999000	0.42202	0.990000	0.47175	0.975000	0.68041	5.331000	0.65905	2.189000	0.69895	0.533000	0.62120	.	MND1-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000365194.2	2.771867	KEEP	Intron	+	8.159623	0.111111	4	32	---	---	---	---	1	0.9293719	54	1	0	68	4	42	0	68	2	0	0	0	0	0	0	4	42	0	68	2	TP
RAI14	26064	broad.mit.edu	37	5	34814686	34814686	+	Splice_Site	SNP	A	A	T			GBM-TCGA-06-2559-Tumor-SM-16Y9G	GBM-TCGA-06-2559-Normal-SM-1QXN8	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-06-2559-Tumor-SM-16Y9G	GBM-TCGA-06-2559-Normal-SM-1QXN8	g.chr5:34814686A>T	ENST00000265109.3	+	12	1139		c.e12-1		RAI14_ENST00000503673.1_Splice_Site|RAI14_ENST00000512629.1_Splice_Site|RAI14_ENST00000506376.1_Splice_Site|RAI14_ENST00000515799.1_Splice_Site|RAI14_ENST00000397449.1_Splice_Site|RAI14_ENST00000428746.2_Splice_Site	NM_001145522.1|NM_015577.2	NP_001138994.1|NP_056392.2	Q9P0K7	RAI14_HUMAN	retinoic acid induced 14	NA		NA				cell cortex|cytoskeleton	protein binding			breast(2)|central_nervous_system(1)|endometrium(2)|kidney(4)|large_intestine(19)|lung(22)|ovary(1)|prostate(1)|skin(2)|upper_aerodigestive_tract(1)|urinary_tract(1)	56	all_lung(31;0.000191)					TTTCTTTTTTAGTTGAGTGAT	0.368	NA	NA												NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA									NA				0													103	93	96	NA		NA	NA	5		NA											NA				34814686		2203	4300	6503	SO:0001630	splice_region_variant			ENSG00000039560	HGNC:14873	NM_015577	Approved	uc011coj.2	NA	Q6V1W9|Q7Z5I4|Q7Z733|Q9P2L2|Q9Y3T5	ENST00000265109.3	37	CCDS34142.1	.	.	.	.	.	.	.	.	.	.	A	21.4	4.147539	0.77888	.	.	ENSG00000039560	ENST00000265109;ENST00000512629;ENST00000428746;ENST00000503673;ENST00000515799;ENST00000506376;ENST00000397449	.	.	.	5.86	5.86	0.93980	.	.	.	.	.	.	.	.	.	.	.	0.80722	D	1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	16.5602	0.84551	1.0:0.0:0.0:0.0	.	.	.	.	.	-1	.	.	.	+	.	.	RAI14	34850443	1.000000	0.71417	0.989000	0.46669	0.830000	0.47004	6.041000	0.70988	2.367000	0.80283	0.528000	0.53228	.	RAI14-002	KNOWN	alternative_5_UTR|basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000366786.1	1.56409	KEEP	Intron	+	13.543954	0.09589	7	66	---	---	---	---	1	0.9636977	56	2	0	140	8	75	0	140	2	0	0	0	0	0	0	8	75	0	140	2	TP
MAP3K1	4214	broad.mit.edu	37	5	56168506	56168506	+	Missense_Mutation	SNP	T	T	C			GBM-TCGA-06-2559-Tumor-SM-16Y9G	GBM-TCGA-06-2559-Normal-SM-1QXN8	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-06-2559-Tumor-SM-16Y9G	GBM-TCGA-06-2559-Normal-SM-1QXN8	g.chr5:56168506T>C	ENST00000399503.3	+	8	1462	c.1462T>C	c.(1462-1464)Tgt>Cgt	p.C488R		NM_005921.1	NP_005912.1	Q13233	M3K1_HUMAN	mitogen-activated protein kinase kinase kinase 1, E3 ubiquitin protein ligase	488		NA			cellular response to mechanical stimulus|innate immune response|MyD88-dependent toll-like receptor signaling pathway|Toll signaling pathway|toll-like receptor 1 signaling pathway|toll-like receptor 2 signaling pathway|toll-like receptor 4 signaling pathway	cytosol	ATP binding|zinc ion binding			NS(1)|breast(19)|endometrium(6)|haematopoietic_and_lymphoid_tissue(1)|kidney(6)|large_intestine(8)|lung(11)|ovary(1)|skin(3)|urinary_tract(1)	57		Lung NSC(810;4.65e-05)|Prostate(74;0.0132)|Breast(144;0.0321)|Ovarian(174;0.223)		OV - Ovarian serous cystadenocarcinoma(10;6.08e-40)		ACCTTTAATATGTCCCCTTTG	0.279	NA	NA												NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA									NA				0													82	78	79	NA		NA	NA	5		NA											NA				56168506		1787	4061	5848	SO:0001583	missense			ENSG00000095015	HGNC:6848	XM_042066	Approved	uc003jqw.4	NA		ENST00000399503.3	37	CCDS43318.1	.	.	.	.	.	.	.	.	.	.	T	21.7	4.187077	0.78789	.	.	ENSG00000095015	ENST00000399503	D	0.99809	-6.86	5.97	5.97	0.96955	Zinc finger, RING/FYVE/PHD-type (1);Zinc finger, RING-type (2);	0.000000	0.85682	D	0.000000	D	0.99641	0.9868	L	0.59436	1.845	0.80722	D	1	D	0.71674	0.998	D	0.78314	0.991	D	0.97766	1.0223	10	0.87932	D	0	.	16.4461	0.83932	0.0:0.0:0.0:1.0	.	488	Q13233	M3K1_HUMAN	R	488	ENSP00000382423:C488R	ENSP00000382423:C488R	C	+	1	0	MAP3K1	56204263	1.000000	0.71417	1.000000	0.80357	0.999000	0.98932	6.908000	0.75730	2.285000	0.76669	0.528000	0.53228	TGT	MAP3K1-001	NOVEL	basic|exp_conf|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000132309.2	266.254946	KEEP		+	266.709285	0.445087	77	96	---	---	---	---	1	0.9795681	6	4	0	210	118	136	0	210	2	0	0	0	0	0	0	118	136	0	210	2	TP
G3BP1	10146	broad.mit.edu	37	5	151170659	151170659	+	Intron	SNP	T	T	A			GBM-TCGA-06-2559-Tumor-SM-16Y9G	GBM-TCGA-06-2559-Normal-SM-1QXN8	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-06-2559-Tumor-SM-16Y9G	GBM-TCGA-06-2559-Normal-SM-1QXN8	g.chr5:151170659T>A	ENST00000394123.3	+	4	496				G3BP1_ENST00000543466.1_Intron|G3BP1_ENST00000356245.3_Intron			Q13283	G3BP1_HUMAN	GTPase activating protein (SH3 domain) binding protein 1	NA		NA			Ras protein signal transduction|transport	cytosol|nucleus|plasma membrane	ATP binding|ATP-dependent DNA helicase activity|ATP-dependent RNA helicase activity|DNA binding|endonuclease activity|protein binding|RNA binding			breast(1)|endometrium(5)|kidney(2)|large_intestine(6)|lung(9)|ovary(1)|skin(3)|urinary_tract(2)	29		all_hematologic(541;0.0338)|Medulloblastoma(196;0.091)	Kidney(363;0.000171)|KIRC - Kidney renal clear cell carcinoma(527;0.000785)			AGTGATCCAATACATGAAAAA	0.348	NA	NA												NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA									NA				0													152	145	147	NA		NA	NA	5		NA											NA				151170659		2203	4300	6503	SO:0001627	intron_variant			ENSG00000145907	HGNC:30292	NM_005754	Approved	uc003lum.3	NA		ENST00000394123.3	37	CCDS4319.1																																																																																			G3BP1-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000252431.1	-40.767649	KEEP		+	6.959903	0.026042	5	187	---	---	---	---	1	0.9001888	4	1	0	139	5	205	0	139	2	0	0	0	0	0	0	5	205	0	139	2	TP
LYRM4	57128	broad.mit.edu	37	6	5109631	5109631	+	3'UTR	SNP	G	G	A			GBM-TCGA-06-2559-Tumor-SM-16Y9G	GBM-TCGA-06-2559-Normal-SM-1QXN8	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-06-2559-Tumor-SM-16Y9G	GBM-TCGA-06-2559-Normal-SM-1QXN8	g.chr6:5109631G>A	ENST00000330636.4	-	0	507				LYRM4_ENST00000468929.1_3'UTR|LYRM4_ENST00000464010.1_3'UTR|LYRM4_ENST00000606472.1_5'Flank	NM_020408.4	NP_065141.3	Q9HD34	LYRM4_HUMAN	LYR motif containing 4	NA		NA				mitochondrion|nucleus				endometrium(1)	1	Ovarian(93;0.11)	all_hematologic(90;0.0901)				GTCCCTGGCCGCCACTGGTGG	0.552	NA	NA												NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA		NSCLC(130;1006 2426 17608 36797)							NA				0													81	85	84	NA		NA	NA	6		NA											NA				5109631		2203	4297	6500	SO:0001624	3_prime_UTR_variant			ENSG00000214113	HGNC:21365	NM_020408	Approved	uc021ykw.1	NA	A8K543|Q5XKP1	ENST00000330636.4	37	CCDS4493.1																																																																																			LYRM4-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000353461.3	18.645422	KEEP		-	23.247339	0.183673	9	40	---	---	---	---	1	0.9999991	13	127	0	131	18	94	0	131	2	0	0	0	0	0	0	18	94	0	131	2	TP
HLA-G	3135	broad.mit.edu	37	6	29797438	29797438	+	Missense_Mutation	SNP	A	A	G			GBM-TCGA-06-2559-Tumor-SM-16Y9G	GBM-TCGA-06-2559-Normal-SM-1QXN8	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-06-2559-Tumor-SM-16Y9G	GBM-TCGA-06-2559-Normal-SM-1QXN8	g.chr6:29797438A>G	ENST00000428701.1	+	5	1041	c.863A>G	c.(862-864)gAg>gGg	p.E288G	HLA-G_ENST00000376828.2_Missense_Mutation_p.E293G|HLA-G_ENST00000376815.3_Intron|HLA-G_ENST00000360323.6_Missense_Mutation_p.E288G|HLA-G_ENST00000376818.3_Missense_Mutation_p.E196G	NM_002127.5	NP_002118.1	P17693	HLAG_HUMAN	major histocompatibility complex, class I, G	288	Alpha-3.|Ig-like C1-type.	NA			antigen processing and presentation of peptide antigen via MHC class I|cellular defense response|interferon-gamma-mediated signaling pathway|regulation of immune response|type I interferon-mediated signaling pathway	integral to membrane|MHC class I protein complex	MHC class I receptor activity			central_nervous_system(1)|endometrium(1)|large_intestine(5)|lung(4)|ovary(3)|pancreas(1)|prostate(5)|skin(1)	21						GTGCAGCATGAGGGGCTGCCG	0.577	NA	NA												NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA									NA				0													55	57	56	NA		NA	NA	6		NA											NA				29797438		2203	4300	6503	SO:0001583	missense			ENSG00000204632	HGNC:4964	NM_002127	Approved	uc003nnw.2	NA		ENST00000428701.1	37	CCDS4668.1	.	.	.	.	.	.	.	.	.	.	.	8.788	0.929977	0.18131	.	.	ENSG00000204632	ENST00000376828;ENST00000428701;ENST00000360323;ENST00000376818	T;T;T;T	0.03413	3.94;3.94;3.94;3.94	1.7	1.7	0.24286	Immunoglobulin C1-set (2);Immunoglobulin-like fold (1);	0.220889	0.22814	U	0.055308	T	0.07638	0.0192	M	0.87617	2.895	0.19300	N	0.999979	P;P;D	0.89917	0.457;0.734;1.0	P;B;D	0.87578	0.463;0.115;0.998	T	0.11470	-1.0586	10	0.87932	D	0	.	3.4889	0.07630	0.7808:0.0:0.2192:0.0	.	293;196;288	Q5RJ85;Q31611;P17693	.;.;HLAG_HUMAN	G	293;288;288;196	ENSP00000366024:E293G;ENSP00000412927:E288G;ENSP00000353472:E288G;ENSP00000366014:E196G	ENSP00000353472:E288G	E	+	2	0	HLA-G	29905417	0.003000	0.15002	0.159000	0.22649	0.013000	0.08279	0.377000	0.20552	0.787000	0.33731	0.242000	0.17961	GAG	HLA-G-201	KNOWN	basic|CCDS	protein_coding	NA	protein_coding		-22.575024	KEEP		+	7.152065	0.02521	3	116	---	---	---	---	1	0.5462742	33	30	0	187	4	154	0	187	2	0	0	0	0	0	0	4	154	0	187	2	TP
UHRF1BP1	54887	broad.mit.edu	37	6	34827265	34827265	+	Silent	SNP	G	G	A			GBM-TCGA-06-2559-Tumor-SM-16Y9G	GBM-TCGA-06-2559-Normal-SM-1QXN8	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-06-2559-Tumor-SM-16Y9G	GBM-TCGA-06-2559-Normal-SM-1QXN8	g.chr6:34827265G>A	ENST00000192788.5	+	14	3303	c.3132G>A	c.(3130-3132)gtG>gtA	p.V1044V	UHRF1BP1_ENST00000452449.2_Silent_p.V1044V	NM_017754.3	NP_060224.3	Q6BDS2	URFB1_HUMAN	UHRF1 binding protein 1	1044		NA								breast(1)|cervix(1)|endometrium(4)|kidney(3)|large_intestine(11)|lung(24)|ovary(3)|prostate(4)|skin(1)|upper_aerodigestive_tract(2)	54						AGGAAGCTGTGTCCCTGACTA	0.517	NA	NA												NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA									NA				0													113	117	116	NA		NA	NA	6		NA											NA				34827265		2114	4223	6337	SO:0001819	synonymous_variant			ENSG00000065060	HGNC:21216	NM_017754	Approved	uc003oju.4	NA	Q9NXE0	ENST00000192788.5	37	CCDS43455.1																																																																																			UHRF1BP1-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000040260.1	416.122008	KEEP		+	418.177992	0.41433	133	188	---	---	---	---	1	0.9661898	4	6	0	180	155	208	0	180	2	0	0	0	0	0	0	155	208	0	180	2	TP
MOCS1	4337	broad.mit.edu	37	6	39893563	39893563	+	Missense_Mutation	SNP	C	C	T			GBM-TCGA-06-2559-Tumor-SM-16Y9G	GBM-TCGA-06-2559-Normal-SM-1QXN8	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-06-2559-Tumor-SM-16Y9G	GBM-TCGA-06-2559-Normal-SM-1QXN8	g.chr6:39893563C>T	ENST00000373186.4	-	2	414	c.277G>A	c.(277-279)Gtc>Atc	p.V93I	MOCS1_ENST00000308559.7_Missense_Mutation_p.V93I|MOCS1_ENST00000373175.4_Missense_Mutation_p.V64I|MOCS1_ENST00000373188.2_Missense_Mutation_p.V93I|MOCS1_ENST00000373195.3_Missense_Mutation_p.V6I|MOCS1_ENST00000340692.5_Missense_Mutation_p.V93I|MOCS1_ENST00000425303.2_Missense_Mutation_p.V93I|MOCS1_ENST00000432280.2_Missense_Mutation_p.V64I	NM_005943.5	NP_005934.2	Q9NZB8	MOCS1_HUMAN	molybdenum cofactor synthesis 1	93	Molybdenum cofactor biosynthesis protein A.	NA			Mo-molybdopterin cofactor biosynthetic process|water-soluble vitamin metabolic process	cytosol|molybdopterin synthase complex|nucleus	4 iron, 4 sulfur cluster binding|catalytic activity|GTP binding|metal ion binding			central_nervous_system(1)|endometrium(5)|kidney(1)|large_intestine(1)|liver(2)|lung(6)|ovary(1)|pancreas(1)|prostate(1)|skin(2)	21	Ovarian(28;0.0355)|Colorectal(47;0.196)					GTCAGCGGGACCCCCTCCTCG	0.622	NA	NA												NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA		NSCLC(84;861 1413 23785 24908 42279)|Melanoma(182;611 2047 9114 11847 26639)							NA				0													49	54	52	NA		NA	NA	6		NA											NA				39893563		2202	4291	6493	SO:0001583	missense			ENSG00000124615	HGNC:7190	NM_005943	Approved	uc003opb.3	NA	B3KPT7|B4DTP1|O14940|O14941|O75710|Q5J7W0|Q5TCE1|Q5TCE2|Q5TCE6|Q5TCE9|Q5TCF0|Q5TCF1|Q8N418|Q9NZB7|Q9UEM1	ENST00000373186.4	37	CCDS4846.1	.	.	.	.	.	.	.	.	.	.	C	17.55	3.418654	0.62622	.	.	ENSG00000124615	ENST00000373186;ENST00000308559;ENST00000373175;ENST00000373188;ENST00000373195;ENST00000340692;ENST00000425303;ENST00000432280	D;D;D;D;T;D;D;D	0.93133	-3.17;-3.17;-3.17;-3.17;1.42;-3.17;-3.17;-3.17	5.23	4.36	0.52297	Elongator protein 3/MiaB/NifB (1);Aldolase-type TIM barrel (1);Radical SAM (1);	0.319164	0.32785	N	0.005658	D	0.89539	0.6744	L	0.39514	1.22	0.43771	D	0.996295	P;P;P;P;B	0.43826	0.596;0.818;0.809;0.571;0.214	P;B;P;B;B	0.50162	0.455;0.437;0.633;0.377;0.182	D	0.88394	0.3010	9	.	.	.	-20.0576	13.7263	0.62761	0.0:0.9244:0.0:0.0756	.	93;93;93;93;93	Q9NZB8-2;Q9NZB8-5;Q9NZB8;Q9NZB8-8;Q9NZB8-6	.;.;MOCS1_HUMAN;.;.	I	93;93;64;93;6;93;93;64	ENSP00000362282:V93I;ENSP00000309843:V93I;ENSP00000362270:V64I;ENSP00000362284:V93I;ENSP00000362291:V6I;ENSP00000344794:V93I;ENSP00000416478:V93I;ENSP00000410809:V64I	.	V	-	1	0	MOCS1	40001541	0.998000	0.40836	0.303000	0.25071	0.315000	0.28087	3.810000	0.55613	1.345000	0.45676	0.485000	0.47835	GTC	MOCS1-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000040472.2	8.684839	KEEP		-	11.212915	0.166667	4	20	---	---	---	---	1	0.7163407	4	11	0	74	5	27	0	74	2	0	0	0	0	0	0	5	27	0	74	2	TP
SLC35F1	222553	broad.mit.edu	37	6	118635189	118635189	+	Splice_Site	SNP	A	A	T			GBM-TCGA-06-2559-Tumor-SM-16Y9G	GBM-TCGA-06-2559-Normal-SM-1QXN8	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-06-2559-Tumor-SM-16Y9G	GBM-TCGA-06-2559-Normal-SM-1QXN8	g.chr6:118635189A>T	ENST00000360388.4	+	8	1203		c.e8-1			NM_001029858.3	NP_001025029.2	Q5T1Q4	S35F1_HUMAN	solute carrier family 35, member F1	NA		NA			transport	integral to membrane				breast(3)|kidney(1)|large_intestine(7)|lung(21)|prostate(1)|skin(1)|upper_aerodigestive_tract(2)	36				GBM - Glioblastoma multiforme(226;0.217)		GTGTTTTTTTAGTTTTCAGGA	0.473	NA	NA												NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA									NA				0													NA	NA	NA	NA		NA	NA			NA											NA				NA		NA	NA	NA	SO:0001630	splice_region_variant			ENSG00000196376	HGNC:21483	XM_167044	Approved	uc003pxx.4	NA	E1P564|Q1RMG1|Q4G0U9|Q4G167|Q6N007	ENST00000360388.4	37	CCDS34524.1	.	.	.	.	.	.	.	.	.	.	A	20.2	3.953854	0.73902	.	.	ENSG00000196376	ENST00000360388	.	.	.	5.71	5.71	0.89125	.	.	.	.	.	.	.	.	.	.	.	0.80722	D	1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	15.9822	0.80121	1.0:0.0:0.0:0.0	.	.	.	.	.	-1	.	.	.	+	.	.	SLC35F1	118741882	1.000000	0.71417	0.995000	0.50966	0.908000	0.53690	7.987000	0.88182	2.186000	0.69663	0.533000	0.62120	.	SLC35F1-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000041991.2	-5.710721	KEEP	Intron	+	16.002448	0.076271	9	109	---	---	---	---	1	0.9962745	129	1	0	114	9	114	0	114	2	0	0	0	0	0	0	9	114	0	114	2	TP
FAM221A	340277	broad.mit.edu	37	7	23740403	23740403	+	Splice_Site	SNP	A	A	T	rs138016346		GBM-TCGA-06-2559-Tumor-SM-16Y9G	GBM-TCGA-06-2559-Normal-SM-1QXN8	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-06-2559-Tumor-SM-16Y9G	GBM-TCGA-06-2559-Normal-SM-1QXN8	g.chr7:23740403A>T	ENST00000344962.4	+	6	834		c.e6-1		FAM221A_ENST00000409192.3_Splice_Site|FAM221A_ENST00000409653.1_Splice_Site|FAM221A_ENST00000409994.3_Splice_Site	NM_199136.3	NP_954587.2	A4D161	CG046_HUMAN	family with sequence similarity 221, member A	NA		NA									NA						TTTCCTTGTTAGTAGGTACAA	0.328	NA	NA												NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA									NA				0													105	121	115	NA		NA	NA	7		NA											NA				23740403		2203	4300	6503	SO:0001630	splice_region_variant			ENSG00000188732	HGNC:27977	NM_199136	Approved	uc003swo.4	NA	Q05CG4|Q4G0Q7|Q6P519	ENST00000344962.4	37	CCDS5385.1	.	.	.	.	.	.	.	.	.	.	A	16.76	3.212344	0.58452	.	.	ENSG00000188732	ENST00000409192;ENST00000344962;ENST00000409653;ENST00000409994	.	.	.	5.71	5.71	0.89125	.	.	.	.	.	.	.	.	.	.	.	0.80722	D	1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	14.8532	0.70313	1.0:0.0:0.0:0.0	.	.	.	.	.	-1	.	.	.	+	.	.	C7orf46	23706928	1.000000	0.71417	0.979000	0.43373	0.889000	0.51656	2.874000	0.48483	2.307000	0.77673	0.528000	0.53228	.	FAM221A-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000250261.1	-43.941365	KEEP	Intron	+	24.175597	0.047923	15	298	---	---	---	---	1	0.9954314	171	13	0	330	16	352	0	330	2	0	0	0	0	0	0	16	352	0	330	2	TP
Unknown	0	broad.mit.edu	37	7	75130895	75130895	+	IGR	SNP	C	C	T			GBM-TCGA-06-2559-Tumor-SM-16Y9G	GBM-TCGA-06-2559-Normal-SM-1QXN8	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-06-2559-Tumor-SM-16Y9G	GBM-TCGA-06-2559-Normal-SM-1QXN8	g.chr7:75130895C>T			NA	NA				POM121C (15347 upstream) : PMS2P3 (6179 downstream)						NA		NA									NA						TCCATGAACCCGAGGGCCAGG	0.592	NA	NA												NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA									NA				0													106	127	119	NA		NA	NA	7		NA											NA				75130895		1508	2705	4213	SO:0001628	intergenic_variant								NA			37																																																																																								0			-229.383244	KEEP			7.228213	0.009412	8	842	---	---	---	---	1	0.004533798	4	6	0	323	9	1000	0	323	2	0	0	0	0	0	0	9	1000	0	323	2	TP
TAF6	6878	broad.mit.edu	37	7	99706049	99706049	+	Missense_Mutation	SNP	G	G	A			GBM-TCGA-06-2559-Tumor-SM-16Y9G	GBM-TCGA-06-2559-Normal-SM-1QXN8	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-06-2559-Tumor-SM-16Y9G	GBM-TCGA-06-2559-Normal-SM-1QXN8	g.chr7:99706049G>A	ENST00000344095.4	-	13	1924	c.1399C>T	c.(1399-1401)Cgg>Tgg	p.R467W	AP4M1_ENST00000421755.1_Intron|TAF6_ENST00000452041.1_Missense_Mutation_p.R467W|TAF6_ENST00000453269.2_Missense_Mutation_p.R467W|TAF6_ENST00000437822.2_Missense_Mutation_p.R504W|TAF6_ENST00000472509.1_Missense_Mutation_p.R524W|TAF6_ENST00000418432.2_Missense_Mutation_p.R391W	NM_005641.3	NP_005632.1	P49848	TAF6_HUMAN	TAF6 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 80kDa	467		NA			negative regulation of cell cycle|negative regulation of cell proliferation|regulation of sequence-specific DNA binding transcription factor activity|transcription elongation from RNA polymerase II promoter|transcription initiation from RNA polymerase II promoter|viral reproduction	cytoplasm|MLL1 complex|transcription factor TFIID complex|transcription factor TFTC complex	DNA binding|protein binding|sequence-specific DNA binding transcription factor activity			breast(2)|central_nervous_system(1)|endometrium(3)|kidney(1)|large_intestine(5)|liver(1)|lung(7)|ovary(2)|pancreas(1)|prostate(1)|urinary_tract(2)	26	Lung NSC(181;0.0181)|all_lung(186;0.0284)|Esophageal squamous(72;0.0439)					GCCTGGGCCCGAGCCTTGACC	0.642	NA	NA												NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA									NA				0													51	58	56	NA		NA	NA	7		NA											NA				99706049		2203	4300	6503	SO:0001583	missense			ENSG00000106290	HGNC:11540	NM_005641	Approved	uc011kji.2	NA	A4D2B2|A4D2B3|D6W5U2|Q6AI29	ENST00000344095.4	37	CCDS5686.1	.	.	.	.	.	.	.	.	.	.	G	20.3	3.970953	0.74246	.	.	ENSG00000106290	ENST00000453269;ENST00000472509;ENST00000452041;ENST00000344095;ENST00000418432;ENST00000437822	T;T;T;T;T	0.73363	-0.6;-0.74;-0.6;-0.6;-0.72	5.58	3.71	0.42584	.	0.000000	0.85682	D	0.000000	D	0.82346	0.5017	M	0.78049	2.395	0.53005	D	0.999962	D;D;D;D;D	0.89917	1.0;1.0;1.0;1.0;1.0	D;D;D;D;D	0.69654	0.948;0.965;0.924;0.924;0.924	T	0.82394	-0.0479	10	0.87932	D	0	-27.9857	5.8627	0.18757	0.0892:0.0:0.5513:0.3595	.	504;467;457;467;391	B4DT11;P49848-2;A4D299;P49848;B3KUR4	.;.;.;TAF6_HUMAN;.	W	467;524;467;467;391;504	ENSP00000389575:R467W;ENSP00000419760:R524W;ENSP00000416396:R467W;ENSP00000344537:R467W;ENSP00000399982:R504W	ENSP00000344537:R467W	R	-	1	2	TAF6	99543985	1.000000	0.71417	1.000000	0.80357	0.943000	0.58893	3.041000	0.49807	1.296000	0.44742	0.491000	0.48974	CGG	TAF6-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000337024.2	76.432785	KEEP		-	83.189925	0.247863	29	88	---	---	---	---	1	1	34	96	0	174	35	110	0	174	2	0	0	0	0	0	0	35	110	0	174	2	TP
KMT2C	58508	broad.mit.edu	37	7	152007049	152007049	+	Splice_Site	SNP	A	A	T			GBM-TCGA-06-2559-Tumor-SM-16Y9G	GBM-TCGA-06-2559-Normal-SM-1QXN8	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-06-2559-Tumor-SM-16Y9G	GBM-TCGA-06-2559-Normal-SM-1QXN8	g.chr7:152007049A>T	ENST00000355193.2	-	6	1068		c.e6+1		KMT2C_ENST00000262189.6_Splice_Site					lysine (K)-specific methyltransferase 2C	NA		NA									NA						TTGTCTACTTACTTCTGTGCT	0.378	NA	NA												NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA									NA				0													90	79	82	NA		NA	NA	7		NA											NA				152007049		2203	4300	6503	SO:0001630	splice_region_variant			ENSG00000055609	HGNC:13726		Approved		NA		ENST00000355193.2	37		.	.	.	.	.	.	.	.	.	.	A	22.6	4.314055	0.81358	.	.	ENSG00000055609	ENST00000262189;ENST00000355193	.	.	.	5.78	5.78	0.91487	.	.	.	.	.	.	.	.	.	.	.	0.80722	D	1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	15.7623	0.78096	1.0:0.0:0.0:0.0	.	.	.	.	.	-1	.	.	.	-	.	.	MLL3	151637982	1.000000	0.71417	1.000000	0.80357	0.954000	0.61252	8.260000	0.89857	2.206000	0.71126	0.533000	0.62120	.	KMT2C-201	KNOWN	basic	protein_coding	NA	protein_coding		-46.382552	KEEP	Intron	-	6.851552	0.023697	5	206	---	---	---	---	1	0.0492	11	3	1	68	5	238	1	68	2	0	0	0	0	0	0	5	238	1	68	2	TP
PDGFRL	5157	broad.mit.edu	37	8	17486160	17486160	+	Missense_Mutation	SNP	G	G	A			GBM-TCGA-06-2559-Tumor-SM-16Y9G	GBM-TCGA-06-2559-Normal-SM-1QXN8	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-06-2559-Tumor-SM-16Y9G	GBM-TCGA-06-2559-Normal-SM-1QXN8	g.chr8:17486160G>A	ENST00000541323.1	+	5	1115	c.670G>A	c.(670-672)Gtt>Att	p.V224I	PDGFRL_ENST00000251630.6_Missense_Mutation_p.V224I|PDGFRL_ENST00000398074.3_Missense_Mutation_p.V224I	NM_006207.2	NP_006198.1	Q15198	PGFRL_HUMAN	platelet-derived growth factor receptor-like	224		NA				extracellular region	platelet activating factor receptor activity|platelet-derived growth factor beta-receptor activity			endometrium(2)|haematopoietic_and_lymphoid_tissue(1)|large_intestine(1)|lung(5)	9				Colorectal(111;0.0752)		AACGGACATTGTTTATGACAT	0.572	NA	NA												NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA									NA				0													119	108	112	NA		NA	NA	8		NA											NA				17486160		2203	4300	6503	SO:0001583	missense			ENSG00000104213	HGNC:8805	NM_006207	Approved	uc003wxr.3	NA	A8K085|Q6FH04	ENST00000541323.1	37	CCDS6003.1	.	.	.	.	.	.	.	.	.	.	G	0.034	-1.317006	0.01331	.	.	ENSG00000104213	ENST00000251630;ENST00000541323;ENST00000398074	T;T;T	0.25749	1.78;1.78;1.78	5.04	-3.16	0.05217	Immunoglobulin-like fold (1);	0.872073	0.10358	N	0.684308	T	0.08447	0.0210	N	0.04508	-0.205	0.09310	N	1	B	0.02656	0.0	B	0.01281	0.0	T	0.38478	-0.9659	10	0.05351	T	0.99	-18.8003	8.7363	0.34530	0.6718:0.0:0.2146:0.1136	.	224	Q15198	PGFRL_HUMAN	I	224	ENSP00000251630:V224I;ENSP00000444211:V224I;ENSP00000381149:V224I	ENSP00000251630:V224I	V	+	1	0	PDGFRL	17530440	0.000000	0.05858	0.000000	0.03702	0.016000	0.09150	-0.673000	0.05239	-0.908000	0.03857	-0.136000	0.14681	GTT	PDGFRL-202	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000253366.3	-4.199286	KEEP		+	48.776634	0.076389	22	266	---	---	---	---	1	0.1835621	3	8	0	159	32	429	0	159	2	0	0	0	0	0	0	32	429	0	159	2	TP
IKBKB	3551	broad.mit.edu	37	8	42163859	42163859	+	Splice_Site	SNP	A	A	T			GBM-TCGA-06-2559-Tumor-SM-16Y9G	GBM-TCGA-06-2559-Normal-SM-1QXN8	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-06-2559-Tumor-SM-16Y9G	GBM-TCGA-06-2559-Normal-SM-1QXN8	g.chr8:42163859A>T	ENST00000520810.1	+	7	663		c.e7-1		IKBKB_ENST00000379708.3_Intron|IKBKB_ENST00000520835.1_Splice_Site|IKBKB_ENST00000519735.1_Splice_Site|IKBKB_ENST00000416505.2_Splice_Site|IKBKB_ENST00000522147.1_Intron	NM_001556.2	NP_001547.1	O14920	IKKB_HUMAN	inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta	NA		NA			anti-apoptosis|innate immune response|MyD88-dependent toll-like receptor signaling pathway|MyD88-independent toll-like receptor signaling pathway|nerve growth factor receptor signaling pathway|positive regulation of I-kappaB kinase/NF-kappaB cascade|positive regulation of NF-kappaB transcription factor activity|positive regulation of transcription, DNA-dependent|T cell receptor signaling pathway|Toll signaling pathway|toll-like receptor 1 signaling pathway|toll-like receptor 2 signaling pathway|toll-like receptor 3 signaling pathway|toll-like receptor 4 signaling pathway	CD40 receptor complex|cytosol|internal side of plasma membrane|membrane raft	ATP binding|identical protein binding|IkappaB kinase activity			breast(4)|lung(1)|ovary(2)|skin(1)	8	all_cancers(6;1.42e-24)|all_epithelial(6;1.02e-25)|all_lung(13;6.21e-12)|Lung NSC(13;1.04e-10)|Ovarian(28;0.00769)|Prostate(17;0.0119)|Colorectal(14;0.0468)|Lung SC(25;0.211)	all_lung(54;0.000434)|Lung NSC(58;0.00161)|Hepatocellular(245;0.0524)|Renal(179;0.0822)|Esophageal squamous(32;0.0954)	BRCA - Breast invasive adenocarcinoma(8;1.37e-10)|Colorectal(10;0.00102)|OV - Ovarian serous cystadenocarcinoma(14;0.00168)|Lung(22;0.00467)|LUSC - Lung squamous cell carcinoma(45;0.024)|COAD - Colon adenocarcinoma(11;0.0264)		Arsenic trioxide(DB01169)|Auranofin(DB00995)	CTTTTGTTTTAGTTAATACAC	0.438	NA	NA												NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA									NA				0													87	80	83	NA		NA	NA	8		NA											NA				42163859		2203	4300	6503	SO:0001630	splice_region_variant			ENSG00000104365	HGNC:5960		Approved	uc003xow.2	NA	B4DZ30|O75327	ENST00000520810.1	37	CCDS6128.1	.	.	.	.	.	.	.	.	.	.	A	25.0	4.595846	0.86953	.	.	ENSG00000104365	ENST00000520810;ENST00000416505;ENST00000519735;ENST00000520835	.	.	.	5.12	5.12	0.69794	.	.	.	.	.	.	.	.	.	.	.	0.80722	D	1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	15.2236	0.73333	1.0:0.0:0.0:0.0	.	.	.	.	.	-1	.	.	.	+	.	.	IKBKB	42283016	1.000000	0.71417	0.999000	0.59377	0.953000	0.61014	9.283000	0.95860	2.050000	0.60909	0.533000	0.62120	.	IKBKB-002	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000377214.1	-1.77584	KEEP	Intron	+	14.915797	0.084211	8	87	---	---	---	---	1	0.8936794	48	0	0	70	9	105	0	70	2	0	0	0	0	0	0	9	105	0	70	2	TP
CTHRC1	115908	broad.mit.edu	37	8	104390318	104390318	+	Missense_Mutation	SNP	C	C	T			GBM-TCGA-06-2559-Tumor-SM-16Y9G	GBM-TCGA-06-2559-Normal-SM-1QXN8	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-06-2559-Tumor-SM-16Y9G	GBM-TCGA-06-2559-Normal-SM-1QXN8	g.chr8:104390318C>T	ENST00000330295.5	+	3	578	c.436C>T	c.(436-438)Cgg>Tgg	p.R146W	CTHRC1_ENST00000520880.1_Missense_Mutation_p.R16W|CTHRC1_ENST00000520337.1_Missense_Mutation_p.R132W	NM_138455.3	NP_612464.1	Q96CG8	CTHR1_HUMAN	collagen triple helix repeat containing 1	146		NA				collagen				endometrium(1)|large_intestine(5)|lung(4)|ovary(1)|urinary_tract(1)	12			OV - Ovarian serous cystadenocarcinoma(57;2.79e-06)|STAD - Stomach adenocarcinoma(118;0.197)			TGGCTCACTTCGGCTAAAATG	0.373	NA	NA												NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA									NA				0													187	181	183	NA		NA	NA	8		NA											NA				104390318		2203	4300	6503	SO:0001583	missense			ENSG00000164932	HGNC:18831	NM_138455	Approved	uc003ylk.4	NA	Q6UW91|Q8IX63	ENST00000330295.5	37	CCDS6299.1	.	.	.	.	.	.	.	.	.	.	C	20.6	4.012940	0.75161	.	.	ENSG00000164932	ENST00000330295;ENST00000520337;ENST00000297577;ENST00000520880	T;T	0.69040	-0.37;0.61	5.51	4.62	0.57501	.	0.000000	0.85682	D	0.000000	D	0.82440	0.5037	M	0.80982	2.52	0.58432	D	0.999998	D	0.89917	1.0	D	0.87578	0.998	D	0.85431	0.1149	10	0.87932	D	0	-19.0796	15.8231	0.78676	0.1367:0.8633:0.0:0.0	.	146	Q96CG8	CTHR1_HUMAN	W	146;132;132;16	ENSP00000330523:R146W;ENSP00000430550:R132W	ENSP00000297577:R132W	R	+	1	2	CTHRC1	104459494	0.896000	0.30565	0.996000	0.52242	0.998000	0.95712	1.793000	0.38764	1.289000	0.44618	0.655000	0.94253	CGG	CTHRC1-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000380792.1	-41.128903	KEEP		+	46.718408	0.04914	20	387	---	---	---	---	1	0.9054536	3	76	0	314	27	512	0	314	2	0	0	0	0	0	0	27	512	0	314	2	TP
RPS6	6194	broad.mit.edu	37	9	19376575	19376575	+	Missense_Mutation	SNP	G	G	A			GBM-TCGA-06-2559-Tumor-SM-16Y9G	GBM-TCGA-06-2559-Normal-SM-1QXN8	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-06-2559-Tumor-SM-16Y9G	GBM-TCGA-06-2559-Normal-SM-1QXN8	g.chr9:19376575G>A	ENST00000380394.4	-	5	629	c.571C>T	c.(571-573)Cgt>Tgt	p.R191C	RPS6_ENST00000498815.1_5'UTR|RPS6_ENST00000380384.1_Missense_Mutation_p.R160C|RPS6_ENST00000315377.4_Missense_Mutation_p.R160C	NM_001010.2	NP_001001.2	P62753	RS6_HUMAN	ribosomal protein S6	191		NA			endocrine pancreas development|glucose homeostasis|insulin receptor signaling pathway|positive regulation of apoptosis|rRNA processing|TOR signaling cascade|translational elongation|translational termination|viral transcription	cytosolic small ribosomal subunit|nucleolus	protein binding			endometrium(3)|lung(2)|ovary(1)|urinary_tract(1)	7		Colorectal(97;3.46e-05)|Myeloproliferative disorder(762;0.0255)		Lung(42;0.161)|LUSC - Lung squamous cell carcinoma(42;0.234)		AGAGCAATACGCCGCCGTTTG	0.423	NA	NA												NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA									NA				0													90	93	92	NA		NA	NA	9		NA											NA				19376575		2203	4300	6503	SO:0001583	missense			ENSG00000137154	HGNC:10429	NM_001010	Approved	uc003znv.1	NA	P08227|P10660|Q4VBY7|Q8N6Z7	ENST00000380394.4	37	CCDS6492.1	.	.	.	.	.	.	.	.	.	.	G	19.09	3.758939	0.69763	.	.	ENSG00000137154	ENST00000380394;ENST00000380384;ENST00000315377	T;T;T	0.49139	0.79;0.79;0.79	4.94	4.94	0.65067	.	0.052106	0.85682	N	0.000000	T	0.52661	0.1748	M	0.79926	2.475	0.80722	D	1	B	0.22851	0.076	B	0.18561	0.022	T	0.53251	-0.8465	9	.	.	.	-3.7482	18.5201	0.90948	0.0:0.0:1.0:0.0	.	191	P62753	RS6_HUMAN	C	191;160;160	ENSP00000369757:R191C;ENSP00000369745:R160C;ENSP00000369743:R160C	.	R	-	1	0	RPS6	19366575	1.000000	0.71417	1.000000	0.80357	0.997000	0.91878	9.422000	0.97458	2.406000	0.81754	0.655000	0.94253	CGT	RPS6-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000051858.1	-48.191779	KEEP		-	14.807978	0.030651	8	253	---	---	---	---	1	1	2	4149	0	227	10	320	0	227	2	0	0	0	0	0	0	10	320	0	227	2	TP
GLIPR2	152007	broad.mit.edu	37	9	36162546	36162546	+	3'UTR	SNP	A	A	G			GBM-TCGA-06-2559-Tumor-SM-16Y9G	GBM-TCGA-06-2559-Normal-SM-1QXN8	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-06-2559-Tumor-SM-16Y9G	GBM-TCGA-06-2559-Normal-SM-1QXN8	g.chr9:36162546A>G	ENST00000396613.3	+	0	917				GLIPR2_ENST00000377960.4_3'UTR|GLIPR2_ENST00000474050.1_3'UTR|GLIPR2_ENST00000377959.1_3'UTR			Q9H4G4	GAPR1_HUMAN	GLI pathogenesis-related 2	NA		NA				extracellular region|Golgi membrane				NS(1)|breast(1)|central_nervous_system(1)|endometrium(1)|haematopoietic_and_lymphoid_tissue(1)|lung(2)|skin(3)	10						GGAAGGTGGCAGACTTAAGAA	0.502	NA	NA												NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA									NA				0													48	44	45	NA		NA	NA	9		NA											NA				36162546		2203	4300	6503	SO:0001624	3_prime_UTR_variant			ENSG00000122694	HGNC:18007	NM_022343	Approved	uc003zyz.3	NA	Q5VZR1|Q8N2S6|Q8WWC9|Q8WX36	ENST00000396613.3	37																																																																																				GLIPR2-201	KNOWN	basic	protein_coding	NA	protein_coding		62.34665	KEEP		+	62.396852	0.461538	18	21	---	---	---	---	1	1	256	236	0	41	18	24	0	41	2	0	0	0	0	0	0	18	24	0	41	2	TP
ZNF658	26149	broad.mit.edu	37	9	40772401	40772401	+	Missense_Mutation	SNP	T	T	A			GBM-TCGA-06-2559-Tumor-SM-16Y9G	GBM-TCGA-06-2559-Normal-SM-1QXN8	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-06-2559-Tumor-SM-16Y9G	GBM-TCGA-06-2559-Normal-SM-1QXN8	g.chr9:40772401T>A	ENST00000602553.1	-	5	3168	c.2874A>T	c.(2872-2874)agA>agT	p.R958S	ZNF658_ENST00000377626.3_Missense_Mutation_p.R958S|ZNF658_ENST00000441795.1_Intron			Q5TYW1	ZN658_HUMAN	zinc finger protein 658	958		NA			regulation of transcription, DNA-dependent|transcription, DNA-dependent	nucleus	DNA binding|zinc ion binding			breast(3)|central_nervous_system(1)|endometrium(6)|kidney(1)|large_intestine(9)|lung(21)|ovary(2)|prostate(1)|upper_aerodigestive_tract(2)	46				GBM - Glioblastoma multiforme(29;0.02)|Lung(182;0.0681)		CTGTGTGAATTCTTTGATGTA	0.438	NA	NA												NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA									NA				0													22	24	23	NA		NA	NA	9		NA											NA				40772401		1496	3161	4657	SO:0001583	missense			ENSG00000196409	HGNC:25226	NM_033160	Approved	uc004abs.2	NA	Q6PIP3|Q96M55|Q9H9S6|Q9UG02	ENST00000602553.1	37	CCDS35023.1	.	.	.	.	.	.	.	.	.	.	t	12.69	2.012267	0.35511	.	.	ENSG00000196409	ENST00000377626	T	0.02395	4.31	2.16	1.01	0.19927	Zinc finger, C2H2-like (1);Zinc finger, C2H2 (3);Zinc finger, C2H2-type/integrase, DNA-binding (1);	.	.	.	.	T	0.09423	0.0232	M	0.67569	2.06	0.80722	D	1	D	0.76494	0.999	D	0.74023	0.982	T	0.07712	-1.0758	9	0.66056	D	0.02	.	5.3348	0.15951	0.0:0.1597:0.0:0.8403	.	958	Q5TYW1	ZN658_HUMAN	S	958	ENSP00000366853:R958S	ENSP00000366853:R958S	R	-	3	2	ZNF658	40762401	0.000000	0.05858	0.054000	0.19295	0.479000	0.33129	-0.396000	0.07278	0.311000	0.23014	0.423000	0.28283	AGA	ZNF658-003	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000467800.1	329.575746	KEEP		-	329.628216	0.517241	105	98	---	---	---	---	1	0.8836749	3	3	0	350	117	119	0	350	2	0	0	0	0	0	0	117	119	0	350	2	TP
STXBP1	6812	broad.mit.edu	37	9	130420652	130420652	+	Splice_Site	SNP	A	A	T			GBM-TCGA-06-2559-Tumor-SM-16Y9G	GBM-TCGA-06-2559-Normal-SM-1QXN8	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-06-2559-Tumor-SM-16Y9G	GBM-TCGA-06-2559-Normal-SM-1QXN8	g.chr9:130420652A>T	ENST00000373302.3	+	4	308		c.e4-1		STXBP1_ENST00000373299.1_Splice_Site	NM_003165.3	NP_003156.1	P61764	STXB1_HUMAN	syntaxin binding protein 1	NA		NA			axon target recognition|energy reserve metabolic process|glutamate secretion|negative regulation of synaptic transmission, GABAergic|neurotransmitter secretion|platelet aggregation|platelet degranulation|protein transport|regulation of insulin secretion|regulation of synaptic vesicle priming|synaptic vesicle maturation|vesicle docking involved in exocytosis	cytosol|mitochondrion|plasma membrane|platelet alpha granule|protein complex	identical protein binding|syntaxin-1 binding|syntaxin-2 binding			breast(1)|endometrium(6)|kidney(1)|large_intestine(6)|lung(7)|skin(2)	23						TTTGTTGTCTAGTTGTGGAAG	0.458	NA	NA												NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA									NA				0													201	201	201	NA		NA	NA	9		NA											NA				130420652		2203	4300	6503	SO:0001630	splice_region_variant			ENSG00000136854	HGNC:11444	NM_003165	Approved	uc004brk.2	NA	B1AM97|Q28208|Q62759|Q64320|Q96TG8	ENST00000373302.3	37	CCDS6874.1	.	.	.	.	.	.	.	.	.	.	A	22.9	4.353654	0.82243	.	.	ENSG00000136854	ENST00000535154;ENST00000373302;ENST00000373299	.	.	.	5.65	4.51	0.55191	.	.	.	.	.	.	.	.	.	.	.	0.80722	D	1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	9.7011	0.40187	0.9181:0.0:0.0819:0.0	.	.	.	.	.	-1	.	.	.	+	.	.	STXBP1	129460473	1.000000	0.71417	1.000000	0.80357	0.990000	0.78478	9.260000	0.95568	0.982000	0.38575	0.528000	0.53228	.	STXBP1-001	NOVEL	basic|exp_conf|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000054228.1	-141.636532	KEEP	Intron	+	9.885001	0.014184	8	556	---	---	---	---	1	0.4463467	80	1	0	423	13	723	0	423	2	0	0	0	0	0	0	13	723	0	423	2	TP
GDI2	2665	broad.mit.edu	37	10	5838827	5838827	+	Splice_Site	SNP	T	T	A			GBM-TCGA-06-2559-Tumor-SM-16Y9G	GBM-TCGA-06-2559-Normal-SM-1QXN8	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-06-2559-Tumor-SM-16Y9G	GBM-TCGA-06-2559-Normal-SM-1QXN8	g.chr10:5838827T>A	ENST00000380191.4	-	3	444		c.e3-2		GDI2_ENST00000380181.3_Splice_Site|GDI2_ENST00000380132.4_Splice_Site	NM_001115156.1|NM_001494.3	NP_001108628.1|NP_001485.2	P50395	GDIB_HUMAN	GDP dissociation inhibitor 2	NA		NA			protein transport|small GTPase mediated signal transduction	cell surface|cytosol|membrane	protein binding|Rab GDP-dissociation inhibitor activity			NS(1)|breast(1)|large_intestine(1)|lung(6)|urinary_tract(1)	10						TTTGTATAACTAAAAGCAAGG	0.308	NA	NA												NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA									NA				0													72	72	72	NA		NA	NA	10		NA											NA				5838827		2203	4300	6503	SO:0001630	splice_region_variant			ENSG00000057608	HGNC:4227	NM_001494	Approved	uc001iil.4	NA	O43928|Q9UQM6	ENST00000380191.4	37	CCDS7071.1	.	.	.	.	.	.	.	.	.	.	T	21.7	4.182383	0.78677	.	.	ENSG00000057608	ENST00000380191;ENST00000380132;ENST00000380181;ENST00000456041;ENST00000418688;ENST00000380127	.	.	.	4.74	4.74	0.60224	.	.	.	.	.	.	.	.	.	.	.	0.80722	D	1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	14.2081	0.65748	0.0:0.0:0.0:1.0	.	.	.	.	.	-1	.	.	.	-	.	.	GDI2	5878833	1.000000	0.71417	1.000000	0.80357	0.975000	0.68041	7.928000	0.87587	1.884000	0.54569	0.533000	0.62120	.	GDI2-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000046580.1	-0.130818	KEEP	Intron	-	7.295728	0.090909	4	40	---	---	---	---	1	0.9754731	385	0	1	121	4	44	1	121	12	0	0	0	0	0	0	4	44	1	121	2	TP
ANK3	288	broad.mit.edu	37	10	61831234	61831234	+	Silent	SNP	A	A	T			GBM-TCGA-06-2559-Tumor-SM-16Y9G	GBM-TCGA-06-2559-Normal-SM-1QXN8	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-06-2559-Tumor-SM-16Y9G	GBM-TCGA-06-2559-Normal-SM-1QXN8	g.chr10:61831234A>T	ENST00000280772.1	-	37	9596	c.9405T>A	c.(9403-9405)acT>acA	p.T3135T	ANK3_ENST00000373827.2_Intron|ANK3_ENST00000355288.2_Intron|ANK3_ENST00000503366.1_Intron	NM_020987.3	NP_066267.2	Q12955	ANK3_HUMAN	ankyrin 3, node of Ranvier (ankyrin G)	3135		NA			establishment of protein localization|signal transduction	basolateral plasma membrane|cytoplasm|cytoskeleton	protein binding			NS(4)|breast(7)|central_nervous_system(5)|endometrium(19)|haematopoietic_and_lymphoid_tissue(5)|kidney(14)|large_intestine(30)|liver(2)|lung(59)|ovary(8)|pancreas(2)|prostate(5)|skin(26)|stomach(2)|upper_aerodigestive_tract(1)|urinary_tract(7)	196						TTTGCTGTCTAGTTGTATAAA	0.418	NA	NA												NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA									NA				0													134	143	140	NA		NA	NA	10		NA											NA				61831234		2203	4300	6503	SO:0001819	synonymous_variant			ENSG00000151150	HGNC:494	NM_020987	Approved	uc001jky.3	NA	Q5VXD5	ENST00000280772.1	37	CCDS7258.1																																																																																			ANK3-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000048201.3	-32.666267	KEEP		-	6.721986	0.030675	5	158	---	---	---	---	1	0.09764638	14	1	0	434	5	204	0	434	2	0	0	0	0	0	0	5	204	0	434	2	TP
ADAMTS14	140766	broad.mit.edu	37	10	72495039	72495039	+	Silent	SNP	C	C	T			GBM-TCGA-06-2559-Tumor-SM-16Y9G	GBM-TCGA-06-2559-Normal-SM-1QXN8	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-06-2559-Tumor-SM-16Y9G	GBM-TCGA-06-2559-Normal-SM-1QXN8	g.chr10:72495039C>T	ENST00000373208.1	+	9	1476	c.1476C>T	c.(1474-1476)ggC>ggT	p.G492G	ADAMTS14_ENST00000373207.1_Silent_p.G489G	NM_139155.2	NP_631894.2	Q8WXS8	ATS14_HUMAN	ADAM metallopeptidase with thrombospondin type 1 motif, 14	489	Disintegrin.	NA			collagen catabolic process|proteolysis	proteinaceous extracellular matrix	metalloendopeptidase activity|zinc ion binding			NS(1)|autonomic_ganglia(1)|endometrium(2)|haematopoietic_and_lymphoid_tissue(1)|kidney(5)|large_intestine(11)|lung(15)|ovary(7)|prostate(3)|skin(1)|upper_aerodigestive_tract(1)|urinary_tract(2)	50						TTGGCAGTGGCTACCAGACCT	0.592	NA	NA												NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA									NA				0													59	58	58	NA		NA	NA	10		NA											NA				72495039		2203	4300	6503	SO:0001819	synonymous_variant			ENSG00000138316	HGNC:14899	NM_080722	Approved	uc001jrg.3	NA	Q5T4G0|Q8TE55|Q8TEY8	ENST00000373208.1	37	CCDS7307.1																																																																																			ADAMTS14-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000048521.1	99.750368	KEEP		+	104.544464	0.9	27	3	---	---	---	---	1	0.9980186	2	1	0	77	36	4	0	77	2	0	0	0	0	0	0	36	4	0	77	2	TP
PTEN	5728	broad.mit.edu	37	10	89692993	89692993	+	Missense_Mutation	SNP	G	G	T			GBM-TCGA-06-2559-Tumor-SM-16Y9G	GBM-TCGA-06-2559-Normal-SM-1QXN8	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Valid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-06-2559-Tumor-SM-16Y9G	GBM-TCGA-06-2559-Normal-SM-1QXN8	g.chr10:89692993G>T	ENST00000371953.3	+	5	1834	c.477G>T	c.(475-477)agG>agT	p.R159S		NM_000314.4	NP_000305.3	P60484	PTEN_HUMAN	phosphatase and tensin homolog	159	Phosphatase tensin-type.	NA			activation of mitotic anaphase-promoting complex activity|apoptosis|canonical Wnt receptor signaling pathway|cell proliferation|central nervous system development|induction of apoptosis|inositol phosphate dephosphorylation|negative regulation of cell migration|negative regulation of cyclin-dependent protein kinase activity involved in G1/S|negative regulation of focal adhesion assembly|negative regulation of G1/S transition of mitotic cell cycle|negative regulation of protein kinase B signaling cascade|negative regulation of protein phosphorylation|nerve growth factor receptor signaling pathway|phosphatidylinositol dephosphorylation|phosphatidylinositol-mediated signaling|positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process|positive regulation of sequence-specific DNA binding transcription factor activity|protein stabilization|regulation of neuron projection development|T cell receptor signaling pathway	cytosol|internal side of plasma membrane|PML body	anaphase-promoting complex binding|enzyme binding|inositol-1,3,4,5-tetrakisphosphate 3-phosphatase activity|lipid binding|magnesium ion binding|PDZ domain binding|phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity|phosphatidylinositol-3,4-bisphosphate 3-phosphatase activity|phosphatidylinositol-3-phosphatase activity|protein serine/threonine phosphatase activity|protein tyrosine phosphatase activity|protein tyrosine/serine/threonine phosphatase activity	p.0?(37)|p.R159S(7)|p.?(5)|p.R55fs*1(5)|p.Y27fs*1(2)|p.F56fs*2(1)		NS(28)|autonomic_ganglia(2)|biliary_tract(6)|bone(5)|breast(92)|central_nervous_system(676)|cervix(26)|endometrium(1068)|eye(8)|haematopoietic_and_lymphoid_tissue(137)|kidney(24)|large_intestine(98)|liver(20)|lung(91)|meninges(2)|oesophagus(2)|ovary(82)|pancreas(6)|prostate(129)|salivary_gland(5)|skin(127)|soft_tissue(19)|stomach(30)|testis(1)|thyroid(29)|upper_aerodigestive_tract(29)|urinary_tract(12)|vulva(17)	2771		all_cancers(4;3.61e-31)|all_epithelial(4;3.96e-23)|Prostate(4;8.12e-23)|Breast(4;0.000111)|Melanoma(5;0.00146)|all_hematologic(4;0.00227)|Colorectal(252;0.00494)|all_neural(4;0.00513)|Acute lymphoblastic leukemia(4;0.0116)|Glioma(4;0.0274)|all_lung(38;0.132)	KIRC - Kidney renal clear cell carcinoma(1;0.214)	UCEC - Uterine corpus endometrioid carcinoma (6;0.000228)|all cancers(1;4.16e-84)|GBM - Glioblastoma multiforme(1;7.77e-49)|Epithelial(1;7.67e-41)|OV - Ovarian serous cystadenocarcinoma(1;6.22e-15)|BRCA - Breast invasive adenocarcinoma(1;1.1e-06)|Lung(2;3.18e-06)|Colorectal(12;4.88e-06)|LUSC - Lung squamous cell carcinoma(2;4.97e-06)|COAD - Colon adenocarcinoma(12;1.13e-05)|Kidney(1;0.000288)|KIRC - Kidney renal clear cell carcinoma(1;0.00037)|STAD - Stomach adenocarcinoma(243;0.218)		GGGAAGTAAGGACCAGAGACA	0.368	NA	31	"""D, Mis, N, F, S"""		"""glioma,  prostate, endometrial"""	"""harmartoma, glioma,  prostate, endometrial"""			Proteus syndrome;Juvenile Polyposis;Hereditary Mixed Polyposis Syndrome type 1;Cowden syndrome;Bannayan-Riley-Ruvalcaba syndrome	HNSCC(9;0.0022)|TCGA GBM(2;<1E-08)|TSP Lung(26;0.18)				NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA			yes	Rec	yes	"""Cowden Syndrome, Bannayan-Riley-Ruvalcaba syndrome"""	10	10q23.3	5728	phosphatase and tensin homolog gene		"""L, E, M, O"""	57	Whole gene deletion(37)|Deletion - Frameshift(8)|Substitution - Missense(7)|Unknown(5)	prostate(16)|central_nervous_system(11)|haematopoietic_and_lymphoid_tissue(8)|skin(6)|lung(5)|breast(3)|ovary(3)|large_intestine(2)|soft_tissue(1)|endometrium(1)|urinary_tract(1)											53	55	54	NA		NA	NA	10		NA											NA				89692993		2203	4300	6503	SO:0001583	missense	Familial Cancer Database	Incl.: Encephalocraniocutaneous Lipomatosis, ECCL, Proteus-like s.;incl.: Juvenile Polyposis of the Stomach;HMPS1, Colorectal Adenoma Carcinoma syndrome, CRAC, CRAC1;CS, Cowden disease, Multiple Hamartoma Syndrome, incl.: Lhermitte-Duclos; part of PTEN hamartoma tumour syndrome (PHTS) / PTEN-MATCHS, Cowden-like syndrome;subset of PTEN-Hamartoma Tumor Syndrome; incl.: Ruvalcaba-Myhre-Smith s.	ENSG00000171862	HGNC:9588	NM_000314	Approved	uc001kfb.3	NA	B2R904|O00633|O02679|Q6ICT7	ENST00000371953.3	37	CCDS31238.1	.	.	.	.	.	.	.	.	.	.	G	27.9	4.874058	0.91664	.	.	ENSG00000171862	ENST00000371953	D	0.99762	-6.67	5.09	5.09	0.68999	Phosphatase tensin type (1);Dual specificity phosphatase, catalytic domain (1);	0.000000	0.85682	D	0.000000	D	0.99878	0.9942	H	0.97365	3.99	0.80722	D	1	D	0.89917	1.0	D	0.87578	0.998	D	0.96285	0.9209	9	.	.	.	-3.7525	18.493	0.90854	0.0:0.0:1.0:0.0	.	159	P60484	PTEN_HUMAN	S	159	ENSP00000361021:R159S	.	R	+	3	2	PTEN	89682973	1.000000	0.71417	1.000000	0.80357	0.998000	0.95712	9.429000	0.97481	2.341000	0.79615	0.563000	0.77884	AGG	PTEN-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000049241.1	173.446954	KEEP		+	175.076425	0.653846	51	27	---	---	---	---	1	1	17	49	0	131	63	33	0	131	2	1	1	182	57	0	269	63	33	0	131	2	TP
PTEN	5728	broad.mit.edu	37	10	89720852	89720852	+	Nonsense_Mutation	SNP	C	C	T	rs121909231		GBM-TCGA-06-2559-Tumor-SM-16Y9G	GBM-TCGA-06-2559-Normal-SM-1QXN8	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Valid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-06-2559-Tumor-SM-16Y9G	GBM-TCGA-06-2559-Normal-SM-1QXN8	g.chr10:89720852C>T	ENST00000371953.3	+	8	2360	c.1003C>T	c.(1003-1005)Cga>Tga	p.R335*	PTEN_ENST00000472832.1_3'UTR	NM_000314.4	NP_000305.3	P60484	PTEN_HUMAN	phosphatase and tensin homolog	335	C2 tensin-type.	NA			activation of mitotic anaphase-promoting complex activity|apoptosis|canonical Wnt receptor signaling pathway|cell proliferation|central nervous system development|induction of apoptosis|inositol phosphate dephosphorylation|negative regulation of cell migration|negative regulation of cyclin-dependent protein kinase activity involved in G1/S|negative regulation of focal adhesion assembly|negative regulation of G1/S transition of mitotic cell cycle|negative regulation of protein kinase B signaling cascade|negative regulation of protein phosphorylation|nerve growth factor receptor signaling pathway|phosphatidylinositol dephosphorylation|phosphatidylinositol-mediated signaling|positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process|positive regulation of sequence-specific DNA binding transcription factor activity|protein stabilization|regulation of neuron projection development|T cell receptor signaling pathway	cytosol|internal side of plasma membrane|PML body	anaphase-promoting complex binding|enzyme binding|inositol-1,3,4,5-tetrakisphosphate 3-phosphatase activity|lipid binding|magnesium ion binding|PDZ domain binding|phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity|phosphatidylinositol-3,4-bisphosphate 3-phosphatase activity|phosphatidylinositol-3-phosphatase activity|protein serine/threonine phosphatase activity|protein tyrosine phosphatase activity|protein tyrosine/serine/threonine phosphatase activity	p.0?(37)|p.R335*(25)|p.R55fs*1(5)|p.?(2)|p.N212fs*1(2)|p.Y27fs*1(2)|p.G165_*404del(1)|p.R335G(1)|p.W274_F341del(1)|p.D326_K342del(1)		NS(28)|autonomic_ganglia(2)|biliary_tract(6)|bone(5)|breast(92)|central_nervous_system(676)|cervix(26)|endometrium(1068)|eye(8)|haematopoietic_and_lymphoid_tissue(137)|kidney(24)|large_intestine(98)|liver(20)|lung(91)|meninges(2)|oesophagus(2)|ovary(82)|pancreas(6)|prostate(129)|salivary_gland(5)|skin(127)|soft_tissue(19)|stomach(30)|testis(1)|thyroid(29)|upper_aerodigestive_tract(29)|urinary_tract(12)|vulva(17)	2771		all_cancers(4;3.61e-31)|all_epithelial(4;3.96e-23)|Prostate(4;8.12e-23)|Breast(4;0.000111)|Melanoma(5;0.00146)|all_hematologic(4;0.00227)|Colorectal(252;0.00494)|all_neural(4;0.00513)|Acute lymphoblastic leukemia(4;0.0116)|Glioma(4;0.0274)|all_lung(38;0.132)	KIRC - Kidney renal clear cell carcinoma(1;0.214)	UCEC - Uterine corpus endometrioid carcinoma (6;0.000228)|all cancers(1;4.16e-84)|GBM - Glioblastoma multiforme(1;7.77e-49)|Epithelial(1;7.67e-41)|OV - Ovarian serous cystadenocarcinoma(1;6.22e-15)|BRCA - Breast invasive adenocarcinoma(1;1.1e-06)|Lung(2;3.18e-06)|Colorectal(12;4.88e-06)|LUSC - Lung squamous cell carcinoma(2;4.97e-06)|COAD - Colon adenocarcinoma(12;1.13e-05)|Kidney(1;0.000288)|KIRC - Kidney renal clear cell carcinoma(1;0.00037)|STAD - Stomach adenocarcinoma(243;0.218)		CAAAGCCAACCGATACTTTTC	0.333	NA	31	"""D, Mis, N, F, S"""		"""glioma,  prostate, endometrial"""	"""harmartoma, glioma,  prostate, endometrial"""			Proteus syndrome;Juvenile Polyposis;Hereditary Mixed Polyposis Syndrome type 1;Cowden syndrome;Bannayan-Riley-Ruvalcaba syndrome	HNSCC(9;0.0022)|TCGA GBM(2;<1E-08)|TSP Lung(26;0.18)				NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA			yes	Rec	yes	"""Cowden Syndrome, Bannayan-Riley-Ruvalcaba syndrome"""	10	10q23.3	5728	phosphatase and tensin homolog gene		"""L, E, M, O"""	77	Whole gene deletion(37)|Substitution - Nonsense(25)|Deletion - Frameshift(9)|Deletion - In frame(3)|Unknown(2)|Substitution - Missense(1)	central_nervous_system(25)|prostate(16)|skin(8)|haematopoietic_and_lymphoid_tissue(7)|endometrium(6)|lung(4)|breast(3)|ovary(3)|urinary_tract(2)|upper_aerodigestive_tract(1)|stomach(1)|soft_tissue(1)	GRCh37	CM971278	PTEN	M	rs121909231						60	63	62	NA		NA	NA	10		NA											NA				89720852		2203	4298	6501	SO:0001587	stop_gained	Familial Cancer Database	Incl.: Encephalocraniocutaneous Lipomatosis, ECCL, Proteus-like s.;incl.: Juvenile Polyposis of the Stomach;HMPS1, Colorectal Adenoma Carcinoma syndrome, CRAC, CRAC1;CS, Cowden disease, Multiple Hamartoma Syndrome, incl.: Lhermitte-Duclos; part of PTEN hamartoma tumour syndrome (PHTS) / PTEN-MATCHS, Cowden-like syndrome;subset of PTEN-Hamartoma Tumor Syndrome; incl.: Ruvalcaba-Myhre-Smith s.	ENSG00000171862	HGNC:9588	NM_000314	Approved	uc001kfb.3	NA	B2R904|O00633|O02679|Q6ICT7	ENST00000371953.3	37	CCDS31238.1	.	.	.	.	.	.	.	.	.	.	C	48	14.209601	0.99784	.	.	ENSG00000171862	ENST00000371953	.	.	.	5.37	4.39	0.52855	.	0.053988	0.64402	D	0.000002	.	.	.	.	.	.	0.80722	A	1	.	.	.	.	.	.	.	.	.	.	.	.	.	0.4934	12.825	0.57714	0.2831:0.7169:0.0:0.0	.	.	.	.	X	335	.	.	R	+	1	2	PTEN	89710832	1.000000	0.71417	1.000000	0.80357	0.997000	0.91878	2.629000	0.46485	2.516000	0.84829	0.591000	0.81541	CGA	PTEN-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000049241.1	3.959677	KEEP		+	18.516452	0.084337	7	76	---	---	---	---	1	0.9917158	3	85	0	206	10	101	0	206	2	1	0.9980974	23	311	4	421	10	101	0	206	9	TP
ATRNL1	26033	broad.mit.edu	37	10	116925316	116925316	+	Splice_Site	SNP	A	A	T			GBM-TCGA-06-2559-Tumor-SM-16Y9G	GBM-TCGA-06-2559-Normal-SM-1QXN8	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-06-2559-Tumor-SM-16Y9G	GBM-TCGA-06-2559-Normal-SM-1QXN8	g.chr10:116925316A>T	ENST00000355044.3	+	7	1130		c.e7-1		ATRNL1_ENST00000527407.1_Intron|ATRNL1_ENST00000529665.1_Splice_Site	NM_207303.2	NP_997186.1	Q5VV63	ATRN1_HUMAN	attractin-like 1	NA		NA				integral to membrane	sugar binding			NS(1)|breast(1)|central_nervous_system(2)|cervix(2)|endometrium(7)|haematopoietic_and_lymphoid_tissue(2)|kidney(8)|large_intestine(11)|liver(2)|lung(44)|ovary(6)|prostate(1)|skin(4)|stomach(1)|upper_aerodigestive_tract(1)|urinary_tract(2)	95		all_lung(145;0.0686)|Breast(234;0.0969)|Lung NSC(174;0.17)|Colorectal(252;0.234)		Epithelial(162;0.00031)|all cancers(201;0.000753)|LUSC - Lung squamous cell carcinoma(1;0.0515)|Lung(30;0.0827)		TCTTGCTTTTAGTTACAATTT	0.328	NA	NA												NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA									NA				0													69	69	69	NA		NA	NA	10		NA											NA				116925316		2203	4296	6499	SO:0001630	splice_region_variant			ENSG00000107518	HGNC:29063	XM_049349	Approved	uc001lcg.3	NA	O60283|Q5JSE8|Q5T5Y9|Q6T256|Q6ZSN4|Q86WX2	ENST00000355044.3	37	CCDS7592.1	.	.	.	.	.	.	.	.	.	.	A	23.1	4.375796	0.82682	.	.	ENSG00000107518	ENST00000355044	.	.	.	5.65	5.65	0.86999	.	.	.	.	.	.	.	.	.	.	.	0.80722	D	1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	15.8897	0.79286	1.0:0.0:0.0:0.0	.	.	.	.	.	-1	.	.	.	+	.	.	ATRNL1	116915306	1.000000	0.71417	1.000000	0.80357	0.935000	0.57460	8.784000	0.91818	2.150000	0.67090	0.528000	0.53228	.	ATRNL1-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000050507.3	-9.469979	KEEP	Intron	+	13.155724	0.061947	7	106	---	---	---	---	1	0.5718454	45	0	1	148	8	121	1	148	3	0	0	0	0	0	0	8	121	1	148	2	TP
C11orf30	56946	broad.mit.edu	37	11	76169225	76169225	+	Splice_Site	SNP	A	A	T			GBM-TCGA-06-2559-Tumor-SM-16Y9G	GBM-TCGA-06-2559-Normal-SM-1QXN8	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-06-2559-Tumor-SM-16Y9G	GBM-TCGA-06-2559-Normal-SM-1QXN8	g.chr11:76169225A>T	ENST00000529032.1	+	4	245		c.e4-1		C11orf30_ENST00000525959.1_3'UTR|C11orf30_ENST00000533248.1_Splice_Site|C11orf30_ENST00000334736.3_Splice_Site|C11orf30_ENST00000525919.1_Splice_Site|C11orf30_ENST00000525038.1_Splice_Site|C11orf30_ENST00000524767.1_Splice_Site|C11orf30_ENST00000524490.1_Splice_Site|C11orf30_ENST00000343878.3_Splice_Site			Q7Z589	EMSY_HUMAN	chromosome 11 open reading frame 30	NA		NA			chromatin modification|DNA repair|regulation of transcription, DNA-dependent|transcription, DNA-dependent	nucleus				NS(1)|breast(4)|central_nervous_system(1)|endometrium(3)|kidney(3)|large_intestine(10)|liver(1)|lung(23)|ovary(5)|prostate(2)|skin(4)|stomach(1)|urinary_tract(2)	60						TTTTTTGTTTAGTATGTCTGG	0.383	NA	NA												NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA									NA				0													79	82	81	NA		NA	NA	11		NA											NA				76169225		2200	4292	6492	SO:0001630	splice_region_variant			ENSG00000158636	HGNC:18071	NM_020193	Approved	uc001oxl.3	NA	Q4G109|Q8NBU6|Q8TE50|Q9H8I9|Q9NRH0	ENST00000529032.1	37	CCDS8244.1	.	.	.	.	.	.	.	.	.	.	A	21.7	4.191963	0.78902	.	.	ENSG00000158636	ENST00000524490;ENST00000334736;ENST00000343878;ENST00000393457;ENST00000524767;ENST00000533248;ENST00000525919;ENST00000525038;ENST00000529032	.	.	.	5.84	5.84	0.93424	.	.	.	.	.	.	.	.	.	.	.	0.80722	D	1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	16.2129	0.82178	1.0:0.0:0.0:0.0	.	.	.	.	.	-1	.	.	.	+	.	.	C11orf30	75846873	1.000000	0.71417	1.000000	0.80357	0.995000	0.86356	9.339000	0.96797	2.220000	0.72140	0.482000	0.46254	.	C11orf30-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000383288.2	-21.163812	KEEP	Intron	+	7.740194	0.045802	6	125	---	---	---	---	1	0.1190477	14	0	0	157	6	160	0	157	2	0	0	0	0	0	0	6	160	0	157	2	TP
CCDC91	55297	broad.mit.edu	37	12	28458580	28458580	+	Splice_Site	SNP	A	A	T			GBM-TCGA-06-2559-Tumor-SM-16Y9G	GBM-TCGA-06-2559-Normal-SM-1QXN8	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-06-2559-Tumor-SM-16Y9G	GBM-TCGA-06-2559-Normal-SM-1QXN8	g.chr12:28458580A>T	ENST00000545336.1	+	7	528		c.e7-1		CCDC91_ENST00000381256.1_Splice_Site|CCDC91_ENST00000540401.1_Splice_Site|CCDC91_ENST00000539107.1_Splice_Site|CCDC91_ENST00000306172.5_Splice_Site|CCDC91_ENST00000381259.1_Splice_Site			Q7Z6B0	CCD91_HUMAN	coiled-coil domain containing 91	NA		NA			protein transport	Golgi apparatus|membrane				NS(1)|breast(3)|central_nervous_system(1)|endometrium(1)|kidney(2)|large_intestine(5)|lung(8)|skin(1)	22	Acute lymphoblastic leukemia(23;0.00718)|all_hematologic(23;0.0113)|Lung SC(9;0.184)					GTTTTTCTTTAGTATCTGGAG	0.393	NA	NA												NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA									NA				0													191	185	187	NA		NA	NA	12		NA											NA				28458580		2203	4300	6503	SO:0001630	splice_region_variant				HGNC:24855	NM_018318	Approved	uc001riq.3	NA	B3KSA3|C9JR07|Q68D43|Q6IA78|Q8NEN7|Q9NUW9	ENST00000545336.1	37	CCDS8716.1	.	.	.	.	.	.	.	.	.	.	A	10.50	1.368066	0.24771	.	.	ENSG00000123106	ENST00000538586;ENST00000539107;ENST00000536442;ENST00000545336;ENST00000543534;ENST00000545737;ENST00000381259;ENST00000381256;ENST00000306172	.	.	.	4.86	4.86	0.63082	.	.	.	.	.	.	.	.	.	.	.	0.80722	D	1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	11.0599	0.47942	1.0:0.0:0.0:0.0	.	.	.	.	.	-1	.	.	.	+	.	.	CCDC91	28349847	0.998000	0.40836	0.923000	0.36655	0.233000	0.25261	4.431000	0.59915	2.172000	0.68678	0.477000	0.44152	.	CCDC91-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000402447.1	-144.574191	KEEP	Intron	+	25.185813	0.023774	16	657	---	---	---	---	1	0.3583431	47	1	0	476	21	814	0	476	2	0	0	0	0	0	0	21	814	0	476	2	TP
SLC4A8	9498	broad.mit.edu	37	12	51853894	51853894	+	Splice_Site	SNP	T	T	A			GBM-TCGA-06-2559-Tumor-SM-16Y9G	GBM-TCGA-06-2559-Normal-SM-1QXN8	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-06-2559-Tumor-SM-16Y9G	GBM-TCGA-06-2559-Normal-SM-1QXN8	g.chr12:51853894T>A	ENST00000453097.2	+	8	1230		c.e8+2		SLC4A8_ENST00000358657.3_Splice_Site|SLC4A8_ENST00000394856.1_Splice_Site|SLC4A8_ENST00000535225.2_Splice_Site|SLC4A8_ENST00000514353.3_Splice_Site	NM_001039960.2|NM_001258401.2	NP_001035049.1|NP_001245330.1	Q2Y0W8	S4A8_HUMAN	solute carrier family 4, sodium bicarbonate cotransporter, member 8	NA		NA			bicarbonate transport|sodium ion transport	integral to membrane|plasma membrane	inorganic anion exchanger activity			NS(1)|breast(2)|central_nervous_system(1)|endometrium(7)|haematopoietic_and_lymphoid_tissue(1)|large_intestine(7)|lung(18)|ovary(3)|pancreas(1)|prostate(1)|skin(6)|stomach(2)|urinary_tract(5)	55				BRCA - Breast invasive adenocarcinoma(357;0.15)		CCCAACAAGGTAAAGGCAAAG	0.383	NA	NA												NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA									NA				0													138	135	136	NA		NA	NA	12		NA											NA				51853894		2203	4300	6503	SO:0001630	splice_region_variant			ENSG00000050438	HGNC:11034	NM_004858	Approved	uc001rys.2	NA	A0MMZ1|O94843|O95233|Q004B4|Q8N3U2|Q8TC60|Q9UKX8	ENST00000453097.2	37	CCDS44890.1	.	.	.	.	.	.	.	.	.	.	T	25.5	4.639555	0.87760	.	.	ENSG00000050438	ENST00000535225;ENST00000358657;ENST00000453097;ENST00000394856;ENST00000319957;ENST00000514353;ENST00000547697;ENST00000551071	.	.	.	5.38	5.38	0.77491	.	.	.	.	.	.	.	.	.	.	.	0.80722	D	1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	14.6856	0.69047	0.0:0.0:0.0:1.0	.	.	.	.	.	-1	.	.	.	+	.	.	SLC4A8	50140161	1.000000	0.71417	1.000000	0.80357	0.968000	0.65278	7.994000	0.88315	2.183000	0.69458	0.533000	0.62120	.	SLC4A8-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000404356.1	-141.622007	KEEP	Intron	+	8.164751	0.014337	8	550	---	---	---	---	1	0.1137333	36	0	0	331	9	640	0	331	2	0	0	0	0	0	0	9	640	0	331	2	TP
AGAP2	116986	broad.mit.edu	37	12	58125706	58125706	+	Silent	SNP	C	C	T	rs145122115		GBM-TCGA-06-2559-Tumor-SM-16Y9G	GBM-TCGA-06-2559-Normal-SM-1QXN8	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-06-2559-Tumor-SM-16Y9G	GBM-TCGA-06-2559-Normal-SM-1QXN8	g.chr12:58125706C>T	ENST00000257897.3	-	8	916	c.831G>A	c.(829-831)ccG>ccA	p.P277P	AGAP2_ENST00000547588.1_Silent_p.P613P	NM_014770.3	NP_055585.1	Q99490	AGAP2_HUMAN	ArfGAP with GTPase domain, ankyrin repeat and PH domain 2	613	Interaction with PLCG1 (By similarity).	NA			axon guidance|negative regulation of neuron apoptosis|negative regulation of protein catabolic process|protein transport|regulation of ARF GTPase activity|small GTPase mediated signal transduction	mitochondrion|nucleolus	ARF GTPase activator activity|GTP binding|zinc ion binding			breast(7)|central_nervous_system(3)|cervix(1)|endometrium(5)|large_intestine(7)|lung(20)|prostate(3)|skin(1)|stomach(1)	48						TCGGTGAGGACGGGAGGGAAG	0.622	NA	NA											C	1	5e-04	NA	0.0028	2184	NA	1	,	,	NA	3e-04	NA	NA	NA	5e-04	0.9547	LOWCOV,EXOME	NA	NA	5e-04	SNP								NA				0								C	,	1,4405	2.1+/-5.4	0,1,2202	55	51	52	NA	1839,831	-8.8	0.9	12	dbSNP_134	52	4,8596	3.7+/-12.6	0,4,4296	no	coding-synonymous,coding-synonymous	AGAP2	NM_001122772.2,NM_014770.3	,	0,5,6498	TT,TC,CC	NA	0.0465,0.0227,0.0384	,	613/1193,277/837	58125706	5,13001	2203	4300	6503	SO:0001819	synonymous_variant			ENSG00000135439	HGNC:16921	NM_014770	Approved	uc001spq.3	NA	A8K9F7|O00578|Q548E0|Q8IWU3	ENST00000257897.3	37	CCDS8951.1	1	4.578754578754579E-4	0	0.0	1	0.0027624309392265192	0	0.0	0	0.0	C	8.714	0.912723	0.17907	2.27E-4	4.65E-4	ENSG00000135439	ENST00000328568	.	.	.	4.63	-8.76	0.00830	.	.	.	.	.	T	0.49881	0.1583	.	.	.	0.80722	D	1	.	.	.	.	.	.	T	0.58696	-0.7591	4	.	.	.	.	10.4235	0.44365	0.1272:0.5646:0.0:0.3082	.	.	.	.	I	477	.	.	V	-	1	0	AGAP2	56411973	0.002000	0.14202	0.865000	0.33974	0.886000	0.51366	-2.005000	0.01460	-1.387000	0.02095	-1.267000	0.01435	GTC	AGAP2-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000408366.1	-92.67561	KEEP		-	58.655673	0.044118	30	650	---	---	---	---	1	0.9999999	21	644	0	32	33	865	0	32	2	0	0	0	0	0	0	33	865	0	32	2	TP
N6AMT2	221143	broad.mit.edu	37	13	21331636	21331636	+	Silent	SNP	G	G	A			GBM-TCGA-06-2559-Tumor-SM-16Y9G	GBM-TCGA-06-2559-Normal-SM-1QXN8	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-06-2559-Tumor-SM-16Y9G	GBM-TCGA-06-2559-Normal-SM-1QXN8	g.chr13:21331636G>A	ENST00000382758.1	-	2	149	c.102C>T	c.(100-102)ggC>ggT	p.G34G	N6AMT2_ENST00000382754.4_Silent_p.G34G|N6AMT2_ENST00000460374.1_5'UTR			Q8WVE0	N6MT2_HUMAN	N-6 adenine-specific DNA methyltransferase 2 (putative)	34		NA					methyltransferase activity|nucleic acid binding			endometrium(1)|large_intestine(3)|lung(3)	7		all_cancers(29;5.91e-19)|all_epithelial(30;1.42e-15)|all_lung(29;5.9e-14)|Lung SC(185;0.0367)		all cancers(112;0.000234)|Epithelial(112;0.000471)|OV - Ovarian serous cystadenocarcinoma(117;0.0111)|Lung(94;0.0161)|LUSC - Lung squamous cell carcinoma(192;0.0431)		TATCATCCTCGCCTGGCTCAA	0.418	NA	NA												NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA									NA				0													185	171	176	NA		NA	NA	13		NA											NA				21331636		2203	4300	6503	SO:0001819	synonymous_variant			ENSG00000150456	HGNC:27351	NM_174928	Approved	uc001uno.1	NA	B5G4V1	ENST00000382758.1	37	CCDS9293.1																																																																																			N6AMT2-002	KNOWN	alternative_5_UTR|basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000044083.1	109.467666	KEEP		-	127.475445	0.20362	45	176	---	---	---	---	1	0.9999592	2	43	0	230	55	204	0	230	2	0	0	0	0	0	0	55	204	0	230	2	TP
CHD8	57680	broad.mit.edu	37	14	21876530	21876530	+	Missense_Mutation	SNP	C	C	G			GBM-TCGA-06-2559-Tumor-SM-16Y9G	GBM-TCGA-06-2559-Normal-SM-1QXN8	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-06-2559-Tumor-SM-16Y9G	GBM-TCGA-06-2559-Normal-SM-1QXN8	g.chr14:21876530C>G	ENST00000399982.2	-	12	2735	c.2671G>C	c.(2671-2673)Ggc>Cgc	p.G891R	CHD8_ENST00000430710.3_Missense_Mutation_p.G612R|CHD8_ENST00000557364.1_Missense_Mutation_p.G891R|CHD8_ENST00000555962.1_Intron	NM_001170629.1	NP_001164100.1	Q9HCK8	CHD8_HUMAN	chromodomain helicase DNA binding protein 8	891	Helicase ATP-binding.	NA			ATP-dependent chromatin remodeling|canonical Wnt receptor signaling pathway|negative regulation of transcription, DNA-dependent|negative regulation of Wnt receptor signaling pathway|positive regulation of transcription from RNA polymerase II promoter|positive regulation of transcription from RNA polymerase III promoter|transcription, DNA-dependent	MLL1 complex	ATP binding|beta-catenin binding|DNA binding|DNA helicase activity|DNA-dependent ATPase activity|methylated histone residue binding|p53 binding			NS(2)|breast(1)|central_nervous_system(1)|cervix(4)|endometrium(8)|haematopoietic_and_lymphoid_tissue(2)|kidney(6)|large_intestine(8)|lung(33)|ovary(6)|prostate(7)|skin(3)|upper_aerodigestive_tract(2)|urinary_tract(2)	85	all_cancers(95;0.00121)		Epithelial(56;2.55e-06)|all cancers(55;1.73e-05)	GBM - Glioblastoma multiforme(265;0.00424)		GCCAGACTGCCATGGTACACA	0.438	NA	NA												NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA									NA				0													114	108	110	NA		NA	NA	14		NA											NA				21876530		1967	4181	6148	SO:0001583	missense				HGNC:20153	NM_020920	Approved	uc001war.2	NA	Q4G0D8|Q68DQ0|Q6DKH9|Q6P440|Q6ZNL7|Q8N3Z9|Q8NCY4|Q8TBR9|Q96F26	ENST00000399982.2	37	CCDS53885.1	.|.	.|.	.|.	.|.	.|.	.|.	.|.	.|.	.|.	.|.	C|C	28.8|28.8	4.948536|4.948536	0.92593|0.92593	.|.	.|.	ENSG00000100888|ENSG00000100888	ENST00000430710;ENST00000399982;ENST00000262707;ENST00000557364|ENST00000555935	D;D;D|.	0.95949|.	-3.86;-3.86;-3.86|.	5.29|5.29	5.29|5.29	0.74685|0.74685	DEAD-like helicase (2);SNF2-related (1);|.	0.000000|.	0.85682|.	D|.	0.000000|.	D|D	0.86125|0.86125	0.5858|0.5858	M|M	0.92122|0.92122	3.275|3.275	0.80722|0.80722	D|D	1|1	D;D|.	0.89917|.	1.0;1.0|.	D;D|.	0.87578|.	0.998;0.996|.	D|D	0.88974|0.88974	0.3403|0.3403	10|5	0.87932|.	D|.	0|.	-18.3065|-18.3065	17.8563|17.8563	0.88764|0.88764	0.0:1.0:0.0:0.0|0.0:1.0:0.0:0.0	.|.	891;612|.	Q9HCK8;Q9HCK8-2|.	CHD8_HUMAN;.|.	R|S	612;891;611;891|116	ENSP00000406288:G612R;ENSP00000382863:G891R;ENSP00000451601:G891R|.	ENSP00000262707:G611R|.	G|W	-|-	1|2	0|0	CHD8|CHD8	20946370|20946370	1.000000|1.000000	0.71417|0.71417	1.000000|1.000000	0.80357|0.80357	0.997000|0.997000	0.91878|0.91878	7.651000|7.651000	0.83577|0.83577	2.744000|2.744000	0.94065|0.94065	0.585000|0.585000	0.79938|0.79938	GGC|TGG	CHD8-201	KNOWN	basic|CCDS	protein_coding	NA	protein_coding		237.421728	KEEP		-	245.784585	0.308594	79	177	---	---	---	---	1	0.9996708	7	22	0	180	94	201	0	180	2	0	0	0	0	0	0	94	201	0	180	2	TP
DHRS2	10202	broad.mit.edu	37	14	24109023	24109023	+	Silent	SNP	C	C	T			GBM-TCGA-06-2559-Tumor-SM-16Y9G	GBM-TCGA-06-2559-Normal-SM-1QXN8	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-06-2559-Tumor-SM-16Y9G	GBM-TCGA-06-2559-Normal-SM-1QXN8	g.chr14:24109023C>T	ENST00000250383.6	+	4	815	c.339C>T	c.(337-339)ggC>ggT	p.G113G	DHRS2_ENST00000553896.1_3'UTR|DHRS2_ENST00000344777.7_Silent_p.G113G	NM_005794.3	NP_005785.1	Q13268	DHRS2_HUMAN	dehydrogenase/reductase (SDR family) member 2	91		NA			C21-steroid hormone metabolic process|cellular response to oxidative stress|myeloid dendritic cell differentiation|negative regulation of apoptosis|negative regulation of cell proliferation|response to toxin	mitochondrion|nuclear envelope	binding|carbonyl reductase (NADPH) activity			endometrium(1)|large_intestine(5)|lung(5)|ovary(1)|skin(1)|upper_aerodigestive_tract(1)	14				GBM - Glioblastoma multiforme(265;0.00659)		ACTGTGGGGGCGTCGACTTCC	0.637	NA	NA												NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA									NA				0													57	56	57	NA		NA	NA	14		NA											NA				24109023		2203	4300	6503	SO:0001819	synonymous_variant			ENSG00000100867	HGNC:18349	NM_182908	Approved	uc001wkt.4	NA	Q53GS4|Q7Z789|Q9H2R2	ENST00000250383.6	37	CCDS9604.1	.	.	.	.	.	.	.	.	.	.	.	3.891	-0.023970	0.07634	.	.	ENSG00000100867	ENST00000557535	.	.	.	4.55	-9.11	0.00711	.	.	.	.	.	T	0.25494	0.0620	.	.	.	0.20307	N	0.999916	.	.	.	.	.	.	T	0.21143	-1.0254	4	.	.	.	.	8.4174	0.32678	0.2446:0.0848:0.0:0.6706	.	.	.	.	C	29	.	.	R	+	1	0	DHRS2	23178863	0.000000	0.05858	0.000000	0.03702	0.001000	0.01503	-3.799000	0.00363	-3.801000	0.00105	-2.073000	0.00383	CGT	DHRS2-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000071842.2	153.028702	KEEP		+	153.567359	0.42735	50	67	---	---	---	---	1	0.5280328	2	1	0	103	63	93	0	103	2	0	0	0	0	0	0	63	93	0	103	2	TP
GNG2	54331	broad.mit.edu	37	14	52417366	52417366	+	Splice_Site	SNP	A	A	T			GBM-TCGA-06-2559-Tumor-SM-16Y9G	GBM-TCGA-06-2559-Normal-SM-1QXN8	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-06-2559-Tumor-SM-16Y9G	GBM-TCGA-06-2559-Normal-SM-1QXN8	g.chr14:52417366A>T	ENST00000335281.4	+	2	377		c.e2-1		GNG2_ENST00000556766.1_Splice_Site|GNG2_ENST00000555472.1_Splice_Site|GNG2_ENST00000554736.1_Splice_Site|GNG2_ENST00000556752.1_Splice_Site|GNG2_ENST00000553299.1_Splice_Site|GNG2_ENST00000554875.1_Splice_Site|GNG2_ENST00000553432.1_Splice_Site|GNG2_ENST00000557376.1_Splice_Site	NM_001243774.1	NP_001230703.1	P59768	GBG2_HUMAN	guanine nucleotide binding protein (G protein), gamma 2	NA		NA			cellular response to glucagon stimulus|energy reserve metabolic process|platelet activation|synaptic transmission	heterotrimeric G-protein complex	protein binding|signal transducer activity			lung(2)|prostate(1)|upper_aerodigestive_tract(1)|urinary_tract(1)	5	all_epithelial(31;0.0659)|Breast(41;0.0684)				Halothane(DB01159)	TTTCTTTTCTAGTGTTTCTGA	0.463	NA	NA												NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA									NA				0													51	48	49	NA		NA	NA	14		NA											NA				52417366		2203	4300	6503	SO:0001630	splice_region_variant				HGNC:4404		Approved	uc001wzj.3	NA	Q5JPE2|Q6P9A9	ENST00000335281.4	37	CCDS32082.1	.	.	.	.	.	.	.	.	.	.	A	10.89	1.479660	0.26511	.	.	ENSG00000186469	ENST00000553432;ENST00000557376;ENST00000554875	.	.	.	5.21	3.97	0.46021	.	.	.	.	.	.	.	.	.	.	.	0.80722	D	1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	7.7395	0.28833	0.8135:0.0:0.0:0.1865	.	.	.	.	.	-1	.	.	.	+	.	.	GNG2	51487116	0.948000	0.32251	0.989000	0.46669	0.295000	0.27426	2.125000	0.42016	2.267000	0.75376	0.533000	0.62120	.	GNG2-002	KNOWN	alternative_5_UTR|basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000411585.1	-61.898765	KEEP	Intron	+	9.060842	0.024735	7	276	---	---	---	---	1	0.04361061	234	2	1	70	7	297	1	70	13	0	0	0	0	0	0	7	297	1	70	2	TP
SIPA1L1	26037	broad.mit.edu	37	14	72139063	72139063	+	Splice_Site	SNP	A	A	T			GBM-TCGA-06-2559-Tumor-SM-16Y9G	GBM-TCGA-06-2559-Normal-SM-1QXN8	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-06-2559-Tumor-SM-16Y9G	GBM-TCGA-06-2559-Normal-SM-1QXN8	g.chr14:72139063A>T	ENST00000555818.1	+	9	3177		c.e9-1		SIPA1L1_ENST00000537413.1_Splice_Site|SIPA1L1_ENST00000358550.2_Splice_Site|SIPA1L1_ENST00000381232.3_Splice_Site	NM_015556.1	NP_056371.1	O43166	SI1L1_HUMAN	signal-induced proliferation-associated 1 like 1	NA		NA			actin cytoskeleton reorganization|activation of Rap GTPase activity|regulation of dendritic spine morphogenesis	cell junction|cytoplasm|dendritic spine|postsynaptic density|postsynaptic membrane|synaptosome	GTPase activator activity			NS(1)|breast(4)|central_nervous_system(1)|cervix(1)|endometrium(11)|kidney(1)|large_intestine(22)|liver(2)|lung(25)|ovary(3)|prostate(3)|skin(3)|stomach(1)	78				all cancers(60;0.00169)|BRCA - Breast invasive adenocarcinoma(234;0.00912)|OV - Ovarian serous cystadenocarcinoma(108;0.0109)		TTCCTTGTCTAGTTTGTTTCA	0.433	NA	NA												NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA									NA				0													88	78	81	NA		NA	NA	14		NA											NA				72139063		2203	4300	6503	SO:0001630	splice_region_variant				HGNC:20284	NM_015556	Approved	uc001xmr.1	NA	O95321|Q9UDU4|Q9UNU4	ENST00000555818.1	37	CCDS9807.1	.	.	.	.	.	.	.	.	.	.	A	16.12	3.032667	0.54790	.	.	ENSG00000197555	ENST00000381232;ENST00000555818;ENST00000358550;ENST00000537413	.	.	.	5.77	5.77	0.91146	.	.	.	.	.	.	.	.	.	.	.	0.80722	D	1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	16.0957	0.81123	1.0:0.0:0.0:0.0	.	.	.	.	.	-1	.	.	.	+	.	.	SIPA1L1	71208816	1.000000	0.71417	0.997000	0.53966	0.507000	0.33981	7.236000	0.78154	2.199000	0.70637	0.533000	0.62120	.	SIPA1L1-002	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000412806.1	-61.849654	KEEP	Intron	+	7.221308	0.02214	6	265	---	---	---	---	1	0.401167	68	0	0	179	6	329	0	179	2	0	0	0	0	0	0	6	329	0	179	2	TP
CTDSPL2	51496	broad.mit.edu	37	15	44751187	44751187	+	Splice_Site	SNP	A	A	T			GBM-TCGA-06-2559-Tumor-SM-16Y9G	GBM-TCGA-06-2559-Normal-SM-1QXN8	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-06-2559-Tumor-SM-16Y9G	GBM-TCGA-06-2559-Normal-SM-1QXN8	g.chr15:44751187A>T	ENST00000260327.4	+	2	539		c.e2-1		CTDSPL2_ENST00000396780.1_Splice_Site|CTDSPL2_ENST00000558966.1_Splice_Site|CTDSPL2_ENST00000558373.1_5'Flank	NM_016396.2	NP_057480.2	Q05D32	CTSL2_HUMAN	CTD (carboxy-terminal domain, RNA polymerase II, polypeptide A) small phosphatase like 2	NA		NA					phosphoprotein phosphatase activity			breast(1)|endometrium(1)|kidney(2)|large_intestine(3)|lung(4)|upper_aerodigestive_tract(2)	13		all_cancers(109;4.36e-14)|all_epithelial(112;9.8e-12)|Lung NSC(122;1.66e-07)|all_lung(180;1.47e-06)|Melanoma(134;0.0122)		all cancers(107;1.02e-20)|GBM - Glioblastoma multiforme(94;1.49e-06)|COAD - Colon adenocarcinoma(120;0.0857)|Colorectal(105;0.0905)		tttCTCTTTTAGTTTTACATG	0.343	NA	NA												NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA									NA				0													35	38	37	NA		NA	NA	15		NA											NA				44751187		2195	4296	6491	SO:0001630	splice_region_variant			ENSG00000137770	HGNC:26936	NM_016396	Approved	uc001ztr.3	NA	Q3ZTU1|Q6AI06|Q8IYI9|Q9NVT2|Q9NZX8|Q9P030	ENST00000260327.4	37	CCDS10110.1																																																																																			CTDSPL2-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000253851.1	18.420105	KEEP	Intron	+	22.406357	0.204082	10	39	---	---	---	---	1	0.9999656	87	7	0	85	11	45	0	85	2	0	0	0	0	0	0	11	45	0	85	2	TP
FUS	2521	broad.mit.edu	37	16	31195528	31195528	+	Splice_Site	SNP	A	A	T			GBM-TCGA-06-2559-Tumor-SM-16Y9G	GBM-TCGA-06-2559-Normal-SM-1QXN8	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-06-2559-Tumor-SM-16Y9G	GBM-TCGA-06-2559-Normal-SM-1QXN8	g.chr16:31195528A>T	ENST00000254108.7	+	5	440		c.e5-1		FUS_ENST00000568685.1_Splice_Site|FUS_ENST00000380244.3_Splice_Site|RP11-388M20.6_ENST00000564743.1_RNA	NM_001170634.1|NM_001170937.1|NM_004960.3	NP_001164105.1|NP_001164408.1|NP_004951.1	P35637	FUS_HUMAN	fused in sarcoma	NA		NA			cell death|nuclear mRNA splicing, via spliceosome	nucleoplasm	DNA binding|nucleotide binding|protein binding|RNA binding|zinc ion binding		FUS/ERG(167)|FUS/DDIT3(631)|FUS/FEV(2)|FUS/ATF1(4)|FUS/CREB3L1(6)|FUS/CREB3L2(158)	breast(3)|endometrium(5)|kidney(3)|large_intestine(1)|lung(5)|prostate(3)|skin(1)|urinary_tract(1)	22		Renal(780;0.000219)|Breast(268;0.00957)|Hepatocellular(780;0.121)		GBM - Glioblastoma multiforme(240;2.31e-05)|Kidney(780;0.000209)		TGTTTTCCCTAGTTACGGTAG	0.507	NA	NA	T	"""DDIT3, ERG, FEV, ATF1, CREB3L2, CREB3L1"""	"""liposarcoma, AML, Ewing sarcoma, angiomatoid fibrous histiocytoma, fibromyxoid sarcoma"""									NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA				Dom	yes		16	16p11.2	2521	"""fusion, derived from t(12;16) malignant liposarcoma"""		"""M, L"""	0													98	99	98	NA		NA	NA	16		NA											NA				31195528		2197	4300	6497	SO:0001630	splice_region_variant			ENSG00000089280	HGNC:4010	NM_004960	Approved	uc002ebe.2	NA	Q9H4A8	ENST00000254108.7	37	CCDS10707.1	.	.	.	.	.	.	.	.	.	.	A	12.51	1.958872	0.34565	.	.	ENSG00000089280	ENST00000254108;ENST00000394533	.	.	.	5.32	5.32	0.75619	.	.	.	.	.	.	.	.	.	.	.	0.80722	D	1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	14.2832	0.66226	1.0:0.0:0.0:0.0	.	.	.	.	.	-1	.	.	.	+	.	.	FUS	31103029	1.000000	0.71417	0.916000	0.36221	0.353000	0.29299	5.623000	0.67757	2.000000	0.58554	0.383000	0.25322	.	FUS-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000255526.2	-50.055896	KEEP	Intron	+	8.571815	0.025532	6	229	---	---	---	---	1	0.9981714	558	9	0	230	7	318	0	230	2	0	0	0	0	0	0	7	318	0	230	2	TP
NLRC5	84166	broad.mit.edu	37	16	57054711	57054711	+	Silent	SNP	C	C	T			GBM-TCGA-06-2559-Tumor-SM-16Y9G	GBM-TCGA-06-2559-Normal-SM-1QXN8	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-06-2559-Tumor-SM-16Y9G	GBM-TCGA-06-2559-Normal-SM-1QXN8	g.chr16:57054711C>T	ENST00000436936.1	+	3	312	c.87C>T	c.(85-87)aaC>aaT	p.N29N	NLRC5_ENST00000262510.6_Silent_p.N29N|NLRC5_ENST00000308149.7_Silent_p.N29N|NLRC5_ENST00000539144.1_Silent_p.N29N			Q86WI3	NLRC5_HUMAN	NLR family, CARD domain containing 5	29		NA			defense response to virus|innate immune response|negative regulation of NF-kappaB transcription factor activity|negative regulation of type I interferon production|negative regulation of type I interferon-mediated signaling pathway|positive regulation of interferon-gamma-mediated signaling pathway|positive regulation of MHC class I biosynthetic process|positive regulation of transcription from RNA polymerase II promoter|positive regulation of type I interferon-mediated signaling pathway|regulation of kinase activity	cytosol|nucleus	ATP binding|protein binding|RNA polymerase II core promoter sequence-specific DNA binding			NS(2)|breast(2)|central_nervous_system(3)|cervix(1)|endometrium(5)|haematopoietic_and_lymphoid_tissue(1)|kidney(3)|large_intestine(16)|lung(21)|ovary(8)|prostate(1)|skin(6)|stomach(1)|upper_aerodigestive_tract(3)|urinary_tract(2)	75		all_neural(199;0.225)				AATGGCTGAACGCCAAGATGA	0.562	NA	NA											C	1	5e-04	NA	NA	2184	NA	1	,	,	NA	3e-04	0.0013	NA	NA	5e-04	1	EXOME	NA	NA	8e-04	SNP								NA				0													98	87	91	NA		NA	NA	16		NA											NA				57054711		2198	4300	6498	SO:0001819	synonymous_variant			ENSG00000140853	HGNC:29933	NM_032206	Approved	uc021tiu.1	NA	B5MEF1|C9JMD8|Q6P4A6|Q86VM7|Q8NF42|Q8TEE2|Q8TEJ1|Q969L7	ENST00000436936.1	37																																																																																				NLRC5-202	KNOWN	basic	protein_coding	NA	protein_coding		208.686069	KEEP		+	209.757848	0.411392	65	93	---	---	---	---	1	0.8517605	3	4	0	113	74	106	0	113	2	0	0	0	0	0	0	74	106	0	113	2	TP
NAE1	8883	broad.mit.edu	37	16	66844677	66844677	+	Splice_Site	SNP	T	T	A			GBM-TCGA-06-2559-Tumor-SM-16Y9G	GBM-TCGA-06-2559-Normal-SM-1QXN8	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-06-2559-Tumor-SM-16Y9G	GBM-TCGA-06-2559-Normal-SM-1QXN8	g.chr16:66844677T>A	ENST00000379463.2	-	15	1209		c.e15-2		NAE1_ENST00000359087.4_Splice_Site|NAE1_ENST00000290810.3_Splice_Site|NAE1_ENST00000394074.2_Splice_Site	NM_001018159.1	NP_001018169.1	Q13564	ULA1_HUMAN	NEDD8 activating enzyme E1 subunit 1	NA		NA			apoptosis|cell cycle|DNA replication|mitotic cell cycle DNA replication checkpoint|protein neddylation|signal transduction	cytoplasm|insoluble fraction|plasma membrane	catalytic activity|protein heterodimerization activity			breast(1)|endometrium(1)|haematopoietic_and_lymphoid_tissue(1)|large_intestine(4)|lung(8)|ovary(1)|upper_aerodigestive_tract(1)|urinary_tract(1)	18		Ovarian(137;0.0563)		OV - Ovarian serous cystadenocarcinoma(108;0.0914)|Epithelial(162;0.214)	Adenosine triphosphate(DB00171)	TCACGGTAACTAAAAAAGAAT	0.343	NA	NA												NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA									NA				0													91	89	90	NA		NA	NA	16		NA											NA				66844677		2200	4300	6500	SO:0001630	splice_region_variant			ENSG00000159593	HGNC:621	NM_003905	Approved	uc002eqf.3	NA	B2R700	ENST00000379463.2	37	CCDS42171.1	.	.	.	.	.	.	.	.	.	.	T	16.14	3.040061	0.55003	.	.	ENSG00000159593	ENST00000359087;ENST00000290810;ENST00000379463;ENST00000394074	.	.	.	5.58	5.58	0.84498	.	.	.	.	.	.	.	.	.	.	.	0.80722	D	1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	15.7654	0.78123	0.0:0.0:0.0:1.0	.	.	.	.	.	-1	.	.	.	-	.	.	NAE1	65402178	1.000000	0.71417	0.965000	0.40720	0.581000	0.36288	6.861000	0.75478	2.127000	0.65507	0.533000	0.62120	.	NAE1-005	NOVEL	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000421041.2	-56.531299	KEEP	Intron	-	6.347356	0.020492	5	239	---	---	---	---	1	0.8861067	210	0	0	207	5	269	0	207	2	0	0	0	0	0	0	5	269	0	207	2	TP
TP53	7157	broad.mit.edu	37	17	7578280	7578280	+	Missense_Mutation	SNP	G	G	A			GBM-TCGA-06-2559-Tumor-SM-16Y9G	GBM-TCGA-06-2559-Normal-SM-1QXN8	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Valid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-06-2559-Tumor-SM-16Y9G	GBM-TCGA-06-2559-Normal-SM-1QXN8	g.chr17:7578280G>A	ENST00000420246.2	-	6	701	c.569C>T	c.(568-570)cCt>cTt	p.P190L	TP53_ENST00000574684.1_Intron|TP53_ENST00000269305.4_Missense_Mutation_p.P190L|TP53_ENST00000413465.2_Missense_Mutation_p.P190L|TP53_ENST00000359597.4_Missense_Mutation_p.P190L|TP53_ENST00000445888.2_Missense_Mutation_p.P190L|TP53_ENST00000455263.2_Missense_Mutation_p.P190L	NM_001126114.2|NM_001276696.1	NP_001119586.1|NP_001263625.1	P04637	P53_HUMAN	tumor protein p53	190	Interaction with AXIN1 (By similarity).|Interaction with HIPK1 (By similarity).|Required for interaction with FBXO42.	NA	P -> A (in sporadic cancers; somatic mutation).|P -> H (in a sporadic cancer; somatic mutation).|P -> L (in sporadic cancers; somatic mutation).|P -> R (in sporadic cancers; somatic mutation).|P -> S (in sporadic cancers; somatic mutation).|P -> T (in sporadic cancers; somatic mutation).		activation of caspase activity by cytochrome c|base-excision repair|blood coagulation|cell cycle arrest|cell differentiation|cell proliferation|cellular protein localization|cellular response to drug|cellular response to glucose starvation|cellular response to hypoxia|cellular response to ionizing radiation|cellular response to UV|determination of adult lifespan|DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest|DNA damage response, signal transduction by p53 class mediator resulting in induction of apoptosis|DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator|ER overload response|interspecies interaction between organisms|negative regulation of apoptosis|negative regulation of cell growth|negative regulation of cell proliferation|negative regulation of helicase activity|negative regulation of transcription from RNA polymerase II promoter|nucleotide-excision repair|oxidative stress-induced premature senescence|positive regulation of histone deacetylation|positive regulation of neuron apoptosis|positive regulation of peptidyl-tyrosine phosphorylation|positive regulation of reactive oxygen species metabolic process|positive regulation of thymocyte apoptosis|positive regulation of transcription from RNA polymerase II promoter|protein localization|protein tetramerization|Ras protein signal transduction|regulation of mitochondrial membrane permeability|replicative senescence|response to antibiotic|response to gamma radiation|response to X-ray	cytoplasm|cytosol|endoplasmic reticulum|insoluble fraction|mitochondrion|nuclear chromatin|nuclear matrix|nucleolus|nucleus|PML body|protein complex|replication fork	ATP binding|chaperone binding|chromatin binding|copper ion binding|damaged DNA binding|DNA strand annealing activity|histone acetyltransferase binding|p53 binding|protease binding|protein binding|protein heterodimerization activity|protein kinase binding|protein N-terminus binding|protein phosphatase 2A binding|RNA polymerase II transcription factor binding|sequence-specific DNA binding transcription factor activity|transcription regulatory region DNA binding|transcription repressor activity|ubiquitin protein ligase binding|zinc ion binding	p.P190L(21)|p.0?(8)|p.?(7)|p.P190fs*57(6)|p.P190del(6)|p.A189_V197delAPPQHLIRV(4)|p.P190R(2)|p.G187fs*16(2)|p.P190F(2)|p.D186_P191delDGLAPP(1)|p.P190H(1)|p.P58fs*>33(1)|p.P191fs*18(1)|p.A189_Q192>E(1)|p.L188_P191del(1)|p.A189_P190>X(1)|p.P97fs*57(1)|p.A189fs*53(1)		NS(16)|adrenal_gland(37)|autonomic_ganglia(16)|biliary_tract(273)|bone(108)|breast(2530)|central_nervous_system(1264)|cervix(68)|endometrium(223)|eye(24)|fallopian_tube(1)|gastrointestinal_tract_(site_indeterminate)(1)|genital_tract(16)|haematopoietic_and_lymphoid_tissue(1301)|kidney(96)|large_intestine(5124)|liver(897)|lung(2388)|meninges(5)|oesophagus(1473)|ovary(1659)|pancreas(452)|penis(10)|peritoneum(33)|pituitary(4)|placenta(1)|pleura(3)|prostate(235)|salivary_gland(43)|skin(791)|small_intestine(14)|soft_tissue(220)|stomach(1158)|testis(11)|thymus(21)|thyroid(54)|upper_aerodigestive_tract(2271)|urinary_tract(1259)|vagina(6)|vulva(79)	24185		all_cancers(10;1.01e-06)|Myeloproliferative disorder(207;0.0122)|Prostate(122;0.081)		GBM - Glioblastoma multiforme(2;1.59e-06)|READ - Rectum adenocarcinoma(115;0.174)		ATGCTGAGGAGGGGCCAGACC	0.552	NA	111	"""Mis, N, F"""		"""breast, colorectal, lung, sarcoma, adrenocortical, glioma, multiple other tumour types"""	"""breast, sarcoma, adrenocortical carcinoma, glioma, multiple other tumour types"""		Other conserved DNA damage response genes	Osteosarcoma, Familial Clustering of;Li-Fraumeni syndrome;Hereditary Breast-Ovarian Cancer, non-BRCA1/2;Hereditary Adrenocortical Cancer;Endometrial Cancer, Familial Clustering of	HNSCC(1;<9.43e-08)|TCGA GBM(1;<1E-08)|TSP Lung(2;<1E-08)|TCGA Ovarian(1;<1.89e-07)|Multiple Myeloma(5;0.019)				NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA		Pancreas(47;798 1329 9957 10801)	yes	Rec	yes	Li-Fraumeni syndrome	17	17p13	7157	tumor protein p53		"""L, E, M, O"""	67	Substitution - Missense(27)|Deletion - In frame(12)|Deletion - Frameshift(11)|Whole gene deletion(8)|Unknown(6)|Complex - deletion inframe(2)|Insertion - Frameshift(1)	large_intestine(11)|upper_aerodigestive_tract(9)|skin(8)|haematopoietic_and_lymphoid_tissue(6)|breast(6)|biliary_tract(5)|bone(5)|central_nervous_system(4)|oesophagus(4)|stomach(2)|liver(2)|ovary(2)|kidney(1)|salivary_gland(1)|prostate(1)											89	80	83	NA		NA	NA	17		NA											NA				7578280		2203	4300	6503	SO:0001583	missense	Familial Cancer Database	Familial Osteogenic Sarcoma;LFS, SBLA syndrome (Sarcoma Breast Leukemia Adrenal cancer), incl.: Cancer with In Vitro Radioresistence, Familial, Li-Fraumeni-like s.;BRCAX;Familial Adrenocortical Carcinoma;	ENSG00000141510	HGNC:11998	NM_000546	Approved	uc002gij.3	NA	Q15086|Q15087|Q15088|Q16535|Q16807|Q16808|Q16809|Q16810|Q16811|Q16848|Q2XN98|Q3LRW1|Q3LRW2|Q3LRW3|Q3LRW4|Q3LRW5|Q86UG1|Q8J016|Q99659|Q9BTM4|Q9HAQ8|Q9NP68|Q9NPJ2|Q9NZD0|Q9UBI2|Q9UQ61	ENST00000420246.2	37	CCDS45606.1	.	.	.	.	.	.	.	.	.	.	G	14.21	2.468425	0.43839	.	.	ENSG00000141510	ENST00000413465;ENST00000359597;ENST00000269305;ENST00000455263;ENST00000420246;ENST00000445888;ENST00000396473;ENST00000545858;ENST00000509690;ENST00000514944;ENST00000414315	D;D;D;D;D;D;D;D	0.99755	-6.64;-6.64;-6.64;-6.64;-6.64;-6.64;-6.64;-6.64	5.41	4.44	0.53790	p53, DNA-binding domain (1);p53-like transcription factor, DNA-binding (1);p53/RUNT-type transcription factor, DNA-binding domain (1);	0.110931	0.64402	D	0.000010	D	0.99622	0.9862	M	0.68593	2.085	0.80722	D	1	D;P;D;P;P;P;D	0.89917	0.987;0.484;0.972;0.765;0.676;0.921;1.0	D;B;P;P;P;P;D	0.91635	0.916;0.306;0.708;0.605;0.533;0.774;0.999	D	0.97802	1.0245	10	0.87932	D	0	-9.8058	12.4639	0.55747	0.0821:0.0:0.9179:0.0	.	151;190;190;97;190;190;190	B4E095;P04637-2;P04637-3;E9PFT5;P04637;Q1MSW8;E7EQX7	.;.;.;.;P53_HUMAN;.;.	L	190;190;190;190;190;190;179;97;58;97;58	ENSP00000410739:P190L;ENSP00000352610:P190L;ENSP00000269305:P190L;ENSP00000398846:P190L;ENSP00000391127:P190L;ENSP00000391478:P190L;ENSP00000425104:P58L;ENSP00000423862:P97L	ENSP00000269305:P190L	P	-	2	0	TP53	7519005	1.000000	0.71417	0.956000	0.39512	0.034000	0.12701	7.957000	0.87870	1.422000	0.47177	0.655000	0.94253	CCT	TP53-005	KNOWN	NMD_exception|basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000367401.1	241.728258	KEEP		-	241.766355	0.482759	70	75	---	---	---	---	1	1	80	90	0	76	84	95	0	76	2	1	1	241	239	0	493	84	95	0	76	2	TP
TP53	7157	broad.mit.edu	37	17	7578466	7578466	+	Missense_Mutation	SNP	G	G	T			GBM-TCGA-06-2559-Tumor-SM-16Y9G	GBM-TCGA-06-2559-Normal-SM-1QXN8	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Valid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-06-2559-Tumor-SM-16Y9G	GBM-TCGA-06-2559-Normal-SM-1QXN8	g.chr17:7578466G>T	ENST00000420246.2	-	5	596	c.464C>A	c.(463-465)aCc>aAc	p.T155N	TP53_ENST00000574684.1_5'Flank|TP53_ENST00000269305.4_Missense_Mutation_p.T155N|TP53_ENST00000413465.2_Missense_Mutation_p.T155N|TP53_ENST00000359597.4_Missense_Mutation_p.T155N|TP53_ENST00000445888.2_Missense_Mutation_p.T155N|TP53_ENST00000455263.2_Missense_Mutation_p.T155N	NM_001126114.2|NM_001276696.1	NP_001119586.1|NP_001263625.1	P04637	P53_HUMAN	tumor protein p53	155	Interaction with AXIN1 (By similarity).|Interaction with HIPK1 (By similarity).|Required for interaction with FBXO42.	NA	T -> A (in sporadic cancers; somatic mutation).|T -> I (in sporadic cancers; somatic mutation).|T -> M (in a sporadic cancer; somatic mutation).|T -> N (in LFS; germline mutation and in sporadic cancers; somatic mutation).|T -> P (in sporadic cancers; somatic mutation).|T -> S (in sporadic cancers; somatic mutation).		activation of caspase activity by cytochrome c|base-excision repair|blood coagulation|cell cycle arrest|cell differentiation|cell proliferation|cellular protein localization|cellular response to drug|cellular response to glucose starvation|cellular response to hypoxia|cellular response to ionizing radiation|cellular response to UV|determination of adult lifespan|DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest|DNA damage response, signal transduction by p53 class mediator resulting in induction of apoptosis|DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator|ER overload response|interspecies interaction between organisms|negative regulation of apoptosis|negative regulation of cell growth|negative regulation of cell proliferation|negative regulation of helicase activity|negative regulation of transcription from RNA polymerase II promoter|nucleotide-excision repair|oxidative stress-induced premature senescence|positive regulation of histone deacetylation|positive regulation of neuron apoptosis|positive regulation of peptidyl-tyrosine phosphorylation|positive regulation of reactive oxygen species metabolic process|positive regulation of thymocyte apoptosis|positive regulation of transcription from RNA polymerase II promoter|protein localization|protein tetramerization|Ras protein signal transduction|regulation of mitochondrial membrane permeability|replicative senescence|response to antibiotic|response to gamma radiation|response to X-ray	cytoplasm|cytosol|endoplasmic reticulum|insoluble fraction|mitochondrion|nuclear chromatin|nuclear matrix|nucleolus|nucleus|PML body|protein complex|replication fork	ATP binding|chaperone binding|chromatin binding|copper ion binding|damaged DNA binding|DNA strand annealing activity|histone acetyltransferase binding|p53 binding|protease binding|protein binding|protein heterodimerization activity|protein kinase binding|protein N-terminus binding|protein phosphatase 2A binding|RNA polymerase II transcription factor binding|sequence-specific DNA binding transcription factor activity|transcription regulatory region DNA binding|transcription repressor activity|ubiquitin protein ligase binding|zinc ion binding	p.T155N(22)|p.T155I(14)|p.0?(8)|p.?(5)|p.P152fs*14(4)|p.G154fs*14(2)|p.T155fs*23(2)|p.P153fs*22(2)|p.P151_V173del23(1)|p.G154_R156delGTR(1)|p.T155fs*25(1)|p.R156_A161del(1)|p.D148_T155delDSTPPPGT(1)|p.D148fs*23(1)|p.S149fs*72(1)|p.T23N(1)|p.T62N(1)|p.T62I(1)|p.T23I(1)|p.T155_A161delTRVRAMA(1)|p.G154fs*22(1)|p.R156fs*25(1)|p.T155_R156delTR(1)|p.T155S(1)		NS(16)|adrenal_gland(37)|autonomic_ganglia(16)|biliary_tract(273)|bone(108)|breast(2530)|central_nervous_system(1264)|cervix(68)|endometrium(223)|eye(24)|fallopian_tube(1)|gastrointestinal_tract_(site_indeterminate)(1)|genital_tract(16)|haematopoietic_and_lymphoid_tissue(1301)|kidney(96)|large_intestine(5124)|liver(897)|lung(2388)|meninges(5)|oesophagus(1473)|ovary(1659)|pancreas(452)|penis(10)|peritoneum(33)|pituitary(4)|placenta(1)|pleura(3)|prostate(235)|salivary_gland(43)|skin(791)|small_intestine(14)|soft_tissue(220)|stomach(1158)|testis(11)|thymus(21)|thyroid(54)|upper_aerodigestive_tract(2271)|urinary_tract(1259)|vagina(6)|vulva(79)	24185		all_cancers(10;1.01e-06)|Myeloproliferative disorder(207;0.0122)|Prostate(122;0.081)		GBM - Glioblastoma multiforme(2;1.59e-06)|READ - Rectum adenocarcinoma(115;0.174)		GCGGACGCGGGTGCCGGGCGG	0.612	NA	111	"""Mis, N, F"""		"""breast, colorectal, lung, sarcoma, adrenocortical, glioma, multiple other tumour types"""	"""breast, sarcoma, adrenocortical carcinoma, glioma, multiple other tumour types"""		Other conserved DNA damage response genes	Osteosarcoma, Familial Clustering of;Li-Fraumeni syndrome;Hereditary Breast-Ovarian Cancer, non-BRCA1/2;Hereditary Adrenocortical Cancer;Endometrial Cancer, Familial Clustering of	HNSCC(1;<9.43e-08)|TCGA GBM(1;<1E-08)|TSP Lung(2;<1E-08)|TCGA Ovarian(1;<1.89e-07)|Multiple Myeloma(5;0.019)				NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA		Pancreas(47;798 1329 9957 10801)	yes	Rec	yes	Li-Fraumeni syndrome	17	17p13	7157	tumor protein p53		"""L, E, M, O"""	75	Substitution - Missense(41)|Deletion - Frameshift(14)|Whole gene deletion(8)|Deletion - In frame(6)|Unknown(5)|Insertion - Frameshift(1)	lung(14)|upper_aerodigestive_tract(11)|breast(8)|skin(6)|stomach(5)|oesophagus(5)|ovary(5)|central_nervous_system(4)|bone(4)|large_intestine(3)|liver(3)|haematopoietic_and_lymphoid_tissue(2)|urinary_tract(2)|pancreas(2)|soft_tissue(1)	GRCh37	CM942117	TP53	M							50	52	51	NA		NA	NA	17		NA											NA				7578466		2203	4300	6503	SO:0001583	missense	Familial Cancer Database	Familial Osteogenic Sarcoma;LFS, SBLA syndrome (Sarcoma Breast Leukemia Adrenal cancer), incl.: Cancer with In Vitro Radioresistence, Familial, Li-Fraumeni-like s.;BRCAX;Familial Adrenocortical Carcinoma;	ENSG00000141510	HGNC:11998	NM_000546	Approved	uc002gij.3	NA	Q15086|Q15087|Q15088|Q16535|Q16807|Q16808|Q16809|Q16810|Q16811|Q16848|Q2XN98|Q3LRW1|Q3LRW2|Q3LRW3|Q3LRW4|Q3LRW5|Q86UG1|Q8J016|Q99659|Q9BTM4|Q9HAQ8|Q9NP68|Q9NPJ2|Q9NZD0|Q9UBI2|Q9UQ61	ENST00000420246.2	37	CCDS45606.1	.	.	.	.	.	.	.	.	.	.	G	11.07	1.529735	0.27387	.	.	ENSG00000141510	ENST00000413465;ENST00000359597;ENST00000269305;ENST00000455263;ENST00000420246;ENST00000445888;ENST00000396473;ENST00000545858;ENST00000509690;ENST00000514944;ENST00000414315;ENST00000508793	D;D;D;D;D;D;D;D;D	0.99778	-6.73;-6.73;-6.73;-6.73;-6.73;-6.73;-6.73;-6.73;-6.73	5.47	-0.466	0.12153	p53, DNA-binding domain (1);p53-like transcription factor, DNA-binding (1);p53/RUNT-type transcription factor, DNA-binding domain (1);	0.718085	0.14119	N	0.340173	D	0.99654	0.9872	M	0.76328	2.33	0.09310	N	1	D;P;B;P;B;P;P	0.56746	0.977;0.579;0.032;0.85;0.326;0.786;0.949	P;P;B;P;P;P;P	0.61201	0.885;0.6;0.098;0.676;0.721;0.782;0.707	D	0.99285	1.0897	10	0.87932	D	0	-6.4954	20.1723	0.98160	0.0:0.5036:0.4964:0.0	.	116;155;155;62;155;155;155	B4E095;P04637-2;P04637-3;E9PFT5;P04637;Q1MSW8;E7EQX7	.;.;.;.;P53_HUMAN;.;.	N	155;155;155;155;155;155;144;62;23;62;23;155	ENSP00000410739:T155N;ENSP00000352610:T155N;ENSP00000269305:T155N;ENSP00000398846:T155N;ENSP00000391127:T155N;ENSP00000391478:T155N;ENSP00000425104:T23N;ENSP00000423862:T62N;ENSP00000424104:T155N	ENSP00000269305:T155N	T	-	2	0	TP53	7519191	0.057000	0.20700	0.000000	0.03702	0.011000	0.07611	0.842000	0.27627	-0.440000	0.07211	-2.650000	0.00149	ACC	TP53-005	KNOWN	NMD_exception|basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000367401.1	283.628419	KEEP		-	283.814362	0.466667	91	104	---	---	---	---	1	1	78	83	0	77	109	145	0	77	2	1	1	107	211	1	339	109	145	0	77	6	TP
ODF4	146852	broad.mit.edu	37	17	8243550	8243550	+	Missense_Mutation	SNP	C	C	T	rs147153349		GBM-TCGA-06-2559-Tumor-SM-16Y9G	GBM-TCGA-06-2559-Normal-SM-1QXN8	NA	NA	NA	NA	NA	NA	NA	Untested,Invalid,Invalid,Valid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-06-2559-Tumor-SM-16Y9G	GBM-TCGA-06-2559-Normal-SM-1QXN8	g.chr17:8243550C>T	ENST00000328248.2	+	1	369	c.181C>T	c.(181-183)Cgc>Tgc	p.R61C	RP11-849F2.4_ENST00000585275.1_lincRNA|ODF4_ENST00000584943.1_Intron	NM_153007.4	NP_694552.2	Q2M2E3	ODFP4_HUMAN	outer dense fiber of sperm tails 4	61		NA			cell differentiation|multicellular organismal development|spermatogenesis	integral to membrane		p.R61S(1)		endometrium(2)|large_intestine(3)|lung(1)|ovary(1)|stomach(1)	8						CTTGGGCCAGCGCCAGAACTC	0.592	NA	NA												NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA									NA				1	Substitution - Missense(1)	lung(1)						C	CYS/ARG	1,4405	2.1+/-5.4	0,1,2202	83	76	79	NA	181	1.3	0	17	dbSNP_134	79	0,8600		0,0,4300	no	missense	ODF4	NM_153007.4	180	0,1,6502	TT,TC,CC	NA	0.0,0.0227,0.0077	possibly-damaging	61/258	8243550	1,13005	2203	4300	6503	SO:0001583	missense			ENSG00000184650	HGNC:19056		Approved	uc002gle.1	NA	Q8J021	ENST00000328248.2	37	CCDS11140.1	.	.	.	.	.	.	.	.	.	.	C	15.57	2.873941	0.51695	2.27E-4	0.0	ENSG00000184650	ENST00000328248	T	0.29397	1.57	4.34	1.26	0.21427	.	0.790513	0.11133	N	0.596122	T	0.19327	0.0464	L	0.48642	1.525	0.09310	N	1	P	0.41546	0.754	B	0.25759	0.063	T	0.16778	-1.0391	10	0.87932	D	0	-3.2119	6.0197	0.19623	0.0:0.6743:0.0:0.3257	.	61	Q2M2E3	ODFP4_HUMAN	C	61	ENSP00000331086:R61C	ENSP00000331086:R61C	R	+	1	0	ODF4	8184275	0.000000	0.05858	0.000000	0.03702	0.001000	0.01503	0.276000	0.18716	0.581000	0.29539	0.655000	0.94253	CGC	ODF4-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000226996.1	133.244425	KEEP		+	133.622083	0.43299	42	55	---	---	---	---	0	0	0	0	0	51	48	72	0	51	2	1	1	123	167	2	290	48	72	0	51	8	TP
DHRS7B	25979	broad.mit.edu	37	17	21094259	21094259	+	Splice_Site	SNP	A	A	T			GBM-TCGA-06-2559-Tumor-SM-16Y9G	GBM-TCGA-06-2559-Normal-SM-1QXN8	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-06-2559-Tumor-SM-16Y9G	GBM-TCGA-06-2559-Normal-SM-1QXN8	g.chr17:21094259A>T	ENST00000395511.3	+	7	1092		c.e7-1		DHRS7B_ENST00000579303.1_Splice_Site|DHRS7B_ENST00000581463.1_Intron	NM_015510.4	NP_056325.2	Q6IAN0	DRS7B_HUMAN	dehydrogenase/reductase (SDR family) member 7B	NA		NA				integral to membrane|peroxisomal membrane	binding|oxidoreductase activity	p.?(1)		endometrium(2)|haematopoietic_and_lymphoid_tissue(1)|lung(2)|pancreas(2)	7						TATTTATTTTAGTTATGGACA	0.517	NA	NA												NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA									NA				1	Unknown(1)	lung(1)											82	81	82	NA		NA	NA	17		NA											NA				21094259		2203	4300	6503	SO:0001630	splice_region_variant				HGNC:24547	NM_015510	Approved	uc002gyo.3	NA	B5MEF4|Q6UX59|Q9BTF9|Q9UFM6|Q9Y3A1	ENST00000395511.3	37	CCDS11215.1	.	.	.	.	.	.	.	.	.	.	A	14.63	2.592061	0.46214	.	.	ENSG00000109016	ENST00000395511;ENST00000346603	.	.	.	5.8	5.8	0.92144	.	.	.	.	.	.	.	.	.	.	.	0.80722	D	1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	16.1502	0.81611	1.0:0.0:0.0:0.0	.	.	.	.	.	-1	.	.	.	+	.	.	DHRS7B	21034851	1.000000	0.71417	0.745000	0.31077	0.287000	0.27160	8.794000	0.91867	2.224000	0.72417	0.533000	0.62120	.	DHRS7B-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000444066.3	-6.9405	KEEP	Intron	+	8.006256	0.055556	4	68	---	---	---	---	1	0.9809365	72	1	0	175	8	79	0	175	2	0	0	0	0	0	0	8	79	0	175	2	TP
SEPT4	5414	broad.mit.edu	37	17	56599396	56599396	+	Silent	SNP	C	C	A			GBM-TCGA-06-2559-Tumor-SM-16Y9G	GBM-TCGA-06-2559-Normal-SM-1QXN8	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-06-2559-Tumor-SM-16Y9G	GBM-TCGA-06-2559-Normal-SM-1QXN8	g.chr17:56599396C>A	ENST00000426861.1	-	6	758	c.672G>T	c.(670-672)ctG>ctT	p.L224L	SEPT4_ENST00000579371.1_Silent_p.L144L|SEPT4_ENST00000580844.1_Silent_p.L144L|SEPT4_ENST00000580809.1_Silent_p.L125L|RP11-112H10.4_ENST00000580589.1_RNA|SEPT4_ENST00000412945.3_Silent_p.L235L|SEPT4_ENST00000583114.1_Silent_p.L96L|SEPT4_ENST00000317268.3_Silent_p.L243L|SEPT4_ENST00000317256.6_Silent_p.L224L|SEPT4_ENST00000457347.2_Silent_p.L258L|SEPT4_ENST00000393086.1_Silent_p.L224L	NM_080415.2	NP_536340.1	O43236	SEPT4_HUMAN	septin 4	243		NA			apoptosis|cell cycle|cytokinesis|regulation of apoptosis	cytoskeleton|mitochondrion|nucleus	GTP binding|GTPase activity|protein binding|structural molecule activity			NS(1)|endometrium(2)|kidney(2)|large_intestine(5)|lung(4)|ovary(1)|prostate(1)|stomach(1)|upper_aerodigestive_tract(1)	18	Medulloblastoma(34;0.127)|all_neural(34;0.237)					TCTTTCGGTTCAGGCCACTCT	0.542	NA	NA												NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA									NA				0													179	148	159	NA		NA	NA	17		NA											NA				56599396		2203	4300	6503	SO:0001819	synonymous_variant			ENSG00000108387	HGNC:9165	NM_080417	Approved	uc002iwm.2	NA	B2RD42|B3KSX9|B4DXC6|B4DXV5|Q6IAP3|Q9H315|Q9UM58	ENST00000426861.1	37	CCDS45743.1																																																																																			SEPT4-004	KNOWN	NMD_exception|basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000445415.1	39.588135	KEEP		-	58.616827	0.149068	24	137	---	---	---	---	1	1	9	156	0	144	32	159	0	144	2	0	0	0	0	0	0	32	159	0	144	2	TP
SMG8	55181	broad.mit.edu	37	17	57290240	57290240	+	Missense_Mutation	SNP	A	A	G			GBM-TCGA-06-2559-Tumor-SM-16Y9G	GBM-TCGA-06-2559-Normal-SM-1QXN8	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-06-2559-Tumor-SM-16Y9G	GBM-TCGA-06-2559-Normal-SM-1QXN8	g.chr17:57290240A>G	ENST00000543872.2	+	4	2320	c.2056A>G	c.(2056-2058)Acc>Gcc	p.T686A	SMG8_ENST00000300917.5_Missense_Mutation_p.T686A|CTD-2510F5.6_ENST00000577660.1_Intron|SMG8_ENST00000580498.1_3'UTR			Q8ND04	SMG8_HUMAN	SMG8 nonsense mediated mRNA decay factor	686		NA			nuclear-transcribed mRNA catabolic process, nonsense-mediated decay|regulation of protein kinase activity		protein binding			NS(1)|breast(5)|cervix(1)|endometrium(3)|kidney(1)|large_intestine(8)|lung(9)|ovary(3)|prostate(1)|skin(1)	33						AGAACCTCAAACCCAAGGAGA	0.453	NA	NA												NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA									NA				0													129	137	134	NA		NA	NA	17		NA											NA				57290240		2203	4300	6503	SO:0001583	missense				HGNC:25551	NM_018149	Approved	uc002ixi.3	NA	Q8N5U5|Q8TDN0|Q9H5P5|Q9NVQ1	ENST00000543872.2	37	CCDS11615.1	.	.	.	.	.	.	.	.	.	.	A	14.37	2.516244	0.44763	.	.	ENSG00000167447	ENST00000300917;ENST00000543872	T;T	0.42900	0.96;0.96	5.82	5.82	0.92795	.	0.091740	0.85682	D	0.000000	T	0.58878	0.2153	L	0.53249	1.67	0.58432	D	0.999999	D	0.63046	0.992	D	0.74348	0.983	T	0.54748	-0.8247	10	0.32370	T	0.25	-14.3639	15.365	0.74513	1.0:0.0:0.0:0.0	.	686	Q8ND04	SMG8_HUMAN	A	686	ENSP00000300917:T686A;ENSP00000438748:T686A	ENSP00000300917:T686A	T	+	1	0	SMG8	54645022	1.000000	0.71417	1.000000	0.80357	0.997000	0.91878	6.916000	0.75776	2.222000	0.72286	0.533000	0.62120	ACC	SMG8-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000445960.2	222.236105	KEEP		+	227.377577	0.331707	68	137	---	---	---	---	1	0.9999988	22	26	0	313	73	155	0	313	2	0	0	0	0	0	0	73	155	0	313	2	TP
MAPRE2	10982	broad.mit.edu	37	18	32650157	32650157	+	Splice_Site	SNP	A	A	T			GBM-TCGA-06-2559-Tumor-SM-16Y9G	GBM-TCGA-06-2559-Normal-SM-1QXN8	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-06-2559-Tumor-SM-16Y9G	GBM-TCGA-06-2559-Normal-SM-1QXN8	g.chr18:32650157A>T	ENST00000436190.2	+	3	360		c.e3-1		MAPRE2_ENST00000589699.1_Splice_Site|MAPRE2_ENST00000413393.1_Splice_Site|MAPRE2_ENST00000538170.2_Intron|MAPRE2_ENST00000300249.5_Splice_Site|MAPRE2_ENST00000588910.1_Splice_Site	NM_001143827.2	NP_001137299.1	Q15555	MARE2_HUMAN	microtubule-associated protein, RP/EB family, member 2	NA		NA			cell division|cell proliferation|mitosis|signal transduction	cytoplasm|microtubule	microtubule binding			central_nervous_system(1)|endometrium(1)|large_intestine(3)|lung(3)|ovary(1)	9						TTTTTTTTCTAGTTGGGGAAT	0.383	NA	NA												NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA									NA				0													133	124	127	NA		NA	NA	18		NA											NA				32650157		2203	4300	6503	SO:0001630	splice_region_variant			ENSG00000166974	HGNC:6891	NM_014268	Approved	uc010xcc.3	NA	B2RE21|Q9UQ33	ENST00000436190.2	37	CCDS45850.1	.	.	.	.	.	.	.	.	.	.	A	23.5	4.420538	0.83559	.	.	ENSG00000166974	ENST00000436190;ENST00000300249	.	.	.	5.48	5.48	0.80851	.	.	.	.	.	.	.	.	.	.	.	0.80722	D	1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	15.5509	0.76152	1.0:0.0:0.0:0.0	.	.	.	.	.	-1	.	.	.	+	.	.	MAPRE2	30904155	1.000000	0.71417	0.981000	0.43875	0.887000	0.51463	7.413000	0.80104	2.060000	0.61445	0.533000	0.62120	.	MAPRE2-002	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000442239.3	-11.40683	KEEP	Intron	+	14.412321	0.062016	8	121	---	---	---	---	1	0.9145808	143	2	1	188	10	153	1	188	5	0	0	0	0	0	0	10	153	1	188	2	TP
PTPRS	5802	broad.mit.edu	37	19	5221107	5221107	+	Missense_Mutation	SNP	T	T	C			GBM-TCGA-06-2559-Tumor-SM-16Y9G	GBM-TCGA-06-2559-Normal-SM-1QXN8	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-06-2559-Tumor-SM-16Y9G	GBM-TCGA-06-2559-Normal-SM-1QXN8	g.chr19:5221107T>C	ENST00000372412.4	-	20	3595	c.3362A>G	c.(3361-3363)aAc>aGc	p.N1121S	PTPRS_ENST00000587303.1_Missense_Mutation_p.N1120S|PTPRS_ENST00000357368.4_Missense_Mutation_p.N1120S|PTPRS_ENST00000353284.2_Missense_Mutation_p.N689S|PTPRS_ENST00000592099.1_Missense_Mutation_p.N689S|PTPRS_ENST00000262963.6_Missense_Mutation_p.N1116S|PTPRS_ENST00000588552.1_5'UTR|PTPRS_ENST00000348075.2_Missense_Mutation_p.N1098S|PTPRS_ENST00000588012.1_Missense_Mutation_p.N1098S			Q13332	PTPRS_HUMAN	protein tyrosine phosphatase, receptor type, S	1120		NA			cell adhesion	integral to plasma membrane	protein binding|transmembrane receptor protein tyrosine phosphatase activity			NS(1)|biliary_tract(1)|central_nervous_system(1)|endometrium(12)|haematopoietic_and_lymphoid_tissue(1)|kidney(3)|large_intestine(12)|liver(1)|lung(9)|ovary(4)|prostate(1)|skin(12)|stomach(2)|upper_aerodigestive_tract(1)	61				UCEC - Uterine corpus endometrioid carcinoma (162;6.64e-05)|BRCA - Breast invasive adenocarcinoma(158;0.0321)|Lung(535;0.182)		GTTGAGCAGGTTGAAGGCAGT	0.622	NA	NA												NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA									NA				0													127	107	114	NA		NA	NA	19		NA											NA				5221107		2203	4300	6503	SO:0001583	missense				HGNC:9681		Approved	uc002mbv.3	NA	O75255|O75870|Q15718|Q16341|Q2M3R7	ENST00000372412.4	37		.	.	.	.	.	.	.	.	.	.	T	13.26	2.184265	0.38609	.	.	ENSG00000105426	ENST00000536396;ENST00000372412;ENST00000357368;ENST00000355005;ENST00000356037;ENST00000262963;ENST00000348075;ENST00000355322;ENST00000544524;ENST00000353284	T;T;T;T;T	0.52526	0.77;0.72;0.72;0.72;0.66	3.78	2.77	0.32553	.	0.074763	0.52532	U	0.000067	T	0.36468	0.0968	L	0.47716	1.5	0.36473	D	0.867406	B;B;B;B;B;P	0.45348	0.041;0.021;0.046;0.128;0.049;0.856	B;B;B;B;B;B	0.37731	0.036;0.022;0.053;0.039;0.016;0.257	T	0.44221	-0.9342	10	0.62326	D	0.03	.	8.8812	0.35376	0.0:0.0898:0.0:0.9102	.	702;689;693;1098;1120;715	F8W800;Q13332-7;F5H2T4;Q13332-6;Q13332;Q59FX6	.;.;.;.;PTPRS_HUMAN;.	S	715;1121;1120;1120;1111;1116;1098;702;693;689	ENSP00000361489:N1121S;ENSP00000349932:N1120S;ENSP00000262963:N1116S;ENSP00000269907:N1098S;ENSP00000327313:N689S	ENSP00000262963:N1116S	N	-	2	0	PTPRS	5172107	0.859000	0.29813	1.000000	0.80357	0.950000	0.60333	1.002000	0.29796	0.541000	0.28827	0.459000	0.35465	AAC	PTPRS-205	KNOWN	basic	protein_coding	NA	protein_coding		111.318182	KEEP		-	111.517018	0.442857	31	39	---	---	---	---	1	1	90	98	1	146	42	50	1	146	7	0	0	0	0	0	0	42	50	1	146	2	TP
ZNF93	81931	broad.mit.edu	37	19	20043989	20043989	+	Splice_Site	SNP	A	A	T			GBM-TCGA-06-2559-Tumor-SM-16Y9G	GBM-TCGA-06-2559-Normal-SM-1QXN8	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-06-2559-Tumor-SM-16Y9G	GBM-TCGA-06-2559-Normal-SM-1QXN8	g.chr19:20043989A>T	ENST00000343769.5	+	4	254		c.e4-1		AC007204.2_ENST00000592245.1_lincRNA	NM_031218.3	NP_112495.2	P35789	ZNF93_HUMAN	zinc finger protein 93	NA		NA				nucleus	DNA binding|sequence-specific DNA binding transcription factor activity|zinc ion binding			endometrium(6)|kidney(2)|large_intestine(4)|lung(8)|pancreas(1)|prostate(1)|skin(1)|stomach(1)	24						TGTTTCTTTCAGTTATATGTT	0.299	NA	NA												NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA									NA				0													35	37	36	NA		NA	NA	19		NA											NA				20043989		2197	4296	6493	SO:0001630	splice_region_variant				HGNC:13169	NM_031218	Approved	uc002non.3	NA	A6NMY2|B9EGT2|Q8N8Q4|Q9H9X5|Q9Y2N8	ENST00000343769.5	37	CCDS32973.1	.	.	.	.	.	.	.	.	.	.	.	11.38	1.622876	0.28889	.	.	ENSG00000184635	ENST00000343769;ENST00000427325;ENST00000430434	.	.	.	0.85	0.85	0.18980	.	.	.	.	.	.	.	.	.	.	.	0.80722	D	1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	3.739	0.08523	1.0:0.0:0.0:0.0	.	.	.	.	.	-1	.	.	.	+	.	.	ZNF93	19904989	0.000000	0.05858	0.432000	0.26747	0.428000	0.31595	-2.338000	0.01103	0.166000	0.19597	0.164000	0.16699	.	ZNF93-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000460808.2	-9.670543	KEEP	Intron	+	7.518647	0.05	4	76	---	---	---	---	1	0.2574683	18	0	0	76	4	86	0	76	2	0	0	0	0	0	0	4	86	0	76	2	TP
IFNAR2	3455	broad.mit.edu	37	21	34615976	34615976	+	Splice_Site	SNP	A	A	T			GBM-TCGA-06-2559-Tumor-SM-16Y9G	GBM-TCGA-06-2559-Normal-SM-1QXN8	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-06-2559-Tumor-SM-16Y9G	GBM-TCGA-06-2559-Normal-SM-1QXN8	g.chr21:34615976A>T	ENST00000404220.3	+	3	384		c.e3-1		IFNAR2_ENST00000420068.1_Splice_Site|IFNAR2_ENST00000382241.3_Splice_Site|IFNAR2_ENST00000382264.3_Splice_Site|IFNAR2_ENST00000413881.1_Intron|IFNAR2_ENST00000342136.4_Splice_Site|IFNAR2_ENST00000342101.3_Splice_Site			P48551	INAR2_HUMAN	interferon (alpha, beta and omega) receptor 2	NA		NA			JAK-STAT cascade|regulation of type I interferon-mediated signaling pathway|response to interferon-alpha|response to virus|type I interferon-mediated signaling pathway	extracellular region|extracellular space|integral to plasma membrane	protein kinase binding|type I interferon binding|type I interferon receptor activity			cervix(1)|endometrium(2)|kidney(1)|large_intestine(3)|lung(2)|prostate(1)|skin(1)	11					Interferon Alfa-2a, Recombinant(DB00034)|Interferon Alfa-2b, Recombinant(DB00105)|Interferon alfa-n1(DB00011)|Interferon alfa-n3(DB00018)|Interferon alfacon-1(DB00069)|Interferon beta-1b(DB00068)|Peginterferon alfa-2a(DB00008)|Peginterferon alfa-2b(DB00022)	TCTTCCTTCTAGTGTATATCA	0.358	NA	NA												NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA									NA				0													258	228	238	NA		NA	NA	21		NA											NA				34615976		2203	4300	6503	SO:0001630	splice_region_variant			ENSG00000159110	HGNC:5433		Approved	uc002yrd.3	NA	A8KAJ4|D3DSE8|D3DSE9|Q15467|Q6FHD7	ENST00000404220.3	37	CCDS13622.1	.	.	.	.	.	.	.	.	.	.	A	13.50	2.254295	0.39896	.	.	ENSG00000159110	ENST00000382264;ENST00000404220;ENST00000382241;ENST00000342136;ENST00000342101;ENST00000447980	.	.	.	4.04	4.04	0.47022	.	.	.	.	.	.	.	.	.	.	.	0.80722	D	1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	9.6552	0.39921	1.0:0.0:0.0:0.0	.	.	.	.	.	-1	.	.	.	+	.	.	IFNAR2	33537846	0.952000	0.32445	0.611000	0.29010	0.200000	0.23975	2.125000	0.42016	2.053000	0.61076	0.260000	0.18958	.	IFNAR2-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000139824.4	-49.526392	KEEP	Intron	+	6.365092	0.022727	5	215	---	---	---	---	1	0.4643226	77	2	0	275	5	283	0	275	2	0	0	0	0	0	0	5	283	0	275	2	TP
MAPK1	5594	broad.mit.edu	37	22	22142672	22142672	+	Missense_Mutation	SNP	G	G	A			GBM-TCGA-06-2559-Tumor-SM-16Y9G	GBM-TCGA-06-2559-Normal-SM-1QXN8	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-06-2559-Tumor-SM-16Y9G	GBM-TCGA-06-2559-Normal-SM-1QXN8	g.chr22:22142672G>A	ENST00000215832.6	-	6	918	c.730C>T	c.(730-732)Ctt>Ttt	p.L244F	MAPK1_ENST00000398822.3_Missense_Mutation_p.L244F|MAPK1_ENST00000544786.1_Intron	NM_002745.4	NP_002736.3	P28482	MK01_HUMAN	mitogen-activated protein kinase 1	244	Protein kinase.	NA			activation of MAPK activity|activation of MAPKK activity|axon guidance|cell cycle|epidermal growth factor receptor signaling pathway|ERK1 and ERK2 cascade|induction of apoptosis|innate immune response|insulin receptor signaling pathway|interspecies interaction between organisms|MyD88-dependent toll-like receptor signaling pathway|MyD88-independent toll-like receptor signaling pathway|nerve growth factor receptor signaling pathway|platelet activation|Ras protein signal transduction|regulation of sequence-specific DNA binding transcription factor activity|stress-activated MAPK cascade|synaptic transmission|Toll signaling pathway|toll-like receptor 1 signaling pathway|toll-like receptor 2 signaling pathway|toll-like receptor 3 signaling pathway|toll-like receptor 4 signaling pathway|transcription, DNA-dependent	cytosol|nucleoplasm	ATP binding|DNA binding|MAP kinase activity|phosphatase binding|RNA polymerase II carboxy-terminal domain kinase activity			NS(1)|breast(1)|central_nervous_system(1)|cervix(1)|endometrium(2)|haematopoietic_and_lymphoid_tissue(1)|kidney(1)|large_intestine(2)|lung(2)|ovary(1)|skin(2)|upper_aerodigestive_tract(1)|urinary_tract(1)	17	Colorectal(54;0.105)	all_lung(157;3.89e-05)		READ - Rectum adenocarcinoma(21;0.0689)	Arsenic trioxide(DB01169)	GGGGATCCAAGAATACCTATC	0.353	NA	NA												NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA									NA				0													74	81	79	NA		NA	NA	22		NA											NA				22142672		2203	4300	6503	SO:0001583	missense			ENSG00000100030	HGNC:6871		Approved	uc002zvn.3	NA		ENST00000215832.6	37	CCDS13795.1	.	.	.	.	.	.	.	.	.	.	G	23.5	4.429166	0.83776	.	.	ENSG00000100030	ENST00000215832;ENST00000415911;ENST00000398822	T;T	0.51817	0.69;0.69	6.03	5.02	0.67125	Serine/threonine-protein kinase-like domain (1);Serine/threonine-protein kinase, catalytic  domain (1);Protein kinase-like domain (1);Protein kinase, catalytic domain (1);	0.000000	0.85682	D	0.000000	T	0.64114	0.2569	M	0.69248	2.105	0.80722	D	1	D	0.67145	0.996	D	0.63283	0.913	T	0.66448	-0.5921	10	0.87932	D	0	-0.7567	14.7365	0.69419	0.0686:0.0:0.9314:0.0	.	244	P28482	MK01_HUMAN	F	244;232;244	ENSP00000215832:L244F;ENSP00000381803:L244F	ENSP00000215832:L244F	L	-	1	0	MAPK1	20472672	1.000000	0.71417	1.000000	0.80357	0.998000	0.95712	5.628000	0.67791	2.854000	0.98071	0.655000	0.94253	CTT	MAPK1-001	KNOWN	basic|exp_conf|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000075396.2	115.911547	KEEP		-	116.420652	0.416667	35	49	---	---	---	---	1	1	108	131	0	200	39	56	0	200	2	0	0	0	0	0	0	39	56	0	200	2	TP
EIF2S3	1968	broad.mit.edu	37	X	24084113	24084113	+	Splice_Site	SNP	A	A	T			GBM-TCGA-06-2559-Tumor-SM-16Y9G	GBM-TCGA-06-2559-Normal-SM-1QXN8	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-06-2559-Tumor-SM-16Y9G	GBM-TCGA-06-2559-Normal-SM-1QXN8	g.chrX:24084113A>T	ENST00000253039.4	+	8	1025		c.e8-1			NM_001415.3	NP_001406.1	P41091	IF2G_HUMAN	eukaryotic translation initiation factor 2, subunit 3 gamma, 52kDa	NA		NA				cytosol	GTP binding|GTPase activity|protein binding|translation initiation factor activity			breast(1)|cervix(1)|endometrium(4)|large_intestine(1)|lung(4)|ovary(1)	12						GTTTTATTTTAGTTATTAGAT	0.303	NA	NA												NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA									NA				0													111	108	109	NA		NA	NA	X		NA											NA				24084113		2203	4299	6502	SO:0001630	splice_region_variant			ENSG00000130741	HGNC:3267	NM_001415	Approved	uc004dbc.3	NA	B5BTZ4	ENST00000253039.4	37	CCDS14210.1	.	.	.	.	.	.	.	.	.	.	N	21.4	4.143064	0.77888	.	.	ENSG00000130741	ENST00000253039	.	.	.	5.49	5.49	0.81192	.	.	.	.	.	.	.	.	.	.	.	0.80722	D	1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	14.804	0.69938	1.0:0.0:0.0:0.0	.	.	.	.	.	-1	.	.	.	+	.	.	EIF2S3	23994034	1.000000	0.71417	1.000000	0.80357	0.916000	0.54674	8.840000	0.92125	1.946000	0.56461	0.438000	0.28831	.	EIF2S3-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000056079.1	-9.702725	KEEP	Intron	+	8.739501	0.05618	5	84	---	---	---	---	1	0.9653878	105	0	0	144	6	101	0	144	2	0	0	0	0	0	0	6	101	0	144	2	TP
BCOR	54880	broad.mit.edu	37	X	39923055	39923055	+	Nonsense_Mutation	SNP	C	C	T			GBM-TCGA-06-2559-Tumor-SM-16Y9G	GBM-TCGA-06-2559-Normal-SM-1QXN8	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-06-2559-Tumor-SM-16Y9G	GBM-TCGA-06-2559-Normal-SM-1QXN8	g.chrX:39923055C>T	ENST00000342274.4	-	8	3913	c.3551G>A	c.(3550-3552)tGg>tAg	p.W1184*	BCOR_ENST00000397354.3_Nonsense_Mutation_p.W1184*|BCOR_ENST00000378455.4_Nonsense_Mutation_p.W1166*|BCOR_ENST00000378444.4_Nonsense_Mutation_p.W1218*|BCOR_ENST00000378463.1_Nonsense_Mutation_p.W61*	NM_001123383.1	NP_001116855.1	Q6W2J9	BCOR_HUMAN	BCL6 corepressor	1218		NA			heart development|histone H2A monoubiquitination|negative regulation of bone mineralization|negative regulation of histone H3-K36 methylation|negative regulation of histone H3-K4 methylation|negative regulation of tooth mineralization|negative regulation of transcription from RNA polymerase II promoter|odontogenesis|palate development|specification of axis polarity|transcription, DNA-dependent	nucleus	heat shock protein binding|histone deacetylase binding|transcription corepressor activity|transcription factor binding|transcription regulatory region DNA binding			breast(4)|central_nervous_system(11)|cervix(1)|endometrium(24)|eye(6)|haematopoietic_and_lymphoid_tissue(33)|kidney(2)|large_intestine(11)|lung(22)|ovary(2)|pancreas(1)|prostate(2)|skin(2)|upper_aerodigestive_tract(3)|urinary_tract(2)	126						CTGCTGCTCCCATCGTTCTCT	0.542	NA	NA	"""F, N, S, T"""	RARA	"""retinoblastoma, AML, APL(translocation)"""		oculo-facio-cardio-dental genetic							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA				Rec	yes		X	Xp11.4	54880	BCL6 corepressor	yes		0													87	78	81	NA		NA	NA	X		NA											NA				39923055		2202	4300	6502	SO:0001587	stop_gained			ENSG00000183337	HGNC:20893	NM_017745	Approved	uc004den.4	NA	D3DWB3|D3DWB4|Q29RF6|Q6P4B6|Q7Z2K7|Q8TEB4|Q96DB3|Q9H232|Q9H233|Q9HCJ7|Q9NXF2	ENST00000342274.4	37	CCDS14250.1	.	.	.	.	.	.	.	.	.	.	C	44	11.009604	0.99503	.	.	ENSG00000183337	ENST00000413905;ENST00000378463;ENST00000378455;ENST00000397354;ENST00000378444;ENST00000342274;ENST00000406200	.	.	.	5.52	5.52	0.82312	.	.	.	.	.	.	.	.	.	.	.	0.80722	A	1	.	.	.	.	.	.	.	.	.	.	0.02654	T	1	-12.4878	16.6977	0.85340	0.0:1.0:0.0:0.0	.	.	.	.	X	88;61;1166;1184;1218;1184;1184	.	ENSP00000345923:W1184X	W	-	2	0	BCOR	39807999	1.000000	0.71417	1.000000	0.80357	0.984000	0.73092	6.691000	0.74573	2.317000	0.78254	0.529000	0.55759	TGG	BCOR-201	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000060670.1	168.661706	KEEP		-	174.970752	0.833333	50	10	---	---	---	---	1	1	15	2	0	107	63	11	0	107	2	0	0	0	0	0	0	63	11	0	107	2	TP
